__________________________________________________________________________________________________________
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
_________________
FORM
_________________
(Mark One)
For the quarterly period ended
OR
For the transition period from ______ to ______
Commission File Number:
_________________
(Exact name of registrant as specified in its charter)
_________________
|
|
|
|
| |
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) |
|
|
(Address of principal executive offices) | (Zip Code) |
(
(Registrant’s telephone number, including area code)
Not Applicable
(Former name, former address and former fiscal year, if changed since last report)
__________________________________
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class | Trading symbol(s) | Name of each exchange on which registered |
__________________________________
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No ¨
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes No ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Accelerated Filer | | |
| Non-accelerated Filer | |
| Smaller Reporting Company | |
|
|
|
| Emerging Growth Company |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).
Yes ¨No
As of May 2, 2022, there were
_________________________________________________________________________________________________________
Lincoln National Corporation
Table of Contents
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
LINCOLN NATIONAL CORPORATION
CONSOLIDATED BALANCE SHEETS
(in millions, except share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of |
|
| As of |
| ||
| March 31, | December 31, | ||||||
|
| 2022 |
|
| 2021 |
| ||
|
|
|
|
|
|
|
|
|
| (Unaudited) |
|
|
|
| |||
ASSETS |
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
Fixed maturity available-for-sale securities, at fair value |
|
|
|
|
|
|
|
|
(amortized cost: 2022 - $ |
| $ | |
|
| $ | |
|
Trading securities |
|
| |
|
|
| |
|
Equity securities |
|
| |
|
|
| |
|
Mortgage loans on real estate, net of allowance for credit losses |
|
|
|
|
|
|
|
|
(portion at fair value: 2022 - $ |
|
| |
|
|
| |
|
Policy loans |
|
| |
|
|
| |
|
Derivative investments |
|
| |
|
|
| |
|
Other investments |
|
| |
|
|
| |
|
Total investments |
|
| |
|
|
| |
|
Cash and invested cash |
|
| |
|
|
| |
|
Deferred acquisition costs and value of business acquired |
|
| |
|
|
| |
|
Premiums and fees receivable |
|
| |
|
|
| |
|
Accrued investment income |
|
| |
|
|
| |
|
Reinsurance recoverables, net of allowance for credit losses |
|
| |
|
|
| |
|
Funds withheld reinsurance assets |
|
| |
|
|
| |
|
Goodwill |
|
| |
|
|
| |
|
Other assets |
|
| |
|
|
| |
|
Separate account assets |
|
| |
|
|
| |
|
Total assets |
| $ | |
|
| $ | |
|
|
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS’ EQUITY |
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
Future contract benefits |
| $ | |
|
| $ | |
|
Other contract holder funds |
|
| |
|
|
| |
|
Short-term debt |
|
| - |
|
|
| |
|
Long-term debt |
|
| |
|
|
| |
|
Reinsurance-related embedded derivatives |
|
| - |
|
|
| |
|
Funds withheld reinsurance liabilities |
|
| |
|
|
| |
|
Payables for collateral on investments |
|
| |
|
|
| |
|
Other liabilities |
|
| |
|
|
| |
|
Separate account liabilities |
|
| |
|
|
| |
|
Total liabilities |
|
| |
|
|
| |
|
|
|
|
|
|
|
|
|
|
Contingencies and Commitments (See Note 10) |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Stockholders’ Equity |
|
|
|
|
|
|
|
|
Preferred stock – |
|
|
|
|
|
|
|
|
Common stock – |
|
|
|
|
|
|
|
|
issued and outstanding as of March 31, 2022, and December 31, 2021, respectively |
|
| |
|
|
| |
|
Retained earnings |
|
| |
|
|
| |
|
Accumulated other comprehensive income (loss) |
|
| |
|
|
| |
|
Total stockholders’ equity |
|
| |
|
|
| |
|
Total liabilities and stockholders’ equity |
| $ | |
|
| $ | |
|
LINCOLN NATIONAL CORPORATION
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(Unaudited, in millions, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Revenues |
|
|
|
|
|
|
Insurance premiums | $ | |
| $ | |
|
Fee income |
| |
|
| |
|
Net investment income |
| |
|
| |
|
Realized gain (loss) |
| |
|
| ( | ) |
Amortization of deferred gain on business sold through reinsurance |
| |
|
| |
|
Other revenues |
| |
|
| |
|
Total revenues |
| |
|
| |
|
Expenses |
|
|
|
|
|
|
Interest credited |
| |
|
| |
|
Benefits |
| |
|
| |
|
Commissions and other expenses |
| |
|
| |
|
Interest and debt expense |
| |
|
| |
|
Spark program expense |
| |
|
| |
|
Total expenses |
| |
|
| |
|
Income (loss) before taxes |
| |
|
| |
|
Federal income tax expense (benefit) |
| ( | ) |
| |
|
Net income (loss) |
| |
|
| |
|
Other comprehensive income (loss), net of tax |
| ( | ) |
| ( | ) |
Comprehensive income (loss) | $ | ( | ) | $ | ( | ) |
|
|
|
|
|
|
|
Net Income (Loss) Per Common Share |
|
|
|
|
|
|
Basic | $ | |
| $ | |
|
Diluted |
| |
|
| |
|
|
|
|
|
|
|
|
Cash Dividends Declared Per Common Share | $ | |
| $ | |
|
LINCOLN NATIONAL CORPORATION
CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(Unaudited, in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Common Stock |
|
|
|
|
|
|
Balance as of beginning-of-year | $ | |
| $ | |
|
Stock compensation/issued for benefit plans |
| |
|
| |
|
Retirement of common stock/cancellation of shares |
| ( | ) |
| ( | ) |
Balance as of end-of-period |
| |
|
| |
|
|
|
|
|
|
|
|
Retained Earnings |
|
|
|
|
|
|
Balance as of beginning-of-year |
| |
|
| |
|
Net income (loss) |
| |
|
| |
|
Retirement of common stock |
| ( | ) |
| ( | ) |
Common stock dividends declared |
| ( | ) |
| ( | ) |
Balance as of end-of-period |
| |
|
| |
|
|
|
|
|
|
|
|
Accumulated Other Comprehensive Income (Loss) |
|
|
|
|
|
|
Balance as of beginning-of-year |
| |
|
| |
|
Other comprehensive income (loss), net of tax |
| ( | ) |
| ( | ) |
Balance as of end-of-period |
| |
|
| |
|
Total stockholders’ equity as of end-of-period | $ | |
| $ | |
|
LINCOLN NATIONAL CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited, in millions)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Cash Flows from Operating Activities |
|
|
|
|
|
|
Net income (loss) | $ | |
| $ | |
|
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating |
|
|
|
|
|
|
activities: |
|
|
|
|
|
|
Realized (gain) loss |
| ( | ) |
| |
|
Trading securities purchases, sales and maturities, net |
| ( | ) |
| |
|
Amortization of deferred gain on business sold through reinsurance |
| ( | ) |
| ( | ) |
Change in: |
|
|
|
|
|
|
Deferred acquisition costs, value of business acquired, deferred sales inducements |
|
|
|
|
|
|
and deferred front-end loads deferrals and interest, net of amortization |
| |
|
| |
|
Premiums and fees receivable |
| ( | ) |
| ( | ) |
Accrued investment income |
| ( | ) |
| ( | ) |
Insurance liabilities and reinsurance-related balances |
| |
|
| ( | ) |
Accrued expenses |
| ( | ) |
| ( | ) |
Federal income tax accruals |
| |
|
| |
|
Other |
| ( | ) |
| ( | ) |
Net cash provided by (used in) operating activities |
| |
|
| ( | ) |
Cash Flows from Investing Activities |
|
|
|
|
|
|
Purchases of available-for-sale securities and equity securities |
| ( | ) |
| ( | ) |
Sales of available-for-sale securities and equity securities |
| |
|
| |
|
Maturities of available-for-sale securities |
| |
|
| |
|
Purchases of alternative investments |
| ( | ) |
| ( | ) |
Sales and repayments of alternative investments |
| |
|
| |
|
Issuance of mortgage loans on real estate |
| ( | ) |
| ( | ) |
Repayment and maturities of mortgage loans on real estate |
| |
|
| |
|
Repayment (issuance) of policy loans, net |
| |
|
| ( | ) |
Net change in collateral on investments, derivatives and related settlements |
| |
|
| |
|
Other |
| ( | ) |
| ( | ) |
Net cash provided by (used in) investing activities |
| ( | ) |
| ( | ) |
Cash Flows from Financing Activities |
|
|
|
|
|
|
Payment of long-term debt, including current maturities |
| ( | ) |
| - |
|
Issuance of long-term debt, net of issuance costs |
| |
|
| - |
|
Payment related to sale-leaseback transactions |
| ( | ) |
| - |
|
Deposits of fixed account values, including the fixed portion of variable |
| |
|
| |
|
Withdrawals of fixed account values, including the fixed portion of variable |
| ( | ) |
| ( | ) |
Transfers to and from separate accounts, net |
| |
|
| ( | ) |
Common stock issued for benefit plans |
| ( | ) |
| |
|
Repurchase of common stock |
| ( | ) |
| ( | ) |
Dividends paid to common stockholders |
| ( | ) |
| ( | ) |
Other |
|
|
|
| ( | ) |
Net cash provided by (used in) financing activities |
| |
|
| |
|
Net increase (decrease) in cash, invested cash and restricted cash |
| ( | ) |
| ( | ) |
Cash, invested cash and restricted cash as of beginning-of-year |
| |
|
| |
|
Cash, invested cash and restricted cash as of end-of-period | $ | |
| $ | |
|
LINCOLN NATIONAL CORPORATION
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Lincoln National Corporation and its subsidiaries (“LNC” or the “Company,” which also may be referred to as “we,” “our” or “us”) operate multiple insurance businesses through
The accompanying unaudited consolidated financial statements are prepared in accordance with United States of America generally accepted accounting principles (“GAAP”) for interim financial information and with the instructions for the Securities and Exchange Commission (“SEC”) Quarterly Report on Form 10-Q, including Article 10 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. The information contained in the Notes to Consolidated Financial Statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”), should be read in connection with the reading of these interim unaudited consolidated financial statements.
Certain GAAP policies, which significantly affect the determination of financial condition, results of operations and cash flows, are summarized in our 2021 Form 10-K.
The following table provides a description of our adoption of new Accounting Standards Updates (“ASUs”) issued by the Financial Accounting Standards Board (“FASB”) and the impact of the adoption on our consolidated financial statements. ASUs not listed below were assessed and determined to be either not applicable or insignificant in presentation or amount.
|
|
|
|
Standard | Description | Effective Date | Effect on Financial Statements or Other Significant Matters |
ASU 2020-04, Reference Rate Reform (Topic 848) and related amendments | The amendments in this update provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments provide optional expedients and exceptions for applying GAAP to contracts, hedging relationships and other transactions impacted by reference rate reform. If certain criteria are met, an entity will not be required to remeasure or reassess contracts impacted by reference rate reform. Additionally, changes to the critical terms of a hedging relationship affected by reference rate reform will not require entities to de-designate the relationship if certain requirements are met. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, with certain exceptions. The amendments are effective for contract modifications made between March 12, 2020, and December 31, 2022. | March 12, 2020 through December 31, 2022 | This standard may be elected and applied prospectively as reference rate reform unfolds. We have elected practical expedients to maintain hedge accounting for certain derivatives. We will continue to evaluate our options under this guidance as our reference rate reform adoption process continues. This ASU has not had a material impact to our consolidated financial condition and results of operations, but we will continue to evaluate those impacts as our transition progresses. |
Standard | Description | Effective Date | Effect on Financial Statements or Other Significant Matters |
ASU 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts and related amendments | These amendments make changes to the accounting and reporting for long-duration contracts issued by an insurance entity that will significantly change how insurers account for long-duration contracts, including how they measure, recognize and make disclosures about insurance liabilities and deferred acquisition costs. Under this ASU, insurers will be required to review cash flow assumptions at least annually and update them if necessary. They also will have to make quarterly updates to the discount rate assumptions they use to measure the liability for future policyholder benefits. The ASU creates a new category of market risk benefits (i.e., features that protect the contract holder from capital market risk and expose the insurer to that risk) that insurers will have to measure at fair value. The ASU provides various transition methods by topic that entities may elect upon adoption. The ASU is effective January 1, 2023, and early adoption is permitted. | January 1, 2023 | We will adopt this ASU effective January 1, 2023, with a transition date of January 1, 2021, using a modified retrospective approach, except for market risk benefits in which we will apply a full retrospective transition approach. |
3. Variable Interest Entities
Consolidated VIEs
Asset information (dollars in millions) for the consolidated variable interest entities (“VIEs”) included on our Consolidated Balance Sheets was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
|
| As of December 31, 2021 |
| ||||||||||||||||
|
| Number |
|
|
|
|
|
|
|
|
| Number |
|
|
|
|
|
|
|
| ||
|
| of |
|
| Notional |
| Carrying |
|
| of |
|
| Notional |
| Carrying |
| ||||||
| Instruments |
| Amounts |
| Value |
| Instruments |
| Amounts |
| Value |
| ||||||||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total return swap |
|
| |
|
| $ | |
| $ |
|
|
|
| |
|
| $ | |
| $ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
There were
Unconsolidated VIEs
Structured Securities
Through our investment activities, we make passive investments in structured securities issued by VIEs for which we are not the manager. These structured securities include our asset-backed securities (“ABS”), residential mortgage-backed securities (“RMBS”) and commercial mortgage-backed securities (“CMBS”). We have not provided financial or other support with respect to these VIEs other than our original investment. We have determined that we are not the primary beneficiary of these VIEs due to the relative size of our investment in comparison to the principal amount of the structured securities issued by the VIEs and the level of credit subordination that reduces our obligation to absorb losses or right to receive benefits. Our maximum exposure to loss on these structured securities is limited to the amortized cost for these investments. We recognize our variable interest in these VIEs at fair value on our Consolidated Balance Sheets. For information about these structured securities, see Note 4.
Limited Partnerships and Limited Liability Companies
4. Investments
Fixed Maturity AFS Securities
The amortized cost, gross unrealized gains, losses, allowance for credit losses and fair value of fixed maturity available-for-sale (“AFS”) securities (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| |||||||||||||
|
|
|
|
|
|
|
|
|
| Allowance |
|
|
|
| |
| Amortized |
| Gross Unrealized |
| for Credit |
| Fair |
| |||||||
| Cost |
| Gains |
| Losses |
| Losses |
| Value |
| |||||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
U.S. government bonds |
| |
|
| |
|
| |
|
| - |
|
| |
|
State and municipal bonds |
| |
|
| |
|
| |
|
| - |
|
| |
|
Foreign government bonds |
| |
|
| |
|
| |
|
| - |
|
| |
|
RMBS |
| |
|
| |
|
| |
|
| |
|
| |
|
CMBS |
| |
|
| |
|
| |
|
| - |
|
| |
|
ABS |
| |
|
| |
|
| |
|
| |
|
| |
|
Hybrid and redeemable preferred securities |
| |
|
| |
|
| |
|
| |
|
| |
|
Total fixed maturity AFS securities | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2021 |
| |||||||||||||
|
|
|
|
|
|
|
|
|
| Allowance |
|
|
|
| |
| Amortized |
| Gross Unrealized |
| for Credit |
| Fair |
| |||||||
| Cost |
| Gains |
| Losses |
| Losses |
| Value |
| |||||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
U.S. government bonds |
| |
|
| |
|
| |
|
| - |
|
| |
|
State and municipal bonds |
| |
|
| |
|
| |
|
| - |
|
| |
|
Foreign government bonds |
| |
|
| |
|
| |
|
| - |
|
| |
|
RMBS |
| |
|
| |
|
| |
|
| |
|
| |
|
CMBS |
| |
|
| |
|
| |
|
| - |
|
| |
|
ABS |
| |
|
| |
|
| |
|
| - |
|
| |
|
Hybrid and redeemable preferred securities |
| |
|
| |
|
| |
|
| |
|
| |
|
Total fixed maturity AFS securities | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
The amortized cost and fair value of fixed maturity AFS securities by contractual maturities (in millions) as of March 31, 2022, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Amortized |
| Fair |
| ||
| Cost |
| Value |
| ||
Due in one year or less | $ | |
| $ | |
|
Due after one year through five years |
| |
|
| |
|
Due after five years through ten years |
| |
|
| |
|
Due after ten years |
| |
|
| |
|
Subtotal |
| |
|
| |
|
Structured securities (RMBS, CMBS, ABS) |
| |
|
| |
|
Total fixed maturity AFS securities | $ | |
| $ | |
|
Actual maturities may differ from contractual maturities because issuers may have the right to call or pre-pay obligations.
The fair value and gross unrealized losses of fixed maturity AFS securities (dollars in millions) for which an allowance for credit losses has not been recorded, aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| |||||||||||||||||
| Less Than or Equal |
| Greater Than |
|
|
|
|
|
|
|
| ||||||||
| to Twelve Months |
| Twelve Months |
| Total |
| |||||||||||||
|
|
| Gross |
|
| Gross |
|
|
| Gross | |||||||||
| Fair | Unrealized | Fair | Unrealized | Fair |
| Unrealized | ||||||||||||
| Value |
| Losses |
| Value |
| Losses |
| Value |
|
| Losses (1) |
| ||||||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
| $ | |
|
U.S. government bonds |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
State and municipal bonds |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
Foreign government bonds |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
RMBS |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
CMBS |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
ABS |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
Hybrid and redeemable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
preferred securities |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
Total fixed maturity AFS securities | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total number of fixed maturity AFS securities in an unrealized loss position |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2021 |
| |||||||||||||||||
| Less Than or Equal |
| Greater Than |
|
|
|
|
|
|
|
| ||||||||
| to Twelve Months |
| Twelve Months |
| Total |
| |||||||||||||
|
|
| Gross |
|
|
| Gross |
|
|
|
|
| Gross |
| |||||
| Fair | Unrealized | Fair | Unrealized | Fair |
| Unrealized | ||||||||||||
| Value |
| Losses |
| Value |
| Losses |
| Value |
|
| Losses (1) |
| ||||||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
| $ | |
|
U.S. government bonds |
| |
|
| - |
|
| |
|
| |
|
| |
|
|
| |
|
State and municipal bonds |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
Foreign government bonds |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
RMBS |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
CMBS |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
ABS |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
Hybrid and redeemable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
preferred securities |
| |
|
| |
|
| |
|
| |
|
| |
|
|
| |
|
Total fixed maturity AFS securities | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total number of fixed maturity AFS securities in an unrealized loss position |
|
|
| |
|
(1)As of March 31, 2022, and December 31, 2021, we recognized $
The fair value, gross unrealized losses (in millions) and number of fixed maturity AFS securities where the fair value had declined and remained below amortized cost by greater than 20% were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| ||||||||
|
|
|
| Gross |
|
| Number |
| ||
| Fair |
| Unrealized |
|
| of |
| |||
| Value |
| Losses |
| Securities (1) | |||||
Less than six months | $ | |
| $ | |
|
|
| |
|
Twelve months or greater |
| |
|
| |
|
|
| |
|
Total | $ | |
| $ | |
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2021 |
| ||||||||
|
|
| Gross |
|
| Number |
| |||
| Fair |
| Unrealized |
|
| of |
| |||
| Value |
| Losses |
| Securities (1) | |||||
Less than six months | $ | |
| $ | |
|
|
| |
|
Twelve months or greater |
| |
|
| |
|
|
| |
|
Total | $ | |
| $ | |
|
|
| |
|
(1)We may reflect a security in more than one aging category based on various purchase dates.
Our gross unrealized losses on fixed maturity AFS securities increased by $
As of March 31, 2022, the unrealized losses associated with our corporate bond, U.S. government bond, state and municipal bond and foreign government bond securities were attributable primarily to widening credit spreads and rising interest rates since purchase. We performed a detailed analysis of the financial performance of the underlying issuers and determined that we expected to recover the entire amortized cost of each impaired security.
Credit ratings express opinions about the credit quality of a security. Securities rated investment grade (those rated BBB- or higher by S&P Global Ratings (“S&P”) or Baa3 or higher by Moody’s Investors Service (“Moody’s”)) are generally considered by the rating
agencies and market participants to be low credit risk. As of March 31, 2022, and December 31, 2021,
As of March 31, 2022, the unrealized losses associated with our mortgage-backed securities and ABS were attributable primarily to widening credit spreads and rising interest rates since purchase. We assessed for credit impairment using a cash flow model that incorporates key assumptions including default rates, severities and prepayment rates. We estimated losses for a security by forecasting the underlying loans in each transaction. The forecasted loan performance was used to project cash flows to the various tranches in the structure, as applicable. Our forecasted cash flows also considered, as applicable, independent industry analyst reports and forecasts and other independent market data. Based upon our assessment of the expected credit losses of the security given the performance of the underlying collateral compared to our subordination or other credit enhancement, we expected to recover the entire amortized cost of each impaired security.
As of March 31, 2022, the unrealized losses associated with our hybrid and redeemable preferred securities were attributable primarily to wider credit spreads caused by illiquidity in the market and subordination within the capital structure, as well as credit risk of underlying issuers. For our hybrid and redeemable preferred securities, we evaluated the financial performance of the underlying issuers based upon credit performance and investment ratings and determined that we expected to recover the entire amortized cost of each impaired security.
Credit Loss Impairment on Fixed Maturity AFS Securities
We regularly review our fixed maturity AFS securities for declines in fair value that we determine to be impairment-related, including those attributable to credit risk factors that may require an allowance for credit losses. Changes in the allowance for credit losses on fixed maturity AFS securities (in millions), aggregated by investment category, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||||||||
| Months Ended |
| ||||||||||
| March 31, 2022 |
| ||||||||||
| Corporate |
|
|
|
|
|
|
|
|
|
| |
| Bonds |
| RMBS |
| Other |
| Total |
| ||||
Balance as of beginning-of-year | $ | |
| $ | |
| $ | |
| $ | |
|
Additions for securities for which credit losses were not |
|
|
|
|
|
|
|
|
|
|
|
|
previously recognized |
| - |
|
| |
|
| |
|
| |
|
Additions from purchases of PCD debt securities (1) |
| - |
|
| - |
|
| - |
|
| - |
|
Reductions for securities disposed |
| ( | ) |
| - |
|
| - |
|
| ( | ) |
Balance as of end-of-period (2) | $ | |
| $ | |
| $ | |
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||||||||
| Months Ended |
| ||||||||||
| March 31, 2021 |
| ||||||||||
| Corporate |
|
|
|
|
|
|
|
|
|
| |
| Bonds |
| RMBS |
| Other |
| Total |
| ||||
Balance as of beginning-of-year | $ | |
| $ | |
| $ | - |
| $ | |
|
Additions from purchases of PCD debt securities (1) |
| - |
|
| - |
|
| - |
|
| - |
|
Additions (reductions) for securities for which credit losses |
|
|
|
|
|
|
|
|
|
|
|
|
were previously recognized |
| |
|
| - |
|
| - |
|
| |
|
Balance as of end-of-period (2) | $ | |
| $ | |
| $ | - |
| $ | |
|
(1)Represents purchased credit-deteriorated (“PCD”) fixed maturity AFS securities.
(2)As of March 31, 2022 and 2021, accrued investment income on fixed maturity AFS securities totaled $
Mortgage Loans on Real Estate
The following provides the current and past due composition of our mortgage loans on real estate (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| As of December 31, 2021 |
| ||||||||||||||
| Commercial |
| Residential |
| Total |
| Commercial |
| Residential |
| Total |
| ||||||
Current | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
30 to 59 days past due |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
60 to 89 days past due |
| |
|
| |
|
| |
|
| - |
|
| |
|
| |
|
90 or more days past due |
| - |
|
| |
|
| |
|
| - |
|
| |
|
| |
|
Allowance for credit losses |
| ( | ) |
| ( | ) |
| ( | ) |
| ( | ) |
| ( | ) |
| ( | ) |
Unamortized premium (discount) |
| ( | ) |
| |
|
| |
|
| ( | ) |
| |
|
| |
|
Mark-to-market gains (losses) (1) |
| ( | ) |
| - |
|
| ( | ) |
| ( | ) |
| - |
|
| ( | ) |
Total carrying value | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
(1)Represents the mark-to-market on certain mortgage loans on real estate for which we have elected the fair value option. See Note 13 for additional information.
Our commercial mortgage loan portfolio has the largest concentrations in California, which accounted for
Our residential mortgage loan portfolio has the largest concentrations in California, which accounted for
As of March 31, 2022, and December 31, 2021, we had
As of March 31, 2022, and December 31, 2021, there were
As of March 31, 2022, and December 31, 2021, there were
Additional information related to impaired mortgage loans on real estate (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Average aggregate carrying value for impaired mortgage loans on real estate | $ | |
| $ | |
|
Interest income recognized on impaired mortgage loans on real estate |
| - |
|
| - |
|
Interest income collected on impaired mortgage loans on real estate |
| - |
|
| - |
|
The amortized cost of mortgage loans on real estate on nonaccrual status (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| As of December 31, 2021 |
| ||||||||
| Nonaccrual |
|
|
|
| Nonaccrual |
|
|
|
| ||
| with no |
|
|
|
| with no |
|
|
|
| ||
| Allowance |
|
|
|
| Allowance |
|
|
|
| ||
| for Credit |
|
|
|
| for Credit |
|
|
|
| ||
| Losses |
| Nonaccrual |
| Losses |
| Nonaccrual |
| ||||
Commercial mortgage loans on real estate | $ |
|
| $ |
|
| $ |
|
| $ |
|
|
Residential mortgage loans on real estate |
| - |
|
| |
|
| - |
|
| |
|
Total | $ | - |
| $ | |
| $ | - |
| $ | |
|
We use loan-to-value and debt-service coverage ratios as credit quality indicators for our commercial mortgage loans on real estate. The amortized cost of commercial mortgage loans on real estate (dollars in millions) by year of origination and credit quality indicator was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| ||||||||||||||||
|
|
|
| Debt- |
|
|
|
| Debt- |
|
|
|
| Debt- |
|
|
|
|
|
|
|
| Service |
|
|
|
| Service |
|
|
|
| Service |
|
|
|
|
| Less |
| Coverage |
| 65% |
| Coverage |
| Greater |
| Coverage |
|
|
| ||||
| than 65% |
| Ratio |
| to 75% |
| Ratio |
| than 75% |
| Ratio |
| Total |
| ||||
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022 | $ | |
|
| $ | |
|
| $ | - |
| - |
| $ | |
| ||
2021 |
| |
|
|
| |
|
|
| - |
| - |
|
| |
| ||
2020 |
| |
|
|
| |
|
|
| - |
| - |
|
| |
| ||
2019 |
| |
|
|
| |
|
|
| - |
| - |
|
| |
| ||
2018 |
| |
|
|
| |
|
|
| |
|
|
| |
| |||
2017 and prior |
| |
|
|
| |
|
|
| |
|
|
| |
| |||
Total | $ | |
|
|
| $ | |
|
|
| $ | |
|
|
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2021 |
| ||||||||||||||||
|
|
|
| Debt- |
|
|
|
| Debt- |
|
|
|
| Debt- |
|
|
|
|
|
|
|
| Service |
|
|
|
| Service |
|
|
|
| Service |
|
|
|
|
| Less |
| Coverage |
| 65% |
| Coverage |
| Greater |
| Coverage |
|
|
| ||||
| than 65% |
| Ratio |
| to 75% |
| Ratio |
| than 75% |
| Ratio |
| Total |
| ||||
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 | $ | |
|
| $ | |
|
| $ | - |
| - |
| $ | |
| ||
2020 |
| |
|
|
| |
|
|
| - |
| - |
|
| |
| ||
2019 |
| |
|
|
| |
|
|
| - |
| - |
|
| |
| ||
2018 |
| |
|
|
| |
|
|
| |
|
|
| |
| |||
2017 |
| |
|
|
| |
|
|
| |
|
|
| |
| |||
2016 and prior |
| |
|
|
| |
|
|
| |
|
|
| |
| |||
Total | $ | |
|
|
| $ | |
|
|
| $ | |
|
|
| $ | |
|
We use loan performance status as the primary credit quality indicator for our residential mortgage loans on real estate. The amortized cost of residential mortgage loans on real estate (in millions) by year of origination and credit quality indicator was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| |||||||||
| Performing |
| Nonperforming |
| Total |
| |||||
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
2022 | $ | |
|
| $ | - |
|
| $ | |
|
2021 |
| |
|
|
| |
|
|
| |
|
2020 |
| |
|
|
| |
|
|
| |
|
2019 |
| |
|
|
| |
|
|
| |
|
2018 |
| |
|
|
| |
|
|
| |
|
2017 and prior |
| - |
|
|
| - |
|
|
| - |
|
Total | $ | |
|
| $ | |
|
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2021 |
| |||||||||
| Performing |
| Nonperforming |
| Total |
| |||||
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
2021 | $ | |
|
| $ | |
|
| $ | |
|
2020 |
| |
|
|
| |
|
|
| |
|
2019 |
| |
|
|
| |
|
|
| |
|
2018 |
| |
|
|
| |
|
|
| |
|
2017 |
| - |
|
|
| - |
|
|
| - |
|
2016 and prior |
| - |
|
|
| - |
|
|
| - |
|
Total | $ | |
|
| $ | |
|
| $ | |
|
Credit Losses on Mortgage Loans on Real Estate
In connection with our recognition of an allowance for credit losses for mortgage loans on real estate, we perform a quantitative analysis using a probability of default/loss given default/exposure at default approach to estimate expected credit losses in our mortgage loan portfolio as well as unfunded commitments related to commercial mortgage loans, exclusive of certain mortgage loans held at fair value.
Changes in the allowance for credit losses on mortgage loans on real estate (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
| For the Three |
| |||||||
| Months Ended |
| |||||||
| March 31, 2022 |
| |||||||
| Commercial |
| Residential |
| Total |
| |||
Balance as of beginning-of-year | $ | |
| $ | |
| $ | |
|
Additions (reductions) from provision for credit loss expense (1) |
| ( | ) |
| |
|
| ( | ) |
Additions from purchases of PCD mortgage loans on real estate |
| - |
|
| - |
|
| - |
|
Balance as of end-of-period (2) | $ | |
| $ | |
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| |||||||
| Months Ended |
| |||||||
| March 31, 2021 |
| |||||||
| Commercial |
| Residential |
| Total |
| |||
Balance as of beginning-of-year | $ | |
| $ | |
| $ | |
|
Additions (reductions) from provision for credit loss expense (1) |
| ( | ) |
| ( | ) |
| ( | ) |
Additions from purchases of PCD mortgage loans on real estate |
| - |
|
| - |
|
| - |
|
Balance as of end-of-period (2) | $ | |
| $ | |
| $ | |
|
(1)Due to improving economic projections, the provision for credit loss expense decreased by $
(2)Accrued investment income on mortgage loans on real estate totaled $
Alternative Investments
As of March 31, 2022, and December 31, 2021, alternative investments included investments in
Impairments on Fixed Maturity AFS Securities
Details underlying credit loss benefit (expense) incurred as a result of impairments that were recognized in net income (loss) and included in realized gain (loss) on fixed maturity AFS securities (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Credit Loss Benefit (Expense) |
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | ( | ) |
RMBS |
| ( | ) |
| - |
|
ABS |
| ( | ) |
| - |
|
Gross credit loss benefit (expense) |
| ( | ) |
| ( | ) |
Associated amortization of DAC, VOBA, DSI and DFEL (1) |
| - |
|
| - |
|
Net credit loss benefit (expense) | $ | ( | ) | $ | ( | ) |
(1)Deferred acquisition costs (“DAC”), value of business acquired (“VOBA”), deferred sales inducements (“DSI”) and deferred front-end loads (“DFEL”).
Payables for Collateral on Investments
The carrying value of the payables for collateral on investments included on our Consolidated Balance Sheets and the fair value of the related investments or collateral (in millions) consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| As of December 31, 2021 |
| ||||||||
| Carrying |
| Fair |
| Carrying |
| Fair |
| ||||
| Value |
| Value |
| Value |
| Value |
| ||||
Collateral payable for derivative investments (1) | $ | |
| $ | |
| $ | |
| $ | |
|
Securities pledged under securities lending agreements (2) |
| |
|
| |
|
| |
|
| |
|
Investments pledged for Federal Home Loan Bank of |
|
|
|
|
|
|
|
|
|
|
|
|
Indianapolis (3) |
| |
|
| |
|
| |
|
| |
|
Total payables for collateral on investments | $ | |
| $ | |
| $ | |
| $ | |
|
(1)We obtain collateral based upon contractual provisions with our counterparties. These agreements take into consideration the counterparties’ credit rating as compared to ours, the fair value of the derivative investments and specified thresholds that if exceeded result in the receipt of cash that is typically invested in cash and invested cash. This also includes interest payable on collateral. See Note 4 for additional information.
(2)Our pledged securities under securities lending agreements are included in fixed maturity AFS securities on our Consolidated Balance Sheets. We generally obtain collateral in an amount equal to
(3)Our pledged investments for Federal Home Loan Bank (“FHLB”) of Indianapolis (“FHLBI”) are included in fixed maturity AFS securities and mortgage loans on real estate on our Consolidated Balance Sheets. The collateral requirements are generally
We have repurchase agreements through which we can obtain liquidity by pledging securities. The collateral requirements are generally
Increase (decrease) in payables for collateral on investments (in millions) consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Collateral payable for derivative investments | $ | ( | ) | $ | |
|
Securities pledged under securities lending agreements |
| |
|
| |
|
Investments pledged for FHLBI |
| |
|
| |
|
Total increase (decrease) in payables for collateral on investments | $ | ( | ) | $ | |
|
We have elected not to offset our securities lending transactions in our consolidated financial statements. The remaining contractual maturities of securities lending transactions accounted for as secured borrowings (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| |||||||||||||
| Overnight and Continuous |
| Up to 30 Days |
| 30 - 90 |
| Greater Than 90 Days |
| Total |
| |||||
Securities Lending |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | - |
| $ | - |
| $ | - |
| $ | |
|
Foreign government bonds |
| |
|
| - |
|
| - |
|
| - |
|
| |
|
Equity securities |
| |
|
| - |
|
| - |
|
| - |
|
| |
|
Total gross secured borrowings | $ | |
| $ | - |
| $ | - |
| $ | - |
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2021 |
| |||||||||||||
| Overnight and Continuous |
| Up to 30 Days |
| 30 - 90 |
| Greater Than 90 Days |
| Total |
| |||||
Securities Lending |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | - |
| $ | - |
| $ | - |
| $ | |
|
Foreign government bonds |
| |
|
| - |
|
| - |
|
| - |
|
| |
|
Equity securities |
| |
|
| - |
|
| - |
|
| - |
|
| |
|
Total gross secured borrowings | $ | |
| $ | - |
| $ | - |
| $ | - |
| $ | |
|
We accept collateral in the form of securities in connection with repurchase agreements. In instances where we are permitted to sell or re-pledge the securities received, we report the fair value of the collateral received and a related obligation to return the collateral in the consolidated financial statements. In addition, we receive securities in connection with securities borrowing agreements that we are permitted to sell or re-pledge. As of March 31, 2022, the fair value of all collateral received that we are permitted to sell or re-pledge was $
Investment Commitments
As of March 31, 2022, our investment commitments were $
Concentrations of Financial Instruments
As of March 31, 2022, and December 31, 2021, our most significant investments in one issuer were our investments in securities issued by the Federal Home Loan Mortgage Corporation with a fair value of $
As of March 31, 2022, and December 31, 2021, our most significant investments in one industry were our investments in securities in the financial services industry with a fair value of $
We maintain an overall risk management strategy that incorporates the use of derivative instruments to minimize significant unplanned fluctuations in earnings that are caused by interest rate risk, foreign currency exchange risk, equity market risk, basis risk and credit risk. We assess these risks by continually identifying and monitoring changes in our exposures that may adversely affect expected future cash flows and by evaluating hedging opportunities.
Derivative activities are monitored by various management committees. The committees are responsible for overseeing the implementation of various hedging strategies that are developed through the analysis of financial simulation models and other internal and industry sources. The resulting hedging strategies are incorporated into our overall risk management strategies.
See Note 13 for additional disclosures related to the fair value of our derivative instruments.
Interest Rate Contracts
We use derivative instruments as part of our interest rate risk management strategy. These instruments are economic hedges unless otherwise noted and include:
Forward-Starting Interest Rate Swaps
We use forward-starting interest rate swaps designated and qualifying as cash flow hedges to hedge our exposure to interest rate fluctuations related to the forecasted purchases of certain assets and anticipated issuances of fixed-rate securities.
We also use forward-starting interest rate swaps to hedge the interest rate exposure within our life products related to the forecasted purchases of certain assets.
Interest Rate Cap Corridors
We use interest rate cap corridors to provide a level of protection from the effect of rising interest rates for certain life insurance products and annuity contracts. Interest rate cap corridors involve purchasing an interest rate cap at a specific cap rate and selling an interest rate cap with a higher cap rate. For each corridor, the amount of quarterly payments, if any, is determined by the rate at which the underlying index rate resets above the original capped rate. The corridor limits the benefit the purchaser can receive as the related interest rate index rises above the higher capped rate. There is no additional liability to us other than the purchase price associated with the interest rate cap corridor.
Interest Rate Futures
We use interest rate futures contracts to hedge the liability exposure on certain options in variable annuity products. These futures contracts require payment between our counterparty and us on a daily basis for changes in the futures index price.
Interest Rate Swap Agreements
We use interest rate swap agreements to hedge the liability exposure on certain options in variable annuity products.
We also use interest rate swap agreements designated and qualifying as cash flow hedges to hedge the interest rate risk of floating-rate bond coupon payments by replicating a fixed-rate bond.
Finally, we use interest rate swap agreements designated and qualifying as fair value hedges to hedge against changes in the fair value of certain fixed-rate long-term debt and fixed maturity securities due to interest rate risks.
Treasury and Reverse Treasury Locks
We use treasury locks designated and qualifying as cash flow hedges to hedge the interest rate exposure related to our issuance of fixed-rate securities or the anticipated future cash flows of floating-rate fixed maturity securities due to changes in interest rates. In addition, we use reverse treasury locks designated and qualifying as cash flow hedges to hedge the interest rate exposure related to the anticipated purchase of fixed-rate securities or the anticipated future cash flows of floating-rate fixed maturity securities due to changes in interest rates. These derivatives are primarily structured to hedge interest rate risk inherent in the assumptions used to price certain liabilities.
Foreign Currency Contracts
We use derivative instruments as part of our foreign currency risk management strategy. These instruments are economic hedges unless otherwise noted and include:
Currency Futures
We use currency futures to hedge foreign exchange risk associated with certain options in variable annuity products. Currency futures exchange one currency for another at a specified date in the future at a specified exchange rate.
Foreign Currency Swaps
We use foreign currency swaps to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies. A foreign currency swap is a contractual agreement to exchange one currency for another at specified dates in the future at a specified exchange rate.
We also use foreign currency swaps designated and qualifying as cash flow hedges to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies.
Foreign Currency Forwards
We use foreign currency forwards to hedge foreign exchange risk of investments in fixed maturity securities denominated in foreign currencies. A foreign currency forward is a contractual agreement to exchange one currency for another at specified dates in the future at a specified current exchange rate.
Equity Market Contracts
We use derivative instruments as part of our equity market risk management strategy that are economic hedges and include:
Call Options Based on the S&P 500® Index and Other Indices
We use call options to hedge the liability exposure on certain options in variable annuity products, indexed variable annuity products and fixed indexed annuity products.
Our indexed annuity and IUL contracts permit the holder to elect an interest rate return or an equity market component, where interest credited to the contracts is linked to the performance of the S&P 500 Index or other indices. Contract holders may elect to rebalance index options at renewal dates. At the end of each indexed term, which can be up to
Consumer Price Index Swaps
We use consumer price index swaps to hedge the liability exposure on certain options in fixed annuity products. Consumer price index swaps are contracts entered into at no cost and whose payoff is the difference between the consumer price index inflation rate and the fixed-rate determined as of inception.
Equity Futures
We use equity futures contracts to hedge the liability exposure on certain options in variable annuity products. These futures contracts require payment between our counterparty and us on a daily basis for changes in the futures index price.
Put Options
We use put options to hedge the liability exposure on certain options in variable annuity products. Put options are contracts that require counterparties to pay us at a specified future date the amount, if any, by which a specified equity index is less than the strike rate stated in the agreement, applied to a notional amount.
Total Return Swaps
We use total return swaps to hedge the liability exposure on certain options in variable annuity products and indexed variable annuity products.
In addition, we use total return swaps to hedge a portion of the liability related to our deferred compensation plans. We receive the total return on a portfolio of indexes and pay a floating-rate of interest.
Credit Contracts
We use derivative instruments as part of our credit risk management strategy that are economic hedges and include:
Credit Default Swaps – Buying Protection
We use credit default swaps (“CDSs”) to hedge the liability exposure on certain options in variable annuity products.
We buy CDSs to hedge against a drop in bond prices due to credit concerns of certain bond issuers. A CDS allows us to put the bond back to the counterparty at par upon a default event by the bond issuer. A default event is defined as bankruptcy, failure to pay, obligation acceleration or restructuring.
CDSs – Selling Protection
We use CDSs to hedge the liability exposure on certain options in variable annuity products.
We sell CDSs to offer credit protection to contract holders and investors. The CDSs hedge the contract holders and investors against a drop in bond prices due to credit concerns of certain bond issuers. A CDS allows the investor to put the bond back to us at par upon a default event by the bond issuer. A default event is defined as bankruptcy, failure to pay, obligation acceleration or restructuring.
Embedded Derivatives
We have embedded derivatives that include:
GLB Reserves Embedded Derivatives
Certain features of these guarantees have elements of both insurance benefits accounted for under the Financial Services – Insurance – Claim Costs and Liabilities for Future Policy Benefits Subtopic of the FASB Accounting Standards Codification (“ASC”) (“benefit reserves”) and embedded derivatives accounted for under the Derivatives and Hedging and the Fair Value Measurements and Disclosures Topics of the FASB ASC (“embedded derivative reserves”). We calculate the value of the benefit reserves and the embedded derivative reserves based on the specific characteristics of each guaranteed living benefit (“GLB”) feature.
We use a hedging strategy designed to mitigate the risk and income statement volatility caused by changes in the equity markets, interest rates and volatility associated with GLBs offered in our variable annuity products, including products with guaranteed withdrawal benefit and guaranteed income benefit features. Changes in the value of the hedge contracts due to changes in equity markets, interest rates and implied volatilities hedge the income statement effect of changes in embedded derivative GLB reserves caused by those same factors. We rebalance our hedge positions based upon changes in these factors as needed. While we actively manage our hedge positions, these hedge positions may not be totally effective in offsetting changes in the embedded derivative reserve due to, among other things, differences in timing between when a market exposure changes and corresponding changes to the hedge positions, extreme swings in the equity markets and interest rates, market volatility, contract holder behavior, divergence between the performance of the underlying funds and the hedging indices, divergence between the actual and expected performance of the hedge instruments and our ability to purchase hedging instruments at prices consistent with our desired risk and return trade-off.
Indexed Annuity and IUL Contracts Embedded Derivatives
Our indexed annuity and IUL contracts permit the holder to elect an interest rate return or an equity market component, where interest credited to the contracts is linked to the performance of the S&P 500® Index or other indices. Contract holders may elect to rebalance index options at renewal dates. At the end of each indexed term, which can be up to six years, we have the opportunity to re-price the indexed component by establishing participation rates, caps, spreads and specified rates, subject to contractual guarantees. We use options that are highly correlated to the portfolio allocation decisions of our contract holders, such that we are economically hedged with respect to equity returns for the current reset period.
Reinsurance-Related Embedded Derivatives
We have certain modified coinsurance and coinsurance with funds withheld reinsurance agreements with embedded derivatives related to the withheld assets of the related funds. These derivatives are considered total return swaps with contractual returns that are attributable to various assets and liabilities associated with these reinsurance agreements.
We have derivative instruments with off-balance-sheet risks whose notional or contract amounts exceed the related credit exposure. Outstanding derivative instruments with off-balance-sheet risks (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| As of December 31, 2021 |
| ||||||||||||||
| Notional |
| Fair Value |
| Notional |
| Fair Value |
| ||||||||||
| Amounts |
| Asset |
| Liability |
| Amounts |
| Asset |
| Liability |
| ||||||
Qualifying Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flow hedges: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts (1) | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
Foreign currency contracts (1) |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Total cash flow hedges |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Fair value hedges: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts (1) |
| |
|
| - |
|
| |
|
| |
|
| - |
|
| |
|
Non-Qualifying Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts (1) |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Foreign currency contracts (1) |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Equity market contracts (1) |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Credit contracts (1) |
| |
|
| - |
|
| - |
|
| |
|
| - |
|
| - |
|
Embedded derivatives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GLB direct (2) |
| - |
|
| |
|
| - |
|
| - |
|
| |
|
| - |
|
GLB ceded (2) |
| - |
|
| |
|
| |
|
| - |
|
| |
|
| |
|
Reinsurance-related (3) |
| - |
|
| |
|
| - |
|
| - |
|
| - |
|
| |
|
Indexed annuity and IUL contracts (2) (4) |
| - |
|
| |
|
| |
|
| - |
|
| |
|
| |
|
Total derivative instruments | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
(1)Reported in derivative investments and other liabilities on our Consolidated Balance Sheets.
(2)Reported in other assets and other liabilities on our Consolidated Balance Sheets.
(3)Reported in other assets and reinsurance-related embedded derivatives on our Consolidated Balance Sheets.
(4)Reported in future contract benefits on our Consolidated Balance Sheets.
The maturity of the notional amounts of derivative instruments (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Remaining Life as of March 31, 2022 |
| ||||||||||||||||
| Less Than |
| 1 - 5 |
| 6 - 10 |
| 11 - 30 |
| Over 30 |
|
|
| ||||||
| 1 Year |
| Years |
| Years |
| Years |
| Years |
| Total |
| ||||||
Interest rate contracts (1) | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
Foreign currency contracts (2) |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Equity market contracts |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
Credit contracts |
| - |
|
| |
|
| |
|
| - |
|
| - |
|
| |
|
Total derivative instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
with notional amounts | $ | |
| $ | |
| $ | |
| $ | |
| $ | |
| $ | |
|
(1)As of March 31, 2022, the latest maturity date for which we were hedging our exposure to the variability in future cash flows for these instruments was
(2)As of March 31, 2022, the latest maturity date for which we were hedging our exposure to the variability in future cash flows for these instruments was
The following amounts (in millions) were recorded on the Consolidated Balance Sheets related to cumulative basis adjustments for fair value hedges:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Cumulative Fair Value |
|
| |||||
|
|
|
|
|
|
|
|
| Hedging Adjustment |
|
| |||||
|
|
|
|
|
|
|
|
| Included in the |
|
| |||||
| Amortized Cost of the |
|
| Amortized Cost of the |
|
| ||||||||||
| Hedged |
|
| Hedged |
|
| ||||||||||
| Assets / (Liabilities) |
|
| Assets / (Liabilities) |
|
| ||||||||||
| As of |
|
| As of |
|
| As of |
|
| As of |
|
| ||||
| March 31, |
|
| December 31, |
|
| March 31, |
|
| December 31, |
|
| ||||
| 2022 |
|
| 2021 |
|
| 2022 |
|
| 2021 |
|
| ||||
Line Item in the Consolidated Balance Sheets in |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
which the Hedged Item is Included |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities, at fair value | $ | |
|
| $ | |
|
| $ | |
|
| $ | |
|
|
Long-term debt (1) |
| ( | ) |
|
| ( | ) |
|
| |
|
|
| |
|
|
(1)Includes $(
The change in our unrealized gain (loss) on derivative instruments within accumulated other comprehensive income (loss) (“AOCI”) (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Unrealized Gain (Loss) on Derivative Instruments |
|
|
|
|
|
|
Balance as of beginning-of-year | $ | ( | ) | $ | ( | ) |
Other comprehensive income (loss): |
|
|
|
|
|
|
Unrealized holding gains (losses) arising during the period: |
|
|
|
|
|
|
Cash flow hedges: |
|
|
|
|
|
|
Interest rate contracts |
| |
|
| |
|
Foreign currency contracts |
| ( | ) |
| ( | ) |
Change in foreign currency exchange rate adjustment |
| |
|
| |
|
Change in DAC, VOBA, DSI and DFEL |
| |
|
| |
|
Income tax benefit (expense) |
| ( | ) |
| ( | ) |
Less: |
|
|
|
|
|
|
Reclassification adjustment for gains (losses) |
|
|
|
|
|
|
included in net income (loss): |
|
|
|
|
|
|
Cash flow hedges: |
|
|
|
|
|
|
Interest rate contracts (1) |
| |
|
| |
|
Interest rate contracts (2) |
| ( | ) |
| ( | ) |
Foreign currency contracts (1) |
| |
|
| |
|
Foreign currency contracts (3) |
| |
|
| ( | ) |
Associated amortization of DAC, VOBA, DSI and DFEL |
| ( | ) |
| ( | ) |
Income tax benefit (expense) |
| ( | ) |
| - |
|
Balance as of end-of-period | $ | ( | ) | $ | ( | ) |
(1)The OCI offset is reported within net investment income on our Consolidated Statements of Comprehensive Income (Loss).
(2)The OCI offset is reported within interest and debt expense on our Consolidated Statements of Comprehensive Income (Loss).
(3)The OCI offset is reported within realized gain (loss) on our Consolidated Statements of Comprehensive Income (Loss).
The effects of qualifying and non-qualifying hedges (in millions) on the Consolidated Statements of Comprehensive Income (Loss) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Gain (Loss) Recognized in Income |
| ||||||||||||||||
| For the Three Months Ended March 31, |
| ||||||||||||||||
| 2022 |
| 2021 |
| ||||||||||||||
| Realized |
| Net |
| Interest |
| Realized |
| Net |
| Interest |
| ||||||
| Gain |
| Investment |
| and Debt |
| Gain |
| Investment |
| and Debt |
| ||||||
| (Loss) |
| Income |
| Expense |
| (Loss) |
| Income |
| Expense |
| ||||||
Total Line Items in which the |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effects of Fair Value or Cash |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Flow Hedges are Recorded | $ | |
| $ | |
| $ | |
| $ | ( | ) | $ | |
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Qualifying Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gain or (loss) on fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hedging relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Hedged items |
| - |
|
| ( | ) |
| |
|
| - |
|
| ( | ) |
| |
|
Derivatives designated as |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hedging instruments |
| - |
|
| |
|
| ( | ) |
| - |
|
| |
|
| ( | ) |
Gain or (loss) on cash flow |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
hedging relationships: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of gain or (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
reclassified from AOCI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
into income |
| - |
|
| |
|
| ( | ) |
| - |
|
| |
|
| ( | ) |
Foreign currency contracts: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Amount of gain or (loss) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
reclassified from AOCI |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
into income |
| |
|
| |
|
| - |
|
| ( | ) |
| |
|
| - |
|
Non-Qualifying Hedges |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts |
| ( | ) |
| - |
|
| - |
|
| ( | ) |
| - |
|
| - |
|
Equity market contracts |
| ( | ) |
| - |
|
| - |
|
| |
|
| - |
|
| - |
|
Embedded derivatives: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GLB |
| ( | ) |
| - |
|
| - |
|
| |
|
| - |
|
| - |
|
Reinsurance-related |
| |
|
| - |
|
| - |
|
| |
|
| - |
|
| - |
|
Indexed annuity and IUL |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
contracts |
| |
|
| - |
|
| - |
|
| ( | ) |
| - |
|
| - |
|
As of March 31, 2022, $
For the three months ended March 31, 2022 and 2021, there were
Information related to our CDSs for which we are the seller (dollars in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of March 31, 2022 |
| ||||||||||||||||
|
|
|
|
|
|
|
| Credit |
|
|
|
|
|
|
|
|
|
|
|
|
| Reason |
| Nature |
| Rating of |
| Number |
|
|
|
| Maximum |
| |
|
|
|
| for |
| of | Underlying | of |
| Fair |
| Potential |
| ||||
Credit Contract Type |
| Maturity |
| Entering |
| Recourse | Obligation (1) | Instruments |
| Value (2) |
| Payout |
| ||||
Basket CDSs |
|
| (3) |
| (4) |
| BBB+ |
| |
| $ | - |
| $ | |
| |
Basket CDSs |
|
| (3) |
| (4) |
| BBB+ |
| |
|
| |
|
| |
| |
|
|
|
|
|
|
|
|
|
| |
| $ | |
| $ | |
|
(1)Represents average credit ratings based on the midpoint of the applicable ratings among Moody’s, S&P and Fitch Ratings, as scaled to the corresponding S&P ratings.
(2)Broker quotes are used to determine the market value of our CDSs.
(3)CDSs were entered into in order to hedge the liability exposure on certain variable annuity products.
As of December 31, 2021, we did not have any exposure related to CDSs for which we are the seller.
Details underlying the associated collateral of our CDSs for which we are the seller if credit risk-related contingent features were triggered (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of |
| As of |
| ||
| March 31, | December 31, | |||||
|
| 2022 |
| 2021 |
| ||
Maximum potential payout |
| $ | |
| $ | - |
|
Less: Counterparty thresholds |
|
| - |
|
| - |
|
Maximum collateral potentially required to post |
| $ | |
| $ | - |
|
Certain of our CDS agreements contain contractual provisions that allow for the netting of collateral with our counterparties related to all of our collateralized financing transactions that we have outstanding. If these netting agreements were not in place, our counterparties would have been required to post $
Credit Risk
We are exposed to credit losses in the event of non-performance by our counterparties on various derivative contracts and reflect assumptions regarding the credit or non-performance risk (“NPR”). The NPR is based upon assumptions for each counterparty’s credit spread over the estimated weighted average life of the counterparty exposure, less collateral held. As of March 31, 2022, the NPR adjustment was
The amounts recognized (in millions) by S&P credit rating of counterparty, for which we had the right to reclaim cash collateral or were obligated to return cash collateral, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| As of December 31, 2021 |
| ||||||||
|
| Collateral |
| Collateral |
| Collateral |
| Collateral |
| ||||
|
| Posted by |
| Posted by |
| Posted by |
| Posted by |
| ||||
S&P |
| Counter- |
| LNC |
| Counter- |
| LNC |
| ||||
Credit |
| Party |
| (Held by |
| Party |
| (Held by |
| ||||
Rating of |
| (Held by |
| Counter- |
| (Held by |
| Counter- |
| ||||
Counterparty |
| LNC) |
| Party) |
| LNC) |
| Party) |
| ||||
AA- |
| $ | |
| $ | ( | ) | $ | |
| $ | ( | ) |
A+ |
|
| |
|
| ( | ) |
| |
|
| ( | ) |
A |
|
| |
|
| ( | ) |
| |
|
| ( | ) |
A- |
|
|
|
|
|
|
|
| - |
|
|
|
|
|
| $ | |
| $ | ( | ) | $ | |
| $ | ( | ) |
Balance Sheet Offsetting
Information related to the effects of offsetting on our Consolidated Balance Sheets (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| |||||||||
|
|
|
|
|
| Embedded |
|
|
|
| ||
|
| Derivative |
|
| Derivative |
|
|
|
| |||
|
| Instruments |
|
| Instruments |
| Total |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Assets |
|
|
|
|
|
|
|
|
|
|
|
|
Gross amount of recognized assets |
| $ | |
|
| $ | |
|
| $ | |
|
Gross amounts offset |
|
| ( | ) |
|
|
|
|
|
| ( | ) |
Net amount of assets (1) |
|
| |
|
|
| |
|
|
| |
|
Gross amounts not offset: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash collateral (2) |
|
| ( | ) |
|
|
|
|
|
| ( | ) |
Non-cash collateral |
|
|
|
|
|
|
|
|
|
| - |
|
Net amount |
| $ |
|
|
| $ | |
|
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Gross amount of recognized liabilities |
| $ | |
|
| $ | |
|
| $ | |
|
Gross amounts offset |
|
| ( | ) |
|
|
|
|
|
| ( | ) |
Net amount of liabilities |
|
| |
|
|
| |
|
|
| |
|
Gross amounts not offset: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash collateral (2) |
|
| ( | ) |
|
|
|
|
|
| ( | ) |
Non-cash collateral |
|
|
|
|
|
|
|
|
|
| - |
|
Net amount |
| $ |
|
|
| $ | |
|
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)Includes deferred premiums receivable (payable) of $(
(2)Excludes excess cash collateral received of $
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2021 |
| |||||||||
|
|
|
|
|
| Embedded |
|
|
|
| ||
|
| Derivative |
|
| Derivative |
|
|
|
| |||
|
| Instruments |
|
| Instruments |
| Total |
| ||||
Financial Assets |
|
|
|
|
|
|
|
|
|
|
|
|
Gross amount of recognized assets |
| $ | |
|
| $ | |
|
| $ | |
|
Gross amounts offset |
|
| ( | ) |
|
| - |
|
|
| ( | ) |
Net amount of assets (1) |
|
| |
|
|
| |
|
|
| |
|
Gross amounts not offset: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash collateral (2) |
|
| ( | ) |
|
| - |
|
|
| ( | ) |
Non-cash collateral |
|
| ( | ) |
|
| - |
|
|
| ( | ) |
Net amount |
| $ | - |
|
| $ | |
|
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Gross amount of recognized liabilities |
| $ | |
|
| $ | |
|
| $ | |
|
Gross amounts offset |
|
| ( | ) |
|
| - |
|
|
| ( | ) |
Net amount of liabilities |
|
| |
|
|
| |
|
|
| |
|
Gross amounts not offset: |
|
|
|
|
|
|
|
|
|
|
|
|
Cash collateral (2) |
|
| ( | ) |
|
| - |
|
|
| ( | ) |
Non-cash collateral |
|
| - |
|
|
| - |
|
|
| - |
|
Net amount |
| $ | - |
|
| $ | |
|
| $ | |
|
(1)Includes deferred premiums receivable (payable) of $
6. Federal Income Taxes
The effective tax rate is the ratio of tax expense (benefit) over pre-tax income (loss). The effective tax rate was (
For the three months ended March 31, 2022, the effective tax rate differed from the prevailing corporate federal income tax rate due primarily to the effects of the preferential tax items exceeding the tax expense at
For the three months ended March 31, 2021, the effective tax rate differed from the prevailing corporate federal income tax rate due primarily to the effects of the preferential tax items.
Information on the guaranteed death benefit (“GDB”) features outstanding (dollars in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of |
|
| As of |
|
| ||
| March 31, |
|
| December 31, |
|
| ||
| 2022 (1) |
|
| 2021 (1) |
|
| ||
Return of Net Deposits |
|
|
|
|
|
|
|
|
Total account value | $ | |
|
| $ | |
|
|
Net amount at risk (2) |
| |
|
|
| |
|
|
Average attained age of contract holders |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Minimum Return |
|
|
|
|
|
|
|
|
Total account value | $ | |
|
| $ | |
|
|
Net amount at risk (2) |
| |
|
|
| |
|
|
Average attained age of contract holders |
|
|
|
|
|
| ||
Guaranteed minimum return |
|
|
|
|
|
| ||
|
|
|
|
|
|
|
|
|
Anniversary Contract Value |
|
|
|
|
|
|
|
|
Total account value | $ | |
|
| $ | |
|
|
Net amount at risk (2) |
| |
|
|
| |
|
|
Average attained age of contract holders |
|
|
|
|
|
|
(1)Our variable contracts with guarantees may offer more than one type of guarantee in each contract; therefore, the amounts listed are not mutually exclusive.
(2)Represents the amount of death benefit in excess of the account balance that is subject to market fluctuations.
The determination of GDB liabilities is based on models that involve a range of scenarios and assumptions, including those regarding expected market rates of return and volatility, contract surrender rates and mortality experience. The following summarizes the balances of and changes in the liabilities for GDBs (in millions), which were recorded in future contract benefits on our Consolidated Balance Sheets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Balance as of beginning-of-year | $ | |
| $ | |
|
|
Changes in reserves |
| |
|
| |
|
|
Benefits paid |
| ( | ) |
| ( | ) |
|
Balance as of end-of-period | $ | |
| $ | |
|
|
Variable Annuity Contracts
Account balances of variable annuity contracts, including those with guarantees, (in millions) were invested in separate account investment options as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of |
|
| As of |
|
| ||
| March 31, |
|
| December 31, |
|
| ||
| 2022 |
|
| 2021 |
|
| ||
Asset Type |
|
|
|
|
|
|
|
|
Domestic equity | $ | |
|
| $ | |
|
|
International equity |
| |
|
|
| |
|
|
Fixed income |
| |
|
|
| |
|
|
Total | $ | |
|
| $ | |
|
|
|
|
|
|
|
|
|
|
|
Secondary Guarantee Products
The liability for unpaid claims consists primarily of long-term disability claims and is reported in future contract benefits on our Consolidated Balance Sheets. Changes in the liability for unpaid claims (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Balance as of beginning-of-year | $ | |
| $ | |
|
Reinsurance recoverable |
| |
|
| |
|
Net balance as of beginning-of-year |
| |
|
| |
|
Incurred related to: |
|
|
|
|
|
|
Current year |
| |
|
| |
|
Prior years: |
|
|
|
|
|
|
Interest |
| |
|
| |
|
All other incurred (1) |
| ( | ) |
| ( | ) |
Total incurred |
| |
|
| |
|
Paid related to: |
|
|
|
|
|
|
Current year |
| ( | ) |
| ( | ) |
Prior years |
| ( | ) |
| ( | ) |
Total paid |
| ( | ) |
| ( | ) |
Net balance as of end-of-period |
| |
|
| |
|
Reinsurance recoverable |
| |
|
| |
|
Balance as of end-of-period | $ | |
| $ | |
|
(1)All other incurred is primarily impacted by the level of claim resolutions in the period compared to that which is expected by the reserve assumption. A negative number implies a favorable result where claim resolutions were more favorable than assumed. Our claim resolution rate assumption used in determining reserves is our expectation of the resolution rate we will experience over the long-term life of the block of claims. It will vary from actual experience in any one period, both favorably and unfavorably.
The interest rate assumption used for discounting long-term claim reserves is an important part of the reserving process due to the long benefit period for these claims. Interest accrued on prior years’ reserves has been calculated on the opening reserve balance less one-half of the prior years’ incurred claim payments at our average reserve discount rate.
Changes in debt (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| |
|
| Months Ended |
|
| |
|
| March 31, |
|
| |
|
| 2022 |
|
| |
Balance as of beginning-of-year |
| $ | |
|
|
|
| |
|
| |
Repayment of |
|
| ( | ) |
|
Unamortized premiums (discounts) |
|
| ( | ) |
|
Unamortized debt issuance costs |
|
| ( | ) |
|
Unamortized adjustments from discontinued hedges |
|
| ( | ) |
|
Fair value hedge on interest rate swap agreements |
|
| ( | ) |
|
Balance as of end-of-period |
| $ | |
|
|
Contingencies
Regulatory and Litigation Matters
Regulatory bodies, such as state insurance departments, the SEC, Financial Industry Regulatory Authority and other regulatory bodies regularly make inquiries and conduct examinations or investigations concerning our compliance with, among other things, insurance laws, securities laws, laws governing the activities of broker-dealers, registered investment advisers and unclaimed property laws.
LNC is involved in various pending or threatened legal or regulatory proceedings, including purported class actions, arising from the conduct of business both in the ordinary course and otherwise. In some of the matters, very large and/or indeterminate amounts, including punitive and treble damages, are sought. Modern pleading practice in the U.S. permits considerable variation in the assertion of monetary damages or other relief. Jurisdictions may permit claimants not to specify the monetary damages sought or may permit claimants to state only that the amount sought is sufficient to invoke the jurisdiction of the trial court. In addition, jurisdictions may permit plaintiffs to allege monetary damages in amounts well exceeding verdicts obtained in the jurisdiction for similar matters. This variability in pleadings, together with the actual experiences of LNC in litigating or resolving through settlement numerous claims over an extended period of time, demonstrates to management that the monetary relief which may be specified in a lawsuit or claim bears little relevance to its merits or disposition value.
Due to the unpredictable nature of litigation, the outcome of a litigation matter and the amount or range of potential loss at particular points in time is normally difficult to ascertain. Uncertainties can include how fact finders will evaluate documentary evidence and the credibility and effectiveness of witness testimony, and how trial and appellate courts will apply the law in the context of the pleadings or evidence presented, whether by motion practice, or at trial or on appeal. Disposition valuations are also subject to the uncertainty of how opposing parties and their counsel will themselves view the relevant evidence and applicable law.
We establish liabilities for litigation and regulatory loss contingencies when information related to the loss contingencies shows both that it is probable that a loss has been incurred and the amount of the loss can be reasonably estimated. It is possible that some matters could require us to pay damages or make other expenditures or establish accruals in amounts that could not be estimated as of March 31, 2022.
For some matters, the Company is able to estimate a reasonably possible range of loss. For such matters in which a loss is probable, an accrual has been made. For such matters where a loss is believed to be reasonably possible, but not probable, no accrual has been made. Accordingly, the estimate contained in this paragraph reflects two types of matters. For some matters included within this estimate, an accrual has been made, but there is a reasonable possibility that an exposure exists in excess of the amount accrued. In these cases, the estimate reflects the reasonably possible range of loss in excess of the accrued amount. For other matters included within this estimation, no accrual has been made because a loss, while potentially estimable, is believed to be reasonably possible but not probable. In these cases, the estimate reflects the reasonably possible loss or range of loss. As of March 31, 2022, we estimate the aggregate range of reasonably possible losses, including amounts in excess of amounts accrued for these matters as of such date, to be up to approximately $
For other matters, we are not currently able to estimate the reasonably possible loss or range of loss. We are often unable to estimate the possible loss or range of loss until developments in such matters have provided sufficient information to support an assessment of the range of possible loss, such as quantification of a damage demand from plaintiffs, discovery from other parties and investigation of factual allegations, rulings by the court on motions or appeals, analysis by experts and the progress of settlement negotiations. On a
quarterly and annual basis, we review relevant information with respect to litigation contingencies and update our accruals, disclosures and estimates of reasonably possible losses or ranges of loss based on such reviews.
Among other matters, we are presently engaged in litigation, including relating to cost of insurance rates (“Cost of Insurance and Other Litigation”), as described below. No accrual has been made for several of these matters. Although a loss is believed to be reasonably possible for these matters, we are not able to estimate a reasonably possible amount or range of potential liability. An adverse outcome in one or more of these matters may have a material impact on our consolidated financial statements, but, based on information currently known, management does not believe those cases are likely to have such an impact.
Reinsurance Disputes
Certain reinsurers have sought rate increases on certain yearly renewable term agreements. We are disputing the requested rate increases under these agreements. We may initiate legal proceedings, as necessary, under these agreements in order to protect our contractual rights. Additionally, reinsurers have initiated, and may in the future initiate, legal proceedings against us. We believe it is unlikely the outcome of these disputes would have a material impact on our consolidated financial statements.
Cost of Insurance and Other Litigation
Cost of Insurance Litigation
Glover v. Connecticut General Life Insurance Company and The Lincoln National Life Insurance Company, filed in the U.S. District Court for the District of Connecticut, No. 3:16-cv-00827, is a putative class action that was served on The Lincoln National Life Insurance Company (“LNL”) on June 8, 2016. Plaintiff is the owner of a universal life insurance policy who alleges that LNL charged more for non-guaranteed cost of insurance than permitted by the policy. Plaintiff seeks to represent all universal life and variable universal life policyholders who owned policies containing non-guaranteed cost of insurance provisions that are similar to those of Plaintiff’s policy and seeks damages on behalf of all such policyholders. On January 11, 2019, the court dismissed Plaintiff’s complaint in its entirety. In response, Plaintiff filed a motion for leave to amend the complaint, which we have opposed.
Hanks v. Lincoln Life & Annuity Company of New York (“LLANY”) and Voya Retirement Insurance and Annuity Company (“Voya”), filed in the U.S. District Court for the Southern District of New York, No. 1:16-cv-6399, is a putative class action that was served on LLANY on August 12, 2016. Plaintiff owns a universal life policy originally issued by Aetna (now Voya) and alleges that (i) Voya breached the terms of the policy when it increased non-guaranteed cost of insurance rates on Plaintiff’s policy; and (ii) LLANY, as reinsurer and administrator of Plaintiff’s policy, engaged in wrongful conduct related to the cost of insurance increase and was unjustly enriched as a result. Plaintiff seeks to represent all owners of Aetna life insurance policies that were subject to non-guaranteed cost of insurance rate increases in 2016 and seeks damages on their behalf. On March 13, 2019, the court issued an order granting plaintiff’s motion for class certification for the breach of contract claim and denying such motion with respect to the unjust enrichment claim against LLANY, and, on September 12, 2019, the court issued an order approving the parties’ joint stipulation of dismissal with respect to the unjust enrichment claim and dismissed LLANY as a defendant in the case. In light of LLANY’s role as reinsurer and administrator under the 1998 coinsurance agreement with Aetna (now Voya), and of the parties’ rights and obligations thereunder, LLANY continues to be actively engaged in the defense of this case. On September 30, 2020, the court denied plaintiff’s motion for summary judgment and granted in part Voya’s motion for summary judgment. On October 22, 2021, the parties informed the presiding judge that they have reached a settlement of the action, subject to court approval. On January 19, 2022, plaintiffs filed a renewed motion for preliminary approval of the class action settlement. The settlement, subject to final approval by the court, consists of $
EFG Bank AG, Cayman Branch, et al. v. The Lincoln National Life Insurance Company, pending in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:17-cv-02592, is a civil action filed on February 1, 2017. Plaintiffs own Legend Series universal life insurance policies originally issued by Jefferson-Pilot (now LNL). Plaintiffs allege that LNL breached the terms of policyholders’ contracts when it increased non-guaranteed cost of insurance rates beginning in 2016. We are vigorously defending this matter.
In re: Lincoln National COI Litigation, pending in the U.S. District Court for the Eastern District of Pennsylvania, Master File No. 2:16-cv-06605-GJP, is a consolidated litigation matter related to multiple putative class action filings that were consolidated by an order dated March 20, 2017. In addition to consolidating a number of existing matters, the order also covers any future cases filed in the same district related to the same subject matter. Plaintiffs own universal life insurance policies originally issued by Jefferson-Pilot (now LNL). Plaintiffs allege that LNL and LNC breached the terms of policyholders’ contracts by increasing non-guaranteed cost of insurance rates beginning in 2016. Plaintiffs seek to represent classes of policyowners and seek damages on their behalf. We are vigorously defending this matter.
In re: Lincoln National 2017 COI Rate Litigation, pending in the U.S. District Court for the Eastern District of Pennsylvania, Master File No. 2:17-cv-04150 is a consolidated litigation matter related to multiple putative class action filings that were consolidated by an order of the court in March 2018. Plaintiffs own universal life insurance policies originally issued by former Jefferson-Pilot (now LNL). Plaintiffs allege that LNL and LNC breached the terms of policyholders’ contracts by increasing non-guaranteed cost of insurance rates beginning in 2017. Plaintiffs seek to represent classes of policyholders and seek damages on their behalf. We are vigorously defending this matter.
Iwanski v. First Penn-Pacific Life Insurance Company (“FPP”), No. 2:18-cv-01573 filed in the U.S. District Court for the Eastern District of Pennsylvania is a putative class action that was filed on April 13, 2018. Plaintiff alleges that defendant FPP breached the terms of his life insurance policy by deducting non-guaranteed cost of insurance charges in excess of what is permitted by the policies. Plaintiff seeks to represent all owners of universal life insurance policies issued by FPP containing non-guaranteed cost of insurance provisions that are similar to those of Plaintiff’s policy and seeks damages on their behalf. Breach of contract is the only cause of action asserted. We are vigorously defending this matter.
TVPX ARS INC., as Securities Intermediary for Consolidated Wealth Management, LTD. v. The Lincoln National Life Insurance Company, filed in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:18-cv-02989, is a putative class action that was filed on July 17, 2018. Plaintiff alleges that LNL charged more for non-guaranteed cost of insurance than permitted by the policy. Plaintiff seeks to represent all universal life and variable universal life policyholders who own policies issued by LNL or its predecessors containing non-guaranteed cost of insurance provisions that are similar to those of Plaintiff’s policy and seeks damages on behalf of all such policyholders. We are vigorously defending this matter.
LSH Co. and Wells Fargo Bank, National Association, as securities intermediary for LSH Co. v. Lincoln National Corporation and The Lincoln National Life Insurance Company, pending in the U.S. District Court for the Eastern District of Pennsylvania, No. 2:18-cv-05529, is a civil action filed on December 21, 2018. Plaintiffs own universal life insurance policies originally issued by Jefferson-Pilot (now LNL). Plaintiffs allege that LNL breached the terms of policyholders’ contracts when it increased non-guaranteed cost of insurance rates in 2016 and 2017. We are vigorously defending this matter.
Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York, pending in the U.S. District Court for the Southern District of New York, No. 1:19-cv-06004, is a putative class action that was filed on June 27, 2019. Plaintiff alleges that LLANY charged more for non-guaranteed cost of insurance than was permitted by the policies. On March 31, 2022, the court issued an order granting plaintiff’s motion for class certification and certified a class of all current or former owners of six universal life insurance products issued by LLANY that were assessed a cost of insurance charge any time on or after June 27, 2013. Plaintiff seeks damages on behalf of the class. We are vigorously defending this matter.
Other Litigation
Andrew Nitkewicz v. Lincoln Life & Annuity Company of New York, pending in the U.S. District Court for the Southern District of New York, No. 1:20-cv-06805, is a putative class action that was filed on August 24, 2020. Plaintiff Andrew Nitkewicz, as trustee of the Joan C. Lupe Trust, seeks to represent all current and former owners of universal life (including variable universal life) policies who own or owned policies issued by LLANY and its predecessors in interest that were in force at any time on or after June 27, 2013, and for which planned annual, semi-annual, or quarterly premiums were paid for any period beyond the end of the policy month of the insured’s death. Plaintiff alleges LLANY failed to refund unearned premium in violation of New York Insurance Law Section 3203(a)(2) in connection with the payment of death benefit claims for certain insurance policies. Plaintiff seeks compensatory damages and pre-judgment interest on behalf of the various classes and sub-class. On July 2, 2021, the court granted, with prejudice, LLANY’s November 2020 motion to dismiss this matter. On July 28, 2021, plaintiff filed a notice of appeal with respect to this ruling.
Common Shares
The changes in our common stock (number of shares) were as follows:
|
|
|
|
|
| For the Three |
| ||
| Months Ended |
| ||
| March 31, |
| ||
| 2022 |
| 2021 |
|
Common Stock |
|
|
|
|
Balance as of beginning-of-year | |
| |
|
Stock compensation/issued for benefit plans | |
| |
|
Retirement/cancellation of shares | ( | ) | ( | ) |
Balance as of end-of-period | |
| |
|
|
|
|
|
|
Common Stock as of End-of-Period |
|
|
|
|
Basic basis | |
| |
|
Diluted basis | |
| |
|
Our common stock is without par value.
Average Shares
A reconciliation of the denominator (number of shares) in the calculations of basic and diluted earnings (loss) per common share was as follows:
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||
| Months Ended |
| ||
| March 31, |
| ||
| 2022 |
| 2021 |
|
Weighted-average shares, as used in basic calculation | |
| |
|
Shares to cover non-vested stock | |
| |
|
Average stock options outstanding during the period | |
| |
|
Assumed acquisition of shares with assumed |
|
|
|
|
proceeds and benefits from exercising stock |
|
|
|
|
options (at average market price for the period) | ( | ) | ( | ) |
Shares repurchasable from measured but |
|
|
|
|
unrecognized stock option expense | ( | ) | ( | ) |
Average deferred compensation shares | |
| - |
|
Weighted-average shares, as used in diluted calculation | |
| |
|
In the event the average market price of LNC common stock exceeds the issue price of stock options and the options have a dilutive effect to our earnings per share (“EPS”), such options will be shown in the table above.
We have participants in our deferred compensation plans who selected LNC stock as the measure for the investment return attributable to all or a portion of their deferral amounts. This obligation is settled in either cash or LNC stock pursuant to the applicable plan document. We exclude deferred units of LNC stock that are antidilutive from our diluted earnings per share calculation.
AOCI
The following summarizes the components and changes in AOCI (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain Other |
|
|
|
|
|
|
Investments |
|
|
|
|
|
|
Balance as of beginning-of-year | $ | |
| $ | |
|
Unrealized holding gains (losses) arising during the period |
| ( | ) |
| ( | ) |
Change in foreign currency exchange rate adjustment |
| ( | ) |
| ( | ) |
Change in DAC, VOBA, DSI, future contract benefits and other contract holder funds |
| |
|
| |
|
Income tax benefit (expense) |
| |
|
| |
|
Less: |
|
|
|
|
|
|
Reclassification adjustment for gains (losses) included in net income (loss) |
| ( | ) |
| |
|
Associated amortization of DAC, VOBA, DSI and DFEL |
| ( | ) |
| ( | ) |
Income tax benefit (expense) |
| |
|
| - |
|
Balance as of end-of-period | $ | |
| $ | |
|
Unrealized Gain (Loss) on Derivative Instruments |
|
|
|
|
|
|
Balance as of beginning-of-year | $ | ( | ) | $ | ( | ) |
Unrealized holding gains (losses) arising during the period |
| |
|
| |
|
Change in foreign currency exchange rate adjustment |
| |
|
| |
|
Change in DAC, VOBA, DSI and DFEL |
| |
|
| |
|
Income tax benefit (expense) |
| ( | ) |
| ( | ) |
Less: |
|
|
|
|
|
|
Reclassification adjustment for gains (losses) included in net income (loss) |
| |
|
| |
|
Associated amortization of DAC, VOBA, DSI and DFEL |
| ( | ) |
| ( | ) |
Income tax benefit (expense) |
| ( | ) |
| - |
|
Balance as of end-of-period | $ | ( | ) | $ | ( | ) |
Foreign Currency Translation Adjustment |
|
|
|
|
|
|
Balance as of beginning-of-year | $ | ( | ) | $ | ( | ) |
Foreign currency translation adjustment arising during the period |
| ( | ) |
| |
|
Balance as of end-of-period | $ | ( | ) | $ | ( | ) |
Funded Status of Employee Benefit Plans |
|
|
|
|
|
|
Balance as of beginning-of-year | $ | ( | ) | $ | ( | ) |
Adjustment arising during the period |
| |
|
| ( | ) |
Income tax benefit (expense) |
| ( | ) |
| - |
|
Balance as of end-of-period | $ | ( | ) | $ | ( | ) |
The following summarizes the reclassifications out of AOCI (in millions) and the associated line item in the Consolidated Statements of Comprehensive Income (Loss):
|
|
|
|
|
|
|
|
|
| For the Three |
|
| |||||
| Months Ended |
|
| |||||
| March 31, |
|
| |||||
| 2022 |
|
| 2021 |
|
| ||
Unrealized Gain (Loss) on Fixed Maturity AFS |
|
|
|
|
|
|
|
|
Securities and Certain Other Investments |
|
|
|
|
|
|
|
|
Gross reclassification | $ | ( | ) |
| $ | |
| Realized gain (loss) |
Associated amortization of DAC, |
|
|
|
|
|
|
|
|
VOBA, DSI and DFEL |
| ( | ) |
|
| ( | ) | Realized gain (loss) |
Reclassification before income |
|
|
|
|
|
|
|
|
tax benefit (expense) |
| ( | ) |
|
| ( | ) | Income (loss) before taxes |
Income tax benefit (expense) |
| |
|
|
| - |
| Federal income tax expense (benefit) |
Reclassification, net of income tax | $ | ( | ) |
| $ | ( | ) | Net income (loss) |
|
|
|
|
|
|
|
|
|
Unrealized Gain (Loss) on Derivative Instruments |
|
|
|
|
|
|
|
|
Gross reclassifications: |
|
|
|
|
|
|
|
|
Interest rate contracts | $ | |
|
| $ | |
| Net investment income |
Interest rate contracts |
| ( | ) |
|
| ( | ) | Interest and debt expense |
Foreign currency contracts |
| |
|
|
| |
| Net investment income |
Foreign currency contracts |
| |
|
|
| ( | ) | Realized gain (loss) |
Total gross reclassifications |
| |
|
|
| |
|
|
Associated amortization of DAC, |
|
|
|
|
|
|
| Commissions and other |
VOBA, DSI and DFEL |
| ( | ) |
|
| ( | ) | expenses |
Reclassifications before income |
|
|
|
|
|
|
|
|
tax benefit (expense) |
| |
|
|
| |
| Income (loss) before taxes |
Income tax benefit (expense) |
| ( | ) |
|
| - |
| Federal income tax expense (benefit) |
Reclassifications, net of income tax | $ | |
|
| $ | |
| Net income (loss) |
Realized gain (loss) on our Consolidated Statements of Comprehensive Income (Loss) includes realized gains and losses from the sale of investments, write-downs for impairments of investments and changes in the allowance for credit losses for financial assets, changes in fair value for mortgage loans on real estate accounted for under the fair value option, changes in fair value of equity securities, certain derivative and embedded derivative gains and losses, gains and losses on the sale of subsidiaries and businesses and net gains and losses on reinsurance embedded derivatives and trading securities. Realized gains and losses on the sale of investments are determined using the specific identification method. Realized gain (loss) is recognized in net income, net of associated amortization of DAC, VOBA, DSI and DFEL. Realized gain (loss) is also net of allocations of investment gains and losses to certain contract holders and certain funds withheld on reinsurance arrangements for which we have a contractual obligation. Details underlying realized gain (loss) (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Fixed maturity AFS securities: |
|
|
|
|
|
|
Gross gains | $ | |
| $ | |
|
Gross losses |
| ( | ) |
| ( | ) |
Credit loss benefit (expense) (1) |
| ( | ) |
| ( | ) |
Realized gain (loss) on equity securities (2) |
| |
|
| |
|
Credit loss benefit (expense) on mortgage loans on real estate |
| |
|
| |
|
Credit loss benefit (expense) on reinsurance-related assets |
| ( | ) |
| - |
|
Other gain (loss) on investments |
| ( | ) |
| |
|
Associated amortization of DAC, VOBA, DSI and DFEL |
|
|
|
|
|
|
and changes in other contract holder funds |
| ( | ) |
| ( | ) |
Total realized gain (loss) related to certain financial assets |
| |
|
| |
|
Realized gain (loss) on the mark-to-market on certain instruments (3)(4) |
| ( | ) |
| |
|
Indexed annuity and IUL contracts net derivative results: (5) |
|
|
|
|
|
|
Gross gain (loss) |
| |
|
| |
|
Associated amortization of DAC, VOBA, DSI and DFEL |
| ( | ) |
| ( | ) |
Variable annuity net derivative results: (6) |
|
|
|
|
|
|
Gross gain (loss) |
| ( | ) |
| ( | ) |
Associated amortization of DAC, VOBA, DSI and DFEL |
| |
|
| |
|
Total realized gain (loss) | $ | |
| $ | ( | ) |
(1)Includes changes in the allowance for credit losses as well as direct write-downs to amortized cost as a result of negative credit events.
(2)Includes market adjustments on equity securities still held of $
(3)Represents changes in the fair values of certain derivative investments (not including those associated with our variable and indexed annuity and IUL contracts net derivative results), reinsurance-related embedded derivatives, mortgage loans on real estate accounted for under the fair value option and trading securities.
(4)Includes gains and losses from fair value changes on mortgage loans on real estate accounted for under the fair value option of $(
(5)Represents the net difference between the change in fair value of the index options that we hold and the change in the fair value of the embedded derivative liabilities of our indexed annuity and IUL contracts along with changes in the fair value of embedded derivative liabilities related to index options we may purchase or sell in the future to hedge contract holder index allocations applicable to future reset periods for our indexed annuity products.
(6)Includes the net difference in the change in embedded derivative reserves of our GLB riders and the change in the fair value of the derivative instruments we own to hedge the change in embedded derivative reserves on our GLB riders and the benefit ratio unlocking on our GLB and GDB riders, including the cost of purchasing the hedging instruments.
13. Fair Value of Financial Instruments
The carrying values and estimated fair values of our financial instruments (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| As of December 31, 2021 |
| ||||||||
| Carrying |
| Fair |
| Carrying |
| Fair |
| ||||
| Value |
| Value |
| Value |
| Value |
| ||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities | $ | |
| $ | |
| $ | |
| $ | |
|
Trading securities |
| |
|
| |
|
| |
|
| |
|
Equity securities |
| |
|
| |
|
| |
|
| |
|
Mortgage loans on real estate |
| |
|
| |
|
| |
|
| |
|
Derivative investments (1) |
| |
|
| |
|
| |
|
| |
|
Other investments |
| |
|
| |
|
| |
|
| |
|
Cash and invested cash |
| |
|
| |
|
| |
|
| |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
GLB direct embedded derivatives |
| |
|
| |
|
| |
|
| |
|
GLB ceded embedded derivatives |
| |
|
| |
|
| |
|
| |
|
Reinsurance-related embedded derivatives |
| |
|
| |
|
| - |
|
| - |
|
Indexed annuity ceded embedded derivatives |
| |
|
| |
|
| |
|
| |
|
Separate account assets |
| |
|
| |
|
| |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
Future contract benefits – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
and IUL contracts embedded derivatives |
| ( | ) |
| ( | ) |
| ( | ) |
| ( | ) |
Other contract holder funds: |
|
|
|
|
|
|
|
|
|
|
|
|
Remaining guaranteed interest and similar contracts |
| ( | ) |
| ( | ) |
| ( | ) |
| ( | ) |
Account values of certain investment contracts |
| ( | ) |
| ( | ) |
| ( | ) |
| ( | ) |
Short-term debt |
| - |
|
| - |
|
| ( | ) |
| ( | ) |
Long-term debt |
| ( | ) |
| ( | ) |
| ( | ) |
| ( | ) |
Reinsurance-related embedded derivatives |
| - |
|
| - |
|
| ( | ) |
| ( | ) |
Other liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities (1) |
| ( | ) |
| ( | ) |
| ( | ) |
| ( | ) |
GLB ceded embedded derivatives |
| ( | ) |
| ( | ) |
| ( | ) |
| ( | ) |
(1)We have master netting agreements with each of our derivative counterparties, which allow for the netting of our derivative asset and liability positions by counterparty.
Valuation Methodologies and Associated Inputs for Financial Instruments Not Carried at Fair Value
The following discussion outlines the methodologies and assumptions used to determine the fair value of our financial instruments not carried at fair value on our Consolidated Balance Sheets. Considerable judgment is required to develop these assumptions used to measure fair value. Accordingly, the estimates shown are not necessarily indicative of the amounts that would be realized in a one-time, current market exchange of all of our financial instruments.
Mortgage Loans on Real Estate
The fair value of mortgage loans on real estate, excluding mortgage loans accounted for using the fair value option, is established using a discounted cash flow method based on credit rating, maturity and future income. The ratings for mortgages in good standing are based on property type, location, market conditions, occupancy, debt-service coverage, loan-to-value, quality of tenancy, borrower and payment record. The fair value for impaired mortgage loans is based on the present value of expected future cash flows discounted at the loan’s effective interest rate, the loan’s market price or the fair value of the collateral if the loan is collateral dependent. The inputs used to measure the fair value of our mortgage loans on real estate, excluding mortgage loans accounted for using the fair value option, are classified as Level 2 within the fair value hierarchy.
Other Investments
The carrying value of our assets classified as other investments, excluding short-term investments, approximates fair value. Other investments includes primarily LPs and other privately held investments that are accounted for using the equity method of accounting and the carrying value is based on our proportional share of the net assets of the LPs. Other investments also includes FHLB stock carried at cost and periodically evaluated for impairment based on ultimate recovery of par value. The inputs used to measure the fair value of our
LPs, other privately held investments and FHLB stock are classified as Level 3 within the fair value hierarchy. The remaining assets in other investments include cash collateral receivables and securities that are not LPs or other privately held investments. The inputs used to measure the fair value of these assets are classified as Level 2 within the fair value hierarchy.
Separate Account Assets
Separate account assets are primarily carried at fair value. A portion of our separate account assets includes LPs, which are accounted for using the equity method of accounting. The carrying value is based on our proportional share of the net assets of the LPs and approximates fair value. The inputs used to measure the fair value of the separate account asset LPs are classified as Level 3 within the fair value hierarchy.
Other Contract Holder Funds
Other contract holder funds include remaining guaranteed interest and similar contracts and account values of certain investment contracts. The fair value for the remaining guaranteed interest and similar contracts is estimated using discounted cash flow calculations as of the balance sheet date. These calculations are based on interest rates currently offered on similar contracts with maturities that are consistent with those remaining for the contracts being valued. As of March 31, 2022, and December 31, 2021, the remaining guaranteed interest and similar contracts carrying value approximated fair value. The fair value of the account values of certain investment contracts is based on their approximate surrender value as of the balance sheet date. The inputs used to measure the fair value of our other contract holder funds are classified as Level 3 within the fair value hierarchy.
Short-Term and Long-Term Debt
The fair value of short-term and long-term debt is based on quoted market prices. The inputs used to measure the fair value of our short-term and long-term debt are classified as Level 2 within the fair value hierarchy.
Fair Value Option
Mortgage loans on real estate, net of allowance for credit losses, as reported on our Consolidated Balance Sheets, includes mortgage loans on real estate for which the fair value option was elected. The fair value option allows us to elect fair value as an alternative measurement for mortgage loans not otherwise reported at fair value. We have made these elections for certain mortgage loans associated with modified coinsurance agreements to help mitigate the inconsistency in earnings that would otherwise result from the use of embedded derivatives included with these loans. Changes in fair value are reflected in realized gain (loss) on our Consolidated Statement of Comprehensive Income (Loss). Changes in fair value due to instrument-specific credit risk are estimated using changes in credit spreads and quality ratings for the period reported. Mortgage loans on real estate for which the fair value option was elected are valued using third-party pricing services. We have procedures in place to review the valuations each quarter to ensure they are reasonable, including utilizing a separate third party to reperform the valuation for a selection of mortgage loans on an annual basis. Due to lack of observable inputs, mortgage loans electing the fair value option are categorized as Level 3 within the fair value hierarchy.
The fair value and aggregate contractual principal for mortgage loans on real estate where the fair value option was elected (in millions) were as follows:
|
|
|
|
|
|
|
|
| As of |
| As of |
|
| ||
| March 31, |
| December 31, |
|
| ||
| 2022 |
| 2021 |
|
| ||
Fair value | $ | |
| $ | |
|
|
Aggregate contractual principal |
| |
|
| |
|
|
As of March 31, 2022, and December 31, 2021,
Financial Instruments Carried at Fair Value
Short-Term Investments
Short-term investments consist of securities with original maturities of one year or less, but greater than three months, and are included in other investments on our Consolidated Balance Sheets. Securities included in short-term investments are carried at fair value, with valuation methods and inputs consistent with those applied to fixed maturity AFS securities.
We did
The following summarizes our financial instruments carried at fair value (in millions) on a recurring basis by the fair value hierarchy levels:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| |||||||||||||
|
| Quoted |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| Prices |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| in Active |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Markets for | Significant | Significant |
|
|
|
| |||||||||
|
| Identical |
| Observable | Unobservable |
| Total |
| ||||||||
|
| Assets |
|
| Inputs |
|
| Inputs |
|
| Fair |
| ||||
|
| (Level 1) |
|
| (Level 2) |
|
| (Level 3) |
|
| Value |
| ||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
| $ | - |
|
| $ | |
|
| $ | |
|
| $ | |
|
U.S. government bonds |
|
| |
|
|
| |
|
|
| - |
|
|
| |
|
State and municipal bonds |
|
| - |
|
|
| |
|
|
| - |
|
|
| |
|
Foreign government bonds |
|
| - |
|
|
| |
|
|
| |
|
|
| |
|
RMBS |
|
| - |
|
|
| |
|
|
| |
|
|
| |
|
CMBS |
|
| - |
|
|
| |
|
|
| |
|
|
| |
|
ABS |
|
| - |
|
|
| |
|
|
| |
|
|
| |
|
Hybrid and redeemable preferred securities |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Trading securities |
|
| - |
|
|
| |
|
|
| |
|
|
| |
|
Equity securities |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Mortgage loans on real estate |
|
| - |
|
|
| - |
|
|
| |
|
|
| |
|
Derivative investments (1) |
|
| - |
|
|
| |
|
|
| |
|
|
| |
|
Other investments – short-term investments |
|
| - |
|
|
| |
|
|
| - |
|
|
| |
|
Cash and invested cash |
|
| - |
|
|
| |
|
|
| - |
|
|
| |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GLB direct embedded derivatives |
|
| - |
|
|
| - |
|
|
| |
|
|
| |
|
GLB ceded embedded derivatives |
|
| - |
|
|
| - |
|
|
| |
|
|
| |
|
Reinsurance-related embedded derivatives |
|
| - |
|
|
| |
|
|
| - |
|
|
| |
|
Indexed annuity ceded embedded derivatives |
|
| - |
|
|
| - |
|
|
| |
|
|
| |
|
Separate account assets |
|
| |
|
|
| |
|
|
| - |
|
|
| |
|
Total assets |
| $ | |
|
| $ | |
|
| $ | |
|
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future contract benefits – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and IUL contracts embedded derivatives |
| $ | - |
|
| $ | - |
|
| $ | ( | ) |
| $ | ( | ) |
Other liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities (1) |
|
| - |
|
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
GLB ceded embedded derivatives |
|
| - |
|
|
| - |
|
|
| ( | ) |
|
| ( | ) |
Total liabilities |
| $ | - |
|
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2021 |
| |||||||||||||
|
| Quoted |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| Prices |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| in Active |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Markets for | Significant | Significant |
|
|
|
| |||||||||
|
| Identical |
| Observable | Unobservable |
| Total |
| ||||||||
|
| Assets |
|
| Inputs |
|
| Inputs |
|
| Fair |
| ||||
|
| (Level 1) |
|
| (Level 2) |
|
| (Level 3) |
|
| Value |
| ||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds |
| $ | - |
|
| $ | |
|
| $ | |
|
| $ | |
|
U.S. government bonds |
|
| |
|
|
| |
|
|
| - |
|
|
| |
|
State and municipal bonds |
|
| - |
|
|
| |
|
|
| - |
|
|
| |
|
Foreign government bonds |
|
| - |
|
|
| |
|
|
| |
|
|
| |
|
RMBS |
|
| - |
|
|
| |
|
|
| |
|
|
| |
|
CMBS |
|
| - |
|
|
| |
|
|
| - |
|
|
| |
|
ABS |
|
| - |
|
|
| |
|
|
| |
|
|
| |
|
Hybrid and redeemable preferred securities |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Trading securities |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Equity securities |
|
| |
|
|
| |
|
|
| |
|
|
| |
|
Mortgage loans on real estate |
|
| - |
|
|
| - |
|
|
| |
|
|
| |
|
Derivative investments (1) |
|
| - |
|
|
| |
|
|
| |
|
|
| |
|
Other investments – short-term investments |
|
| - |
|
|
| |
|
|
| - |
|
|
| |
|
Cash and invested cash |
|
| - |
|
|
| |
|
|
| - |
|
|
| |
|
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GLB direct embedded derivatives |
|
| - |
|
|
| - |
|
|
| |
|
|
| |
|
GLB ceded embedded derivatives |
|
| - |
|
|
| - |
|
|
| |
|
|
| |
|
Indexed annuity ceded embedded derivatives |
|
| - |
|
|
| - |
|
|
| |
|
|
| |
|
Separate account assets |
|
| |
|
|
| |
|
|
| - |
|
|
| |
|
Total assets |
| $ | |
|
| $ | |
|
| $ | |
|
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future contract benefits – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and IUL contracts embedded derivatives |
| $ | - |
|
| $ | - |
|
| $ | ( | ) |
| $ | ( | ) |
Reinsurance-related embedded derivatives |
|
| - |
|
|
| ( | ) |
|
| - |
|
|
| ( | ) |
Other liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities (1) |
|
| - |
|
|
| ( | ) |
|
| ( | ) |
|
| ( | ) |
GLB ceded embedded derivatives |
|
| - |
|
|
| - |
|
|
| ( | ) |
|
| ( | ) |
Total liabilities |
| $ | - |
|
| $ | ( | ) |
| $ | ( | ) |
| $ | ( | ) |
(1)Derivative investment assets and liabilities are presented within the fair value hierarchy on a gross basis by derivative type and not on a master netting basis by counterparty.
The following summarizes changes to our financial instruments carried at fair value (in millions) and classified within Level 3 of the fair value hierarchy. This summary excludes any effect of amortization of DAC, VOBA, DSI and DFEL. The gains and losses below may include changes in fair value due in part to observable inputs that are a component of the valuation methodology.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three Months Ended March 31, 2022 |
| ||||||||||||||||
|
|
|
|
|
|
| Gains | Issuances, | Transfers |
|
|
|
| |||||
|
|
|
| Items |
| (Losses) |
| Sales, |
| Into or |
|
|
|
| ||||
|
|
|
| Included |
| in | Maturities, | Out |
|
|
|
| ||||||
| Beginning |
| in |
| OCI | Settlements, | of |
| Ending |
| ||||||||
| Fair |
| Net |
| and |
| Calls, |
| Level 3, |
| Fair |
| ||||||
| Value |
| Income |
| Other (1) |
| Net |
| Net |
| Value |
| ||||||
Investments: (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | |
| $ | ( | ) | $ | |
| $ | |
| $ | |
|
Foreign government bonds |
| |
|
|
|
|
| ( | ) |
|
|
|
|
|
|
| |
|
RMBS |
| |
|
|
|
|
|
|
|
| |
|
| ( | ) |
| |
|
CMBS |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
| |
|
ABS |
| |
|
|
|
|
| ( | ) |
| |
|
| ( | ) |
| |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
| |
|
|
|
|
| |
|
|
|
|
|
|
|
| |
|
Trading securities |
| |
|
| ( | ) |
|
|
|
| |
|
| ( | ) |
| |
|
Equity securities |
| |
|
| |
|
|
|
|
| ( | ) |
|
|
|
| |
|
Mortgage loans on real estate |
| |
|
| ( | ) |
| ( | ) |
| ( | ) |
|
|
|
| |
|
Derivative investments |
| |
|
| |
|
| ( | ) |
|
|
|
| ( | ) |
| |
|
Other assets: (3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GLB direct embedded derivatives |
| |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
| |
|
GLB ceded embedded derivatives |
| |
|
| ( | ) |
|
|
|
|
|
|
|
|
|
| |
|
Indexed annuity ceded embedded derivatives |
| |
|
| ( | ) |
|
|
|
| |
|
|
|
|
| |
|
Future contract benefits – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and IUL contracts embedded derivatives (3) |
| ( | ) |
| |
|
|
|
|
| ( | ) |
|
|
|
| ( | ) |
Other liabilities – GLB ceded embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives (3) |
| ( | ) |
| |
|
|
|
|
|
|
|
|
|
|
| ( | ) |
Total, net | $ | |
| $ | |
| $ | ( | ) | $ | |
| $ | |
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three Months Ended March 31, 2021 |
| ||||||||||||||||
|
|
|
|
|
|
| Gains | Issuances, | Transfers |
|
|
|
| |||||
|
|
|
| Items |
| (Losses) |
| Sales, |
| Into or |
|
|
|
| ||||
|
|
|
| Included |
| in | Maturities, | Out |
|
|
|
| ||||||
| Beginning |
| in |
| OCI | Settlements, | of |
| Ending |
| ||||||||
| Fair |
| Net |
| and |
| Calls, |
| Level 3, |
| Fair |
| ||||||
| Value |
| Income |
| Other (1) |
| Net |
| Net |
| Value |
| ||||||
Investments: (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | |
| $ | ( | ) | $ | |
| $ | ( | ) | $ | |
|
U.S. government bonds |
| |
|
| - |
|
| - |
|
| - |
|
| - |
|
| |
|
Foreign government bonds |
| |
|
| - |
|
| ( | ) |
| - |
|
| - |
|
| |
|
RMBS |
| |
|
| - |
|
| - |
|
| - |
|
| - |
|
| |
|
CMBS |
| - |
|
| |
|
| - |
|
| - |
|
| - |
|
| |
|
ABS |
| |
|
| - |
|
| ( | ) |
| |
|
| ( | ) |
| |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
| |
|
| - |
|
| |
|
| ( | ) |
| - |
|
| |
|
Trading securities |
| |
|
| ( | ) |
| - |
|
| |
|
| |
|
| |
|
Equity securities |
| |
|
| |
|
| - |
|
| ( | ) |
| - |
|
| |
|
Mortgage loans on real estate |
| |
|
| |
|
| |
|
| |
|
| - |
|
| |
|
Derivative investments |
| |
|
| |
|
| - |
|
| ( | ) |
| - |
|
| |
|
Other assets: (3) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GLB direct embedded derivatives |
| |
|
| |
|
| - |
|
| - |
|
| - |
|
| |
|
GLB ceded embedded derivatives |
| |
|
| ( | ) |
| - |
|
| - |
|
| - |
|
| |
|
Indexed annuity ceded embedded derivatives |
| |
|
| |
|
| - |
|
| ( | ) |
| - |
|
| |
|
Future contract benefits – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and IUL contracts embedded derivatives (3) |
| ( | ) |
| ( | ) |
| - |
|
| |
|
| - |
|
| ( | ) |
Other liabilities – GLB ceded embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives (3) |
| - |
|
| ( | ) |
| - |
|
| - |
|
| - |
|
| ( | ) |
Total, net | $ | |
| $ | |
| $ | ( | ) | $ | |
| $ | ( | ) | $ | |
|
(1)The changes in fair value of the interest rate swaps are offset by an adjustment to derivative investments (see Note 5).
(2)Amortization and accretion of premiums and discounts are included in net investment income on our Consolidated Statements of Comprehensive Income (Loss). Gains (losses) from sales, maturities, settlements and calls and credit loss expense are included in realized gain (loss) on our Consolidated Statements of Comprehensive Income (Loss).
(3)Gains (losses) from the changes in fair value are included in realized gain (loss) on our Consolidated Statements of Comprehensive Income (Loss).
The following provides the components of the items included in issuances, sales, maturities, settlements and calls, net, excluding any effect of amortization of DAC, VOBA, DSI and DFEL and changes in future contract benefits, (in millions) as reported above:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three Months Ended March 31, 2022 |
| ||||||||||||||||
| Issuances |
| Sales |
| Maturities | Settlements | Calls |
| Total |
| ||||||||
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | - |
| $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | |
|
RMBS |
| |
|
| - |
|
| - |
|
| - |
|
| - |
|
| |
|
CMBS |
| |
|
| - |
|
| - |
|
| - |
|
| - |
|
| |
|
ABS |
| |
|
| - |
|
| - |
|
| ( | ) |
| ( | ) |
| |
|
Trading securities |
| |
|
| ( | ) |
| - |
|
| ( | ) |
| - |
|
| |
|
Equity securities |
| - |
|
| ( | ) |
| - |
|
| - |
|
| - |
|
| ( | ) |
Mortgage loans on real estate |
| |
|
| - |
|
| - |
|
| ( | ) |
| - |
|
| ( | ) |
Other assets – indexed annuity ceded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
embedded derivatives |
| |
|
| - |
|
| - |
|
| |
|
| - |
|
| |
|
Future contract benefits – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and IUL contracts embedded derivatives |
| ( | ) |
| - |
|
| - |
|
| |
|
| - |
|
| ( | ) |
Total, net | $ | |
| $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three Months Ended March 31, 2021 |
| ||||||||||||||||
| Issuances |
| Sales |
| Maturities | Settlements | Calls |
| Total |
| ||||||||
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | |
|
ABS |
| |
|
| - |
|
| - |
|
| ( | ) |
| - |
|
| |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
securities |
| - |
|
| ( | ) |
| - |
|
| - |
|
| - |
|
| ( | ) |
Trading securities |
| |
|
| ( | ) |
| - |
|
| ( | ) |
| - |
|
| |
|
Equity securities |
| |
|
| ( | ) |
| - |
|
| - |
|
| - |
|
| ( | ) |
Mortgage loans on real estate |
| |
|
| ( | ) |
| - |
|
| - |
|
| - |
|
| |
|
Derivative investments |
| |
|
| ( | ) |
| ( | ) |
| - |
|
| - |
|
| ( | ) |
Other assets – indexed annuity ceded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
embedded derivatives |
| |
|
| - |
|
| - |
|
| ( | ) |
| - |
|
| ( | ) |
Future contract benefits – indexed annuity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
and IUL contracts embedded derivatives |
| ( | ) |
| - |
|
| - |
|
| |
|
| - |
|
| |
|
Total, net | $ | |
| $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | ( | ) | $ | |
|
The following summarizes changes in unrealized gains (losses) included in net income, excluding any effect of amortization of DAC, VOBA, DSI and DFEL and changes in future contract benefits, related to financial instruments carried at fair value classified within Level 3 that we still held (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Trading securities | $ | ( | ) | $ | ( | ) |
|
Equity securities |
| |
|
| |
|
|
Mortgage loans on real estate |
| ( | ) |
| |
|
|
Derivative investments |
| |
|
| |
|
|
GLB embedded derivatives |
| |
|
| |
|
|
Embedded derivatives – indexed annuity |
|
|
|
|
|
|
|
and IUL contracts |
| |
|
| |
|
|
Total, net (1) | $ | |
| $ | |
|
|
(1)Included in realized gain (loss) on our Consolidated Statements of Comprehensive Income (Loss).
The following summarizes changes in unrealized gains (losses) included in OCI, net of tax, excluding any effect of amortization of DAC, VOBA, DSI and DFEL and changes in future contract benefits, related to financial instruments carried at fair value classified within Level 3 that we still held (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
Corporate bonds | $ | ( | ) | $ | ( | ) |
|
Foreign government bonds |
| ( | ) |
| ( | ) |
|
ABS |
| ( | ) |
| ( | ) |
|
Hybrid and redeemable preferred |
|
|
|
|
|
|
|
securities |
| |
|
| |
|
|
Mortgage loans on real estate |
| - |
|
| |
|
|
Total, net | $ | ( | ) | $ | ( | ) |
|
The following provides the components of the transfers into and out of Level 3 (in millions) as reported above:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| For the Three |
| ||||||||||||||
| Months Ended |
| Months Ended |
| ||||||||||||||
| March 31, 2022 |
| March 31, 2021 |
| ||||||||||||||
| Transfers |
| Transfers |
|
|
|
| Transfers |
| Transfers |
|
|
|
| ||||
| Into |
| Out of |
|
|
|
| Into |
| Out of |
|
|
|
| ||||
| Level 3 |
| Level 3 |
| Total |
| Level 3 |
| Level 3 |
| Total |
| ||||||
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| $ | ( | ) | $ | |
| $ | |
| $ | ( | ) | $ | ( | ) |
RMBS |
| - |
|
| ( | ) |
| ( | ) |
| - |
|
| - |
|
| - |
|
ABS |
| - |
|
| ( | ) |
| ( | ) |
| - |
|
| ( | ) |
| ( | ) |
Trading securities |
| - |
|
| ( | ) |
| ( | ) |
| |
|
| ( | ) |
| |
|
Derivative investments |
| - |
|
| ( | ) |
| ( | ) |
| - |
|
| - |
|
| - |
|
Total, net | $ | |
| $ | ( | ) | $ | |
| $ | |
| $ | ( | ) | $ | ( | ) |
Transfers into and out of Level 3 are generally the result of observable market information on financial instruments no longer being available or becoming available to our pricing vendors. For the three months ended March 31, 2022 and 2021, transfers in and out of Level 3 were attributable primarily to the financial instruments’ observable market information no longer being available or becoming available.
The following summarizes the fair value (in millions), valuation techniques and significant unobservable inputs of the Level 3 fair value measurements as of March 31, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Weighted | ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Average | ||
| Fair |
| Valuation |
| Significant |
| Assumption or |
| Input | ||||||||||
| Value |
| Technique |
| Unobservable Inputs |
| Input Ranges |
| Range (1) | ||||||||||
Assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investments: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS and |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
trading securities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate bonds | $ | |
| Discounted cash flow |
| Liquidity/duration adjustment (2) |
| % |
| - | % |
| % |
| |||||
Foreign government |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
bonds |
| |
| Discounted cash flow |
| Liquidity/duration adjustment (2) |
| % |
| - | % |
| % |
| |||||
ABS |
| |
| Discounted cash flow |
| Liquidity/duration adjustment (2) |
| % |
| - | % |
| % |
| |||||
Hybrid and redeemable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
preferred securities |
| |
| Discounted cash flow |
| Liquidity/duration adjustment (2) |
| % |
| - | % |
| % |
| |||||
Equity securities |
| |
| Discounted cash flow |
| Liquidity/duration adjustment (2) |
| % |
| - | % |
| % |
| |||||
Other assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GLB direct and ceded |
| |
| Discounted cash flow |
| Long-term lapse rate (3) |
| % |
| - | % |
| (10) |
|
| ||||
embedded derivatives |
|
|
|
|
| Utilization of guaranteed withdrawals (4) | % |
| - | % |
| % |
| ||||||
|
|
|
|
|
|
| Claims utilization factor (5) |
| % |
| - | % |
| (10) |
|
| |||
|
|
|
|
|
|
| Premiums utilization factor (5) |
| % |
| - | % |
| (10) |
|
| |||
|
|
|
|
|
|
| NPR (6) |
| % |
| - | % |
| % |
| ||||
|
|
|
|
|
|
| Mortality rate (7) |
|
|
|
|
| (9) |
|
| (10) |
|
| |
|
|
|
|
|
|
| Volatility (8) |
| % |
| - | % |
| % |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
Indexed annuity ceded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
embedded derivatives |
| |
| Discounted cash flow |
| Lapse rate (3) |
| % |
| - | % |
| (10) |
|
| ||||
|
|
|
|
|
|
| Mortality rate (7) |
|
|
|
|
| (9) |
|
| (10) |
|
| |
Liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Future contract benefits – |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
indexed annuity contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
embedded derivatives | $ | ( | ) | Discounted cash flow |
| Lapse rate (3) |
| % |
| - | % |
| (10) |
|
| ||||
|
|
|
|
|
|
| Mortality rate (7) |
|
|
|
|
| (9) |
|
| (10) |
|
| |
Other liabilities – |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GLB ceded embedded |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
derivatives |
| ( | ) | Discounted cash flow |
| Long-term lapse rate (3) |
| % |
| - | % |
| (10) |
|
| ||||
|
|
|
|
|
|
| Utilization of guaranteed withdrawals (4) | % |
| - | % |
| % |
| |||||
|
|
|
|
|
|
| Claims utilization factor (5) |
| % |
| - | % |
| (10) |
|
| |||
|
|
|
|
|
|
| Premiums utilization factor (5) |
| % |
| - | % |
| (10) |
|
| |||
|
|
|
|
|
|
| NPR (6) |
| % |
| - | % |
| % |
| ||||
|
|
|
|
|
|
| Mortality rate (7) |
|
|
|
|
| (9) |
|
| (10) |
|
| |
|
|
|
|
|
|
| Volatility (8) |
| % |
| - | % |
| % |
|
(1)Unobservable inputs were weighted by the relative fair value of the instruments, unless otherwise noted.
(2)The liquidity/duration adjustment input represents an estimated market participant composite of adjustments attributable to liquidity premiums, expected durations, structures and credit quality that would be applied to the market observable information of an investment.
(3)The lapse rate input represents the estimated probability of a contract surrendering during a year, and thereby forgoing any future benefits. The range for indexed annuity contracts represents the lapse rates during the surrender charge period.
(4)The utilization of guaranteed withdrawals input represents the estimated percentage of contract holders that utilize the guaranteed withdrawal feature.
(5)The utilization factors are applied to the present value of claims or premiums, as appropriate, in the GLB reserve calculation to estimate the impact of inefficient withdrawal behavior, including taking less than or more than the maximum guaranteed withdrawal.
(6)The NPR input represents the estimated additional credit spread that market participants would apply to the market observable discount rate when pricing a contract. The NPR input was weighted by the absolute value of the sensitivity of the reserve to the NPR assumption.
(7)The mortality rate input represents the estimated probability of when an individual belonging to a particular group, categorized according to age or some other factor such as gender, will die.
(8)The volatility input represents overall volatilities assumed for the underlying variable annuity funds, which include a mixture of equity and fixed-income assets. Fair value of the variable annuity GLB embedded derivatives would increase if higher volatilities were used for valuation. Volatility assumptions vary by fund due to the benchmarking of different indices. The volatility input was weighted by the relative account value assigned to each index.
(9)The mortality rate is based on a combination of company and industry experience, adjusted for improvement factors.
(10)A weighted average input range is not a meaningful measurement for lapse rate, utilization factors or mortality rate.
From the table above, we have excluded Level 3 fair value measurements obtained from independent, third-party pricing sources. We do not develop the significant inputs used to measure the fair value of these assets and liabilities, and the information regarding the significant inputs is not readily available to us. Independent broker-quoted fair values are non-binding quotes developed by market makers or broker-dealers obtained from third-party sources recognized as market participants. The fair value of a broker-quoted asset or liability is based solely on the receipt of an updated quote from a single market maker or a broker-dealer recognized as a market participant as we do not adjust broker quotes when used as the fair value measurement for an asset or liability. Significant increases or decreases in any of the quotes received from a third-party broker-dealer may result in a significantly higher or lower fair value measurement.
Changes in any of the significant inputs presented in the table above would have resulted in a significant change in the fair value measurement of the asset or liability as follows:
Investments – An increase in the liquidity/duration adjustment input would have resulted in a decrease in the fair value measurement.
Indexed annuity contracts embedded derivatives – For direct embedded derivatives, an increase in the lapse rate or mortality rate inputs would have resulted in a decrease in the fair value measurement.
GLB embedded derivatives – Assuming our GLB direct embedded derivatives are in a liability position: an increase in our lapse rate, NPR or mortality rate inputs would have resulted in a decrease in the fair value measurement; and an increase in the utilization of guaranteed withdrawal or volatility inputs would have resulted in an increase in the fair value measurement.
We provide products and services and report results through our Annuities, Retirement Plan Services, Life Insurance and Group Protection segments. We also have Other Operations, which includes the financial data for operations that are not directly related to the business segments. Our reporting segments reflect the manner by which our chief operating decision makers view and manage the business. A discussion of these segments and Other Operations is found in Note 21 to the consolidated financial statements in our 2021 Form 10-K.
Segment operating revenues and income (loss) from operations are internal measures used by our management and Board of Directors to evaluate and assess the results of our segments. Income (loss) from operations is GAAP net income excluding the after-tax effects of the following items, as applicable:
Realized gains and losses associated with the following (“excluded realized gain (loss)”):
Sales or disposals and impairments of financial assets;
Changes in the fair value of equity securities;
Changes in the fair value of derivatives, embedded derivatives within certain reinsurance arrangements and trading securities (“gain (loss) on the mark-to-market on certain instruments”);
Changes in the fair value of the derivatives we own to hedge our GDB riders within our variable annuities;
Changes in the fair value of the embedded derivatives of our GLB riders reflected within variable annuity net derivative results accounted for at fair value;
Changes in the fair value of the derivatives we own to hedge our GLB riders reflected within variable annuity net derivative results; and
Changes in the fair value of the embedded derivative liabilities related to index options we may purchase or sell in the future to hedge contract holder index allocations applicable to future reset periods for our indexed annuity products accounted for at fair value (“indexed annuity forward-starting option”);
Changes in reserves resulting from benefit ratio unlocking on our GDB and GLB riders (“benefit ratio unlocking”);
Income (loss) from reserve changes, net of related amortization, on business sold through reinsurance;
Gains (losses) on modification or early extinguishment of debt;
Losses from the impairment of intangible assets;
Income (loss) from discontinued operations;
Transaction and integration costs related to mergers and acquisitions including the acquisition or divestiture, through reinsurance or other means, of businesses or blocks of business; and
Income (loss) from the initial adoption of new accounting standards, regulations, and policy changes including the net impact from the Tax Cuts and Jobs Act.
Operating revenues represent GAAP revenues excluding the pre-tax effects of the following items, as applicable:
Excluded realized gain (loss);
Revenue adjustments from the initial adoption of new accounting standards;
Amortization of DFEL arising from changes in GDB and GLB benefit ratio unlocking; and
Amortization of deferred gains arising from reserve changes on business sold through reinsurance.
The tables below reconcile our segment measures of performance to the GAAP measures presented in our Consolidated Statements of Comprehensive Income (Loss) (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Revenues |
|
|
|
|
|
|
Operating revenues: |
|
|
|
|
|
|
Annuities | $ | |
| $ | |
|
Retirement Plan Services |
| |
|
| |
|
Life Insurance |
| |
|
| |
|
Group Protection |
| |
|
| |
|
Other Operations |
| |
|
| |
|
Excluded realized gain (loss), pre-tax |
| ( | ) |
| ( | ) |
Amortization of DFEL associated |
|
|
|
|
|
|
with benefit ratio unlocking, pre-tax |
| ( | ) |
| |
|
Total revenues | $ | |
| $ | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Net Income (Loss) |
|
|
|
|
|
|
Income (loss) from operations: |
|
|
|
|
|
|
Annuities | $ | |
| $ | |
|
Retirement Plan Services |
| |
|
| |
|
Life Insurance |
| |
|
| |
|
Group Protection |
| ( | ) |
| ( | ) |
Other Operations |
| ( | ) |
| ( | ) |
Excluded realized gain (loss), after-tax |
| ( | ) |
| ( | ) |
Benefit ratio unlocking, after-tax |
| ( | ) |
| |
|
Net income (loss) | $ | |
| $ | |
|
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Index to Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
|
| Page |
48 | |
49 | |
49 | |
50 | |
52 | |
54 | |
58 | |
62 | |
67 | |
71 | |
73 | |
75 | |
87 |
The following Management’s Discussion and Analysis (“MD&A”) is intended to help the reader understand the financial condition as of March 31, 2022, compared with December 31, 2021, and the results of operations for the three months ended March 31, 2022, compared with the corresponding period in 2021 of Lincoln National Corporation and its consolidated subsidiaries. Unless otherwise stated or the context otherwise requires, “LNC,” “Company,” “we,” “our” or “us” refers to Lincoln National Corporation and its consolidated subsidiaries.
The MD&A is provided as a supplement to, and should be read in conjunction with, our consolidated financial statements and the accompanying notes to the consolidated financial statements (“Notes”) presented in “Part I – Item 1. Financial Statements”; our Form 10-K for the year ended December 31, 2021 (“2021 Form 10-K”); and other reports filed with the Securities and Exchange Commission (“SEC”). For more detailed information on the risks and uncertainties associated with the Company’s business activities, see the risks described in “Part I – Item 1A. Risk Factors” in our 2021 Form 10-K.
FORWARD-LOOKING STATEMENTS – CAUTIONARY LANGUAGE
Certain statements made in this report and in other written or oral statements made by us or on our behalf are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 (“PSLRA”). A forward-looking statement is a statement that is not a historical fact and, without limitation, includes any statement that may predict, forecast, indicate or imply future results, performance or achievements. Forward-looking statements may contain words like: “anticipate,” “believe,” “estimate,” “expect,” “project,” “shall,” “will” and other words or phrases with similar meaning in connection with a discussion of future operating or financial performance. In particular, these include statements relating to future actions, trends in our businesses, prospective services or products, future performance or financial results and the outcome of contingencies, such as legal proceedings. We claim the protection afforded by the safe harbor for forward-looking statements provided by the PSLRA.
Forward-looking statements are subject to risks and uncertainties. Actual results could differ materially from those expressed in or implied by such forward-looking statements due to a variety of factors, including:
The continuation of the COVID-19 pandemic, or future outbreaks of COVID-19, and uncertainty surrounding the length and severity of future impacts on the global economy and on our business, results of operations and financial condition;
Further deterioration in general economic and business conditions that may affect account values, investment results, guaranteed benefit liabilities, premium levels and claims experience;
Adverse global capital and credit market conditions that may affect our ability to raise capital, if necessary, and may cause us to realize impairments on investments and certain intangible assets, including goodwill and the valuation allowance against deferred tax assets, which may reduce future earnings and/or affect our financial condition and ability to raise additional capital or refinance existing debt as it matures;
The inability of our subsidiaries to pay dividends to the holding company in sufficient amounts, which could harm the holding company’s ability to meet its obligations;
Legislative, regulatory or tax changes, both domestic and foreign, that affect: the cost of, or demand for, our subsidiaries’ products; the required amount of reserves and/or surplus; our ability to conduct business and our captive reinsurance arrangements as well as restrictions on the payment of revenue sharing and 12b-1 distribution fees;
The impact of U.S. federal tax reform legislation on our business, earnings and capital;
The impact of Regulation Best Interest or other regulations adopted by the SEC, the Department of Labor or other federal or state regulators or self-regulatory organizations relating to the standard of care owed by investment advisers and/or broker-dealers that could affect our distribution model;
Actions taken by reinsurers to raise rates on in-force business;
Further declines in or sustained low interest rates causing a reduction in investment income, the interest margins of our businesses, estimated gross profits (“EGPs”) and demand for our products;
Rapidly increasing interest rates causing contract holders to surrender life insurance and annuity policies, thereby causing realized investment losses, and reduced hedge performance related to variable annuities;
The impact of the implementation of the provisions of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the regulation of derivatives transactions;
The initiation of legal or regulatory proceedings against us, and the outcome of any legal or regulatory proceedings, such as: adverse actions related to present or past business practices common in businesses in which we compete; adverse decisions in significant actions including, but not limited to, actions brought by federal and state authorities and class action cases; new decisions that result in changes in law; and unexpected trial court rulings;
A decline or continued volatility in the equity markets causing a reduction in the sales of our subsidiaries’ products; a reduction of asset-based fees that our subsidiaries charge on various investment and insurance products; an acceleration of the net amortization of deferred acquisition costs (“DAC”), value of business acquired (“VOBA”), deferred sales inducements (“DSI”) and deferred front-end loads (“DFEL”); and an increase in liabilities related to guaranteed benefit features of our subsidiaries’ variable annuity products;
Ineffectiveness of our risk management policies and procedures, including various hedging strategies used to offset the effect of changes in the value of liabilities due to changes in the level and volatility of the equity markets and interest rates;
A deviation in actual experience regarding future persistency, mortality, morbidity, interest rates or equity market returns from the assumptions used in pricing our subsidiaries’ products, in establishing related insurance reserves and in the net amortization of DAC, VOBA, DSI and DFEL, which may reduce future earnings;
Changes in accounting principles that may affect our business, results of operations and financial condition, including the adoption effective January 1, 2023, of Financial Accounting Standards Board (“FASB”) Accounting Standards Update (“ASU”) 2018-12, Targeted Improvements to the Accounting for Long-Duration Contracts;
Lowering of one or more of our debt ratings issued by nationally recognized statistical rating organizations and the adverse effect such action may have on our ability to raise capital and on our liquidity and financial condition;
Lowering of one or more of the insurer financial strength ratings of our insurance subsidiaries and the adverse effect such action may have on the premium writings, policy retention, profitability of our insurance subsidiaries and liquidity;
Significant credit, accounting, fraud, corporate governance or other issues that may adversely affect the value of certain financial assets, as well as counterparties to which we are exposed to credit risk, requiring that we realize losses on financial assets;
Interruption in telecommunication, information technology or other operational systems or failure to safeguard the confidentiality or privacy of sensitive data on such systems, including from cyberattacks or other breaches of our data security systems;
The effect of acquisitions and divestitures, restructurings, product withdrawals and other unusual items;
The inability to realize or sustain the benefits we expect from, greater than expected investments in, and the potential impact of efforts related to, our strategic initiatives, including the Spark Initiative;
The adequacy and collectability of reinsurance that we have obtained;
Future pandemics, acts of terrorism, war or other man-made and natural catastrophes that may adversely affect our businesses and the cost and availability of reinsurance;
Competitive conditions, including pricing pressures, new product offerings and the emergence of new competitors, that may affect the level of premiums and fees that our subsidiaries can charge for their products;
The unknown effect on our subsidiaries’ businesses resulting from evolving market preferences and the changing demographics of our client base; and
The unanticipated loss of key management, financial planners or wholesalers.
The risks and uncertainties included here are not exhaustive. Our most recent Form 10-K as well as other reports that we file with the SEC include additional factors that could affect our businesses and financial performance. Moreover, we operate in a rapidly changing and competitive environment. New risk factors emerge from time to time, and it is not possible for management to predict all such risk factors.
Further, it is not possible to assess the effect of all risk factors on our businesses or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results. In addition, we disclaim any obligation to update any forward-looking statements to reflect events or circumstances that occur after the date of this report.
INTRODUCTION
Executive Summary
We are a holding company that operates multiple insurance and retirement businesses through subsidiary companies. We sell a wide range of wealth protection, accumulation, retirement income and group protection products and solutions through our four business segments:
Annuities;
Retirement Plan Services;
Life Insurance; and
Group Protection
We also have Other Operations, which includes the financial data for operations that are not directly related to the business segments. See “Part I – Item 1. Business” in our 2021 Form 10-K for a discussion of our business segments and products.
In this report, in addition to providing consolidated revenues and net income (loss), we also provide segment operating revenues and income (loss) from operations because we believe they are meaningful measures of revenues and the profitability of our operating segments. Operating revenues and income (loss) from operations are the financial performance measures we use to evaluate and assess the results of our segments. Accordingly, we define and report operating revenues and income (loss) from operations by segment in Note 14. Our management believes that operating revenues and income (loss) from operations explain the results of our ongoing businesses in a manner that allows for a better understanding of the underlying trends in our current businesses. Certain items are excluded from operating revenue and income (loss) from operations because they are unpredictable and not necessarily indicative of current operating fundamentals or future performance of the business segments, and, in many instances, decisions regarding these items do not necessarily relate to the operations of the individual segments. In addition, we believe that our definitions of operating revenues and income (loss)
from operations will provide investors with a more valuable measure of our performance because it better reveals trends in our businesses.
We provide information about our segments’ and Other Operations’ operating revenue and expense line items and realized gain (loss), key drivers of changes and historical details underlying the line items below. For factors that could cause actual results to differ materially from those set forth, see “Forward-Looking Statements – Cautionary Language” above and “Part I – Item 1A. Risk Factors” in our 2021 Form 10-K.
Industry trends, significant operational matters and outlook are described in “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” of our 2021 Form 10-K, which is further updated by the discussion that follows.
COVID-19 Pandemic
The health, economic and business conditions precipitated by the worldwide COVID-19 pandemic that emerged in 2020 continue to adversely affect us and are expected to continue to adversely affect our business, results of operations and financial condition in the second quarter of 2022. We continue to monitor U.S. CDC reports related to COVID-19 and the potential impacts of the COVID-19 pandemic on our Life Insurance and Group Protection segments. See “Additional Information” within Results of Life Insurance and Results of Group Protection below for expected impacts of the COVID-19 pandemic in the second quarter of 2022.
The ultimate impact on our business, results of operations and financial condition depends on the severity and duration of the COVID-19 pandemic and related health, economic and business impacts and actions taken by governmental authorities and other third parties in response, each of which is uncertain, rapidly changing and difficult to predict. For more information on the risks related to the COVID-19 pandemic, see “Part I – Item 1A. Risk Factors – Market Conditions – The impacts of the COVID-19 pandemic have adversely affected and are expected to continue to adversely affect our business and results of operations, and the future impacts of the COVID-19 pandemic on the company’s business, results of operations and financial condition remain uncertain” in our 2021 Form 10-K.
Interest Rate Environment
In light of substantial progress since 2020 in the labor markets, elevated inflation and geopolitical events, the Federal Reserve announced in March 2022 the first increase to the federal funds rate target range since December 2018. Subsequently, in May 2022, the Federal Reserve announced an additional 50 basis points increase to the federal funds rate target range, setting the range at 0.75% to 1.00%, and stated that it anticipates ongoing increases throughout 2022. Additionally, the Federal Reserve announced that it will reduce its holdings of Treasury securities, agency debt and agency mortgage-backed securities at a measured pace beginning in June 2022. Although short-term interest rates may continue to rise during the year, we expect the low interest rate environment to continue to adversely affect our businesses through spread compression, which we expect to moderate over time as interest rates continue to rise. We continue to be proactive in our investment strategies, product designs, crediting rate strategies, expense management actions and overall asset-liability practices to mitigate the risk of unfavorable consequences in this continued low interest rate environment.
We have provided disclosures around interest rate risk in “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements, and changes in interest rates may also result in increased contract withdrawals,” “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates – Annual Assumption Review – Long-Term New Money Investment Yield Sensitivity” and “Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2021 Form 10-K.
Spark Initiative
In the fourth quarter of 2021, we formally communicated our new expense savings initiative, the Spark Initiative. Because we have almost completed the investments related to our strategic digitization initiative first announced in 2016, beginning in the fourth quarter of 2021, we integrated the actual and expected remaining amounts associated with that initiative into the amounts associated with the Spark Initiative. For more information about the Spark Initiative, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” in our 2021 Form 10-K.
Critical Accounting Policies and Estimates
The MD&A included in our 2021 Form 10-K contains a detailed discussion of our critical accounting policies and estimates. The following information updates the “Critical Accounting Policies and Estimates” provided in our 2021 Form 10-K, and therefore, should be read in conjunction with that disclosure.
DAC, VOBA, DSI and DFEL
Reversion to the Mean
As variable fund returns do not move in a systematic manner, we reset the baseline of account values from which EGPs are projected, which we refer to as our reversion to the mean (“RTM”) process, as discussed in our 2021 Form 10-K.
If we had unlocked our RTM assumption as of March 31, 2022, we would have recorded favorable unlocking of approximately $300 million, pre-tax, primarily within our Annuities segment.
Investments
Investment Valuation
The following summarizes investments on our Consolidated Balance Sheets carried at fair value by pricing source and fair value hierarchy level (in millions) as of March 31, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Quoted |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| Prices |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
| in Active |
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Markets for | Significant | Significant |
|
|
|
| |||||||||
|
| Identical |
| Observable | Unobservable |
|
|
|
| |||||||
|
| Assets |
|
| Inputs |
|
| Inputs |
|
| Total |
| ||||
|
| (Level 1) |
|
| (Level 2) |
|
| (Level 3) |
|
| Fair Value |
| ||||
Priced by third-party pricing services |
| $ | 461 |
|
| $ | 97,456 |
|
| $ | 193 |
|
| $ | 98,110 |
|
Priced by independent broker quotations |
|
| - |
|
|
| - |
|
|
| 4,411 |
|
|
| 4,411 |
|
Priced by matrices |
|
| - |
|
|
| 14,256 |
|
|
| - |
|
|
| 14,256 |
|
Priced by other methods (1) |
|
| - |
|
|
| - |
|
|
| 3,853 |
|
|
| 3,853 |
|
Total |
| $ | 461 |
|
| $ | 111,712 |
|
| $ | 8,457 |
|
| $ | 120,630 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Percent of total |
|
| 0% |
|
|
| 93% |
|
|
| 7% |
|
|
| 100% |
|
(1)Represents primarily securities for which pricing models were used to compute fair value.
For more information about the valuation of our financial instruments carried at fair value, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Critical Accounting Policies and Estimates – Investments – Investment Valuation” in our 2021 Form 10-K and Note 13 herein.
Derivatives
Our accounting policies for derivatives and the potential effect on interest spreads in a falling rate environment are discussed in Note 5 herein and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2021 Form 10-K.
Future Contract Benefits
Guaranteed Living Benefits
Within our annuity business, we have certain products that contain GLB features. The proportion of our variable annuity account values that contained GLB features to our total annuity account values, net of reinsurance, was 49% and 52% as of March 31, 2022 and 2021, respectively. Underperforming equity markets increase our exposure to potential benefits with the GLB features. A contract with a GLB feature is “in the money” if the contract holder’s account balance falls below the present value of guaranteed withdrawal or income benefits, assuming no lapses. As of March 31, 2022 and 2021, 19% and 9%, respectively, of all in-force contracts with a GLB feature were “in the money,” and our exposure, after reinsurance, as of March 31, 2022 and 2021, was $1.1 billion and $541 million, respectively. However, the only way the contract holder can realize the excess of the present value of benefits over the account value of the contract is through a series of withdrawals or income payments that do not exceed a maximum amount. If, after the series of withdrawals or income payments, the account value is exhausted, the contract holder will continue to receive a series of annuity payments. The account value can also fluctuate with equity market returns on a daily basis resulting in increases or decreases in the excess of the present value of benefits over account value.
For information on our variable annuity hedge program performance, see our discussion in “Realized Gain (Loss) – Variable Annuity Net Derivative Results” below.
For information on our estimates of the potential instantaneous effect to net income (loss) that could result from sudden changes that may occur in equity markets, interest rates and implied market volatilities, see our discussion in “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Critical Accounting Policies and Estimates – Future Contract Benefits – GLB” in our 2021 Form 10-K.
RESULTS OF CONSOLIDATED OPERATIONS
Details underlying the consolidated results, deposits, net flows and account values (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Net Income (Loss) |
|
|
|
|
|
|
|
Income (loss) from operations: |
|
|
|
|
|
|
|
Annuities | $ | 302 |
| $ | 290 |
|
|
Retirement Plan Services |
| 55 |
|
| 57 |
|
|
Life Insurance |
| 58 |
|
| 107 |
|
|
Group Protection |
| (41 | ) |
| (26 | ) |
|
Other Operations |
| (80 | ) |
| (78 | ) |
|
Excluded realized gain (loss), after-tax |
| (20 | ) |
| (180 | ) |
|
Benefit ratio unlocking, after-tax |
| (170 | ) |
| 55 |
|
|
Net income (loss) | $ | 104 |
| $ | 225 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Deposits |
|
|
|
|
|
|
|
Annuities | $ | 2,705 |
| $ | 2,814 |
|
|
Retirement Plan Services |
| 3,367 |
|
| 2,640 |
|
|
Life Insurance |
| 1,334 |
|
| 1,219 |
|
|
Total deposits | $ | 7,406 |
| $ | 6,673 |
|
|
|
|
|
|
|
|
|
|
Net Flows |
|
|
|
|
|
|
|
Annuities | $ | (553 | ) | $ | (776 | ) |
|
Retirement Plan Services |
| 946 |
|
| 347 |
|
|
Life Insurance |
| 883 |
|
| 793 |
|
|
Total net flows | $ | 1,276 |
| $ | 364 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Account Values |
|
|
|
|
|
|
|
Annuities | $ | 162,144 |
| $ | 161,123 |
|
|
Retirement Plan Services |
| 95,343 |
|
| 91,157 |
|
|
Life Insurance |
| 50,626 |
|
| 58,410 |
|
|
Total account values | $ | 308,113 |
| $ | 310,690 |
|
|
Comparison of the Three Months Ended March 31, 2022 to 2021
Net income decreased due primarily to the following:
Lower investment income on alternative investments.
Unfavorable variable annuity net derivative results.
Unfavorable disability experience in our Group Protection segment.
Higher Spark program expense as part of our Spark Initiative.
The impact of the fourth quarter 2021 reinsurance agreement in our Life Insurance segment.
Spread compression due to average new money rates trailing our current portfolio yields, partially offset by actions implemented to reduce interest crediting rates.
The decrease in net income was partially offset by the following:
Lower mortality claims in our Life Insurance and Group Protection segments attributable to the COVID-19 pandemic.
Higher prepayment and bond make-whole premiums.
Federal income tax benefit in 2022 as compared to federal income tax expense in 2021.
Growth in business in force and group earned premiums.
For a discussion of the COVID-19 pandemic, see “Introduction – Executive Summary” above and “Part I – Item 1A. Risk Factors – Market Conditions – The impacts of the COVID-19 pandemic have adversely affected and are expected to continue to adversely affect our business and results of operations, and the future impacts of the COVID-19 pandemic on the company’s business, results of operations and financial condition remain uncertain” in our 2021 Form 10-K.
RESULTS OF ANNUITIES
Income (Loss) from Operations
Details underlying the results for Annuities (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Operating Revenues |
|
|
|
|
|
|
|
Insurance premiums (1) | $ | 30 |
| $ | 32 |
|
|
Fee income |
| 658 |
|
| 652 |
|
|
Net investment income |
| 360 |
|
| 328 |
|
|
Operating realized gain (loss) (2) |
| 54 |
|
| 50 |
|
|
Amortization of deferred gain on |
|
|
|
|
|
|
|
business sold through reinsurance |
| 6 |
|
| 6 |
|
|
Other revenues (3) |
| 124 |
|
| 136 |
|
|
Total operating revenues |
| 1,232 |
|
| 1,204 |
|
|
Operating Expenses |
|
|
|
|
|
|
|
Interest credited |
| 207 |
|
| 199 |
|
|
Benefits (1) |
| 152 |
|
| 141 |
|
|
Commissions and other expenses |
| 522 |
|
| 514 |
|
|
Total operating expenses |
| 881 |
|
| 854 |
|
|
Income (loss) from operations before taxes |
| 351 |
|
| 350 |
|
|
Federal income tax expense (benefit) |
| 49 |
|
| 60 |
|
|
Income (loss) from operations | $ | 302 |
| $ | 290 |
|
|
(1)Insurance premiums include primarily our income annuities that have a corresponding offset in benefits. Benefits include changes in income annuity reserves driven by premiums.
(2)See “Realized Gain (Loss)” below.
(3)Consists primarily of revenues attributable to broker-dealer services, which are subject to market volatility and the net settlement related to certain reinsurance transactions, which has a corresponding offset in net investment income and interest credited.
Comparison of the Three Months Ended March 31, 2022 to 2021
Income from operations for this segment increased due primarily to the following:
Higher net investment income, net of interest credited, driven by prepayment and bond make-whole premiums and higher average gross fixed account values, partially offset by lower investment income on alternative investments within our surplus portfolio.
Lower federal income tax expense due to unfavorable tax return true-ups in 2021 driven by the separate account dividends-received deduction (“DRD”).
The increase in income from operations was partially offset by higher benefits driven by an increase in the growth of our GLB benefit reserves due to market performance.
Additional Information
For a discussion of the COVID-19 pandemic, see “Introduction – Executive Summary” above and “Part I – 1A. Risk Factors – Market Conditions – The impacts of the COVID-19 pandemic have adversely affected and are expected to continue to adversely affect our business and results of operations, and the future impacts of the COVID-19 pandemic on the company’s business, results of operations and financial condition remain uncertain” in our 2021 Form 10-K.
New deposits are an important component of net flows and key to our efforts to grow our business. Although deposits do not significantly affect current period income from operations, they can significantly impact future income from operations.
The other component of net flows relates to the retention of new business and account values. An important measure of retention is the reduction in account values caused by full surrenders, deaths and other contract benefits. These outflows as a percentage of average gross account values were 7% and 8% for the three months ended March 31, 2022 and 2021, respectively.
Our fixed and indexed variable annuities have discretionary fixed and indexed crediting rates that reset on an annual or periodic basis and may be subject to surrender charges. Our ability to retain these annuities will be subject to current competitive conditions at the time interest rates for these products reset. We expect to manage the effects of spreads on near-term income from operations through portfolio management and, to a lesser extent, crediting rate actions, which assumes no significant changes in net flows or other changes that may cause interest rate spreads to differ from our expectations. For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements, and changes in interest rates may also result in increased contract withdrawals” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2021 Form 10-K.
Fee Income
Details underlying fee income, account values and net flows (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Fee Income |
|
|
|
|
|
|
Mortality, expense and other assessments | $ | 652 |
| $ | 649 |
|
Surrender charges |
| 4 |
|
| 1 |
|
DFEL: |
|
|
|
|
|
|
Deferrals |
| (6 | ) |
| (7 | ) |
Amortization, net of interest |
| 8 |
|
| 9 |
|
Total fee income | $ | 658 |
| $ | 652 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of or For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Variable Account Value Information |
|
|
|
|
|
|
Variable annuity deposits (1) | $ | 1,137 |
| $ | 1,097 |
|
Increases (decreases) in variable annuity |
|
|
|
|
|
|
account values: |
|
|
|
|
|
|
Net flows (1) |
| (1,421 | ) |
| (1,790 | ) |
Change in market value (1) |
| (9,099 | ) |
| 4,162 |
|
Contract holder assessments (1) |
| (691 | ) |
| (684 | ) |
Transfers to the variable portion |
|
|
|
|
|
|
of variable annuity products |
|
|
|
|
|
|
from the fixed portion of |
|
|
|
|
|
|
variable annuity products |
| 140 |
|
| 158 |
|
Variable annuity account values (1) |
| 125,676 |
|
| 130,036 |
|
Average daily variable annuity account |
|
|
|
|
|
|
values (1) |
| 127,688 |
|
| 130,030 |
|
Average daily S&P 500® Index (2) |
| 4,467 |
|
| 3,861 |
|
(1)Excludes the fixed portion of variable.
(2)We generally use the S&P 500 Index as a benchmark for the performance of our variable account values. The account values of our variable annuity contracts are invested by our policyholders in a variety of investment options including, but not limited to, domestic and international equity securities and fixed income, which do not necessarily align with S&P 500 Index performance. See Note 7 for additional information.
We charge contract holders mortality and expense assessments on variable annuity accounts to cover insurance and administrative expenses. These assessments are a function of the rates priced into the product and the average daily variable account values. Average daily variable account values are driven by net flows and variable fund returns. Charges on GLB riders are assessed based on a contractual rate that is applied either to the account value or the guaranteed amount. We may collect surrender charges when our fixed and variable annuity contract holders surrender their contracts during the surrender charge period to protect us from premature withdrawals. Fee income includes charges on both our variable and fixed annuity products, but excludes the attributed fees on our GLB riders; see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Realized Gain (Loss) – Operating Realized Gain (Loss)” in our 2021 Form 10-K for discussion of these attributed fees.
Net Investment Income and Interest Credited
Details underlying net investment income, interest credited and fixed account values (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Net Investment Income |
|
|
|
|
|
|
Fixed maturity AFS securities, |
|
|
|
|
|
|
mortgage loans on real estate and |
|
|
|
|
|
|
other, net of investment expenses | $ | 303 |
| $ | 276 |
|
Commercial mortgage loan prepayment and |
|
|
|
|
|
|
bond make-whole premiums (1) |
| 19 |
|
| 7 |
|
Surplus investments (2) |
| 38 |
|
| 45 |
|
Total net investment income | $ | 360 |
| $ | 328 |
|
|
|
|
|
|
|
|
Interest Credited |
|
|
|
|
|
|
Amount provided to contract holders | $ | 203 |
| $ | 195 |
|
DSI deferrals |
| (1 | ) |
| (1 | ) |
Interest credited before DSI amortization |
| 202 |
|
| 194 |
|
DSI amortization |
| 5 |
|
| 5 |
|
Total interest credited | $ | 207 |
| $ | 199 |
|
(1)See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of or For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Fixed Account Value Information |
|
|
|
|
|
|
Fixed annuity deposits (1) | $ | 1,568 |
| $ | 1,717 |
|
Increases (decreases) in fixed annuity |
|
|
|
|
|
|
account values: |
|
|
|
|
|
|
Net flows (1) |
| 868 |
|
| 1,014 |
|
Contract holder assessments (1) |
| (16 | ) |
| (25 | ) |
Transfers from the fixed portion |
|
|
|
|
|
|
of variable annuity products to |
|
|
|
|
|
|
the variable portion of variable |
|
|
|
|
|
|
annuity products |
| (140 | ) |
| (158 | ) |
Reinvested interest credited (1) |
| (359 | ) |
| 754 |
|
Fixed annuity account values (1)(2) |
| 36,468 |
|
| 31,087 |
|
Average fixed account values (1)(2) |
| 35,940 |
|
| 30,069 |
|
(1)Includes the fixed portion of variable.
(2)Net of reinsurance ceded.
A portion of our investment income earned is credited to the contract holders of our deferred fixed annuity products, including the fixed portion of variable annuity contracts. We expect to earn a spread between what we earn on the underlying general account investments supporting the fixed annuity product line, including the fixed portion of variable annuity contracts, and what we credit to our fixed annuity contract holders’ accounts, including the fixed portion of variable annuity contracts. Changes in commercial mortgage loan prepayments and bond make-whole premiums, investment income on alternative investments and surplus investment income can vary significantly from period to period due to a number of factors and, therefore, may contribute to investment income results that are not indicative of the underlying trends.
Benefits
Benefits for this segment include changes in income annuity reserves driven by premiums, changes in benefit reserves and costs associated with the hedging of our benefit ratio unlocking on benefit reserves associated with our variable annuity GDB and GLB riders. For a corresponding offset of changes in income annuity reserves, see footnote 1 of “Income (Loss) from Operations” above.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Commissions and Other Expenses |
|
|
|
|
|
|
Commissions: |
|
|
|
|
|
|
Deferrable | $ | 102 |
| $ | 111 |
|
Non-deferrable |
| 166 |
|
| 164 |
|
General and administrative expenses |
| 102 |
|
| 106 |
|
Inter-segment reimbursement associated |
|
|
|
|
|
|
with reserve financing and |
|
|
|
|
|
|
LOC expenses (1) |
| 1 |
|
| 1 |
|
Taxes, licenses and fees |
| 15 |
|
| 12 |
|
Total expenses incurred, excluding |
|
|
|
|
|
|
broker-dealer |
| 386 |
|
| 394 |
|
DAC deferrals |
| (118 | ) |
| (127 | ) |
Total pre-broker-dealer expenses |
|
|
|
|
|
|
incurred, excluding amortization, |
|
|
|
|
|
|
net of interest |
| 268 |
|
| 267 |
|
DAC and VOBA amortization, |
|
|
|
|
|
|
net of interest |
| 112 |
|
| 111 |
|
Broker-dealer expenses incurred |
| 142 |
|
| 136 |
|
Total commissions and other expenses |
|
|
|
|
|
|
expenses | $ | 522 |
| $ | 514 |
|
|
|
|
|
|
|
|
DAC Deferrals |
|
|
|
|
|
|
As a percentage of sales/deposits |
| 4.4% |
|
| 4.5% |
|
(1)Includes reimbursements to Annuities from the Life Insurance segment for reserve financing, net of expenses incurred by Annuities for its use of letters of credit (“LOCs”). The inter-segment amounts are not reported on our Consolidated Statements of Comprehensive Income (Loss).
Commissions and other costs that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized over the lives of the contracts in relation to EGPs. Certain types of commissions, such as trail commissions that are based on account values, are expensed as incurred rather than deferred and amortized. Broker-dealer expenses that vary with and are related to sales are expensed as incurred and not deferred and amortized. Fluctuations in these expenses correspond with fluctuations in other revenues. For more information, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates – DAC, VOBA, DSI and DFEL” in our 2021 Form 10-K.
RESULTS OF RETIREMENT PLAN SERVICES
Income (Loss) from Operations
Details underlying the results for Retirement Plan Services (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Operating Revenues |
|
|
|
|
|
|
|
Fee income | $ | 70 |
| $ | 71 |
|
|
Net investment income |
| 238 |
|
| 248 |
|
|
Other revenues (1) |
| 10 |
|
| 8 |
|
|
Total operating revenues |
| 318 |
|
| 327 |
|
|
Operating Expenses |
|
|
|
|
|
|
|
Interest credited |
| 152 |
|
| 155 |
|
|
Benefits |
| 1 |
|
| 1 |
|
|
Commissions and other expenses |
| 101 |
|
| 101 |
|
|
Total operating expenses |
| 254 |
|
| 257 |
|
|
Income (loss) from operations before taxes |
| 64 |
|
| 70 |
|
|
Federal income tax expense (benefit) |
| 9 |
|
| 13 |
|
|
Income (loss) from operations | $ | 55 |
| $ | 57 |
|
|
(1)Consists primarily of mutual fund account program revenues from mid to large employers.
Comparison of the Three Months Ended March 31, 2022 to 2021
Income from operations for this segment decreased due primarily to lower net investment income, net of interest credited, driven by lower investment income on alternative investments within our surplus portfolio and spread compression due to average new money rates trailing our current portfolio yields, partially offset by higher average fixed account values and prepayment and bond make-whole premiums. The decrease in income from operations was partially offset by lower federal income tax expense due to unfavorable tax return true-ups in 2021 driven by the separate account DRD.
Additional Information
For a discussion of the COVID-19 pandemic, see “Introduction – Executive Summary” above and “Part I – Item 1A. Risk Factors – Market Conditions – The impacts of the COVID-19 pandemic have adversely affected and are expected to continue to adversely affect our business and results of operations, and the future impacts of the COVID-19 pandemic on the company’s business, results of operations and financial condition remain uncertain” in our 2021 Form 10-K.
Net flows in this business fluctuate based on the timing of larger plans being implemented and terminating over the course of the year.
New deposits are an important component of net flows and key to our efforts to grow our business. Although deposits do not significantly affect current period income from operations, they can significantly impact future income from operations. The other component of net flows relates to the retention of the business. An important measure of retention is the reduction in account values caused by plan sponsor terminations and participant withdrawals. These outflows as a percentage of average account values were 10% for the three months ended March 31, 2022 and 2021.
Our net flows are negatively affected by the continued net outflows from our oldest blocks of annuities business (as presented on our Net Flows By Market table below as “Multi-Fund® and other”), which are among our higher margin product lines in this segment, due to the fact that they are mature blocks with low distribution and servicing costs. The proportion of these products to our total account values was 18% and 19% as of March 31, 2022 and 2021, respectively. Due to this overall shift in business mix toward products with lower returns, new deposit production continues to be necessary to maintain earnings at current levels.
Our fixed annuity business includes products with discretionary and index-based crediting rates that are reset on either a quarterly or semi-annual basis. Our ability to retain quarterly or semi-annual reset annuities will be subject to current competitive conditions at the time interest rates for these products reset. We expect to manage the effects of spreads on near-term income from operations through portfolio management and, to a lesser extent, crediting rate actions, which assumes no significant changes in net flows into or out of our fixed accounts or other changes that may cause interest rate spreads to differ from our expectations. For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain
statutory requirements, and changes in interest rates may also result in increased contract withdrawals” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2021 Form 10-K.
Fee Income
Details underlying fee income, net flows and account values (in millions) were as follows:
\
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Fee Income |
|
|
|
|
|
|
|
Annuity expense assessments | $ | 52 |
| $ | 52 |
|
|
Mutual fund fees |
| 18 |
|
| 19 |
|
|
Total fee income | $ | 70 |
| $ | 71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Net Flows By Market |
|
|
|
|
|
|
|
Small market | $ | (116 | ) | $ | (28 | ) |
|
Mid – large market |
| 1,350 |
|
| 680 |
|
|
Multi-Fund® and other |
| (288 | ) |
| (305 | ) |
|
Total net flows | $ | 946 |
| $ | 347 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of or For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Variable Account Value Information |
|
|
|
|
|
|
|
Variable annuity deposits (1) | $ | 925 |
| $ | 573 |
|
|
Increases (decreases) in variable annuity |
|
|
|
|
|
|
|
account values: |
|
|
|
|
|
|
|
Net flows (1) |
| 155 |
|
| (127 | ) |
|
Change in market value (1) |
| (1,293 | ) |
| 834 |
|
|
Contract holder assessments (1) |
| (44 | ) |
| (44 | ) |
|
Variable annuity account values (1) |
| 19,714 |
|
| 19,370 |
|
|
Average daily variable annuity account |
|
|
|
|
|
|
|
values (1) |
| 19,749 |
|
| 19,197 |
|
|
Average daily S&P 500® Index |
| 4,467 |
|
| 3,861 |
|
|
(1)Excludes the fixed portion of variable.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of or For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Mutual Fund Account Value Information |
|
|
|
|
|
|
|
Mutual fund deposits | $ | 1,870 |
| $ | 1,577 |
|
|
Mutual fund net flows |
| 773 |
|
| 567 |
|
|
Mutual fund account values (1) |
| 51,671 |
|
| 48,779 |
|
|
(1)Mutual funds are not included in the separate accounts reported on our Consolidated Balance Sheets as we do not have any ownership interest in them.
Our fee income is primarily composed of expense assessments that we charge to cover insurance and administrative expenses, and mutual fund fees earned for services we provide to our mutual fund programs. Fee income is primarily based on average account values, both fixed and variable, which are driven by net flows and the equity markets. Fee income is also driven by non-account value-related items such as participant counts. We may collect surrender charges when our fixed and variable annuity contract holders surrender their contracts during the surrender charge period to protect us from premature withdrawals.
Net Investment Income and Interest Credited
Details underlying net investment income, interest credited and fixed account values (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Net Investment Income |
|
|
|
|
|
|
|
Fixed maturity AFS securities, |
|
|
|
|
|
|
|
mortgage loans on real estate and |
|
|
|
|
|
|
|
other, net of investment expenses | $ | 206 |
| $ | 209 |
|
|
Commercial mortgage loan prepayment and |
|
|
|
|
|
|
|
bond make-whole premiums (1) |
| 11 |
|
| 10 |
|
|
Surplus investments (2) |
| 21 |
|
| 29 |
|
|
Total net investment income | $ | 238 |
| $ | 248 |
|
|
|
|
|
|
|
|
|
|
Interest Credited | $ | 152 |
| $ | 155 |
|
|
(1)See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of or For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Fixed Account Value Information |
|
|
|
|
|
|
|
Fixed annuity deposits (1) | $ | 572 |
| $ | 490 |
|
|
Increases (decreases) in fixed annuity |
|
|
|
|
|
|
|
account values: |
|
|
|
|
|
|
|
Net flows (1) |
| 18 |
|
| (93 | ) |
|
Reinvested interest credited (1) |
| 150 |
|
| 153 |
|
|
Contract holder assessments (1) |
| (3 | ) |
| (3 | ) |
|
Fixed annuity account values (1) |
| 23,958 |
|
| 23,008 |
|
|
Average fixed account values (1) |
| 23,784 |
|
| 23,016 |
|
|
(1)Includes the fixed portion of variable.
A portion of our investment income earned is credited to the contract holders of our fixed annuity products, including the fixed portion of variable annuity contracts. We expect to earn a spread between what we earn on the underlying general account investments supporting the fixed annuity product line, including the fixed portion of variable annuity contracts, and what we credit to our fixed annuity contract holders’ accounts, including the fixed portion of variable annuity contracts. Commercial mortgage loan prepayments and bond make-whole premiums, investment income on alternative investments and surplus investment income can vary significantly from period to period due to a number of factors and, therefore, may contribute to investment income results that are not indicative of the underlying trends.
Benefits
Benefits for this segment include changes in annuity benefit reserves.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Commissions and Other Expenses |
|
|
|
|
|
|
|
Commissions: |
|
|
|
|
|
|
|
Deferrable | $ | 1 |
| $ | 2 |
|
|
Non-deferrable |
| 19 |
|
| 19 |
|
|
General and administrative expenses |
| 73 |
|
| 72 |
|
|
Taxes, licenses and fees |
| 6 |
|
| 5 |
|
|
Total expenses incurred |
| 99 |
|
| 98 |
|
|
DAC deferrals |
| (5 | ) |
| (5 | ) |
|
Total expenses recognized before |
|
|
|
|
|
|
|
amortization |
| 94 |
|
| 93 |
|
|
DAC and VOBA amortization, |
|
|
|
|
|
|
|
net of interest |
| 7 |
|
| 8 |
|
|
Total commissions and other |
|
|
|
|
|
|
|
expenses | $ | 101 |
| $ | 101 |
|
|
|
|
|
|
|
|
|
|
DAC Deferrals |
|
|
|
|
|
|
|
As a percentage of annuity sales/deposits |
| 0.3% |
|
| 0.5% |
|
|
Commissions and other costs that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized over the lives of the contracts in relation to EGPs. Certain types of commissions, such as trail commissions that are based on account values, are expensed as incurred rather than deferred and amortized. Distribution expenses associated with the sale of mutual fund products are expensed as incurred. For more information, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates – DAC, VOBA, DSI and DFEL” in our 2021 Form 10-K.
RESULTS OF LIFE INSURANCE
Income (Loss) from Operations
Details underlying the results for Life Insurance (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Operating Revenues |
|
|
|
|
|
|
|
Insurance premiums (1) | $ | 277 |
| $ | 253 |
|
|
Fee income |
| 846 |
|
| 867 |
|
|
Net investment income |
| 688 |
|
| 809 |
|
|
Operating realized gain (loss) (2) |
| 1 |
|
| (2 | ) |
|
Amortization of deferred gain on |
|
|
|
|
|
|
|
business sold through reinsurance |
| 12 |
|
| 3 |
|
|
Other revenues |
| 1 |
|
| 9 |
|
|
Total operating revenues |
| 1,825 |
|
| 1,939 |
|
|
Operating Expenses |
|
|
|
|
|
|
|
Interest credited |
| 325 |
|
| 370 |
|
|
Benefits |
| 1,126 |
|
| 1,173 |
|
|
Commissions and other expenses |
| 309 |
|
| 266 |
|
|
Total operating expenses |
| 1,760 |
|
| 1,809 |
|
|
Income (loss) from operations before taxes |
| 65 |
|
| 130 |
|
|
Federal income tax expense (benefit) |
| 7 |
|
| 23 |
|
|
Income (loss) from operations | $ | 58 |
| $ | 107 |
|
|
(1)Includes term insurance premiums, which have a corresponding partial offset in benefits for changes in reserves.
(2)See “Realized Gain (Loss)” below.
Comparison of the Three Months Ended March 31, 2022 to 2021
Income from operations for this segment decreased due primarily to the following:
Lower net investment income, net of interest credited, driven by lower investment income on alternative investments, spread compression due to average new money rates trailing our current portfolio yields and the impact of the fourth quarter 2021 reinsurance agreement, partially offset by higher prepayment and bond make-whole premiums.
Higher commissions and other expenses due to higher amortization rates, partially offset by expense management.
Lower fee income due to the impact of the fourth quarter 2021 reinsurance agreement, partially offset by growth in business in force and higher DFEL amortization rates.
The decrease in income from operations was partially offset by the following:
Lower benefits due to lower mortality claims attributable to the COVID-19 pandemic and the impact of the fourth quarter 2021 reinsurance agreement.
Higher amortization of deferred gain on business sold through reinsurance as a result of the fourth quarter 2021 reinsurance agreement.
Additional Information
Effective October 1, 2021, we entered into a reinsurance agreement with Security Life of Denver Insurance Company (a subsidiary of Resolution Life that we refer to herein as “Resolution Life”) to reinsure liabilities under a block of in-force executive benefit and universal life policies. For more information, see “Liquidity and Capital Resources – Holding Company Sources and Uses of Liquidity and Capital – Return of Capital to Common Stockholders” below. We expect an ongoing reduction in income from operations in future periods as a result of this reinsurance agreement.
While U.S. pandemic deaths have improved, we continue to expect elevated mortality in the second quarter of 2022. For a discussion of the COVID-19 pandemic, see “Introduction – Executive Summary” above and “Part I – Item 1A. Risk Factors – Market Conditions – The impacts of the COVID-19 pandemic have adversely affected and are expected to continue to adversely affect our business and
results of operations, and the future impacts of the COVID-19 pandemic on the company’s business, results of operations and financial condition remain uncertain” in our 2021 Form 10-K.
For information on interest rate spreads and interest rate risk, see “Part I – Item 1A. Risk Factors – Market Conditions – Changes in interest rates and sustained low interest rates may cause interest rate spreads to decrease, impacting our profitability, and make it more challenging to meet certain statutory requirements, and changes in interest rates may also result in increased contract withdrawals” and “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk” in our 2021 Form 10-K.
Insurance Premiums
Insurance premiums relate to traditional products and are a function of the rates priced into the product and insurance in force. Insurance in force, in turn, is driven by sales, persistency and mortality claims.
Fee Income
Details underlying fee income, sales, net flows, account values and in-force face amount (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Fee Income |
|
|
|
|
|
|
Cost of insurance assessments | $ | 571 |
| $ | 606 |
|
Expense assessments |
| 374 |
|
| 354 |
|
Surrender charges |
| 8 |
|
| 9 |
|
DFEL: |
|
|
|
|
|
|
Deferrals |
| (250 | ) |
| (224 | ) |
Amortization, net of interest |
| 143 |
|
| 122 |
|
Total fee income | $ | 846 |
| $ | 867 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Sales by Product |
|
|
|
|
|
|
IUL/UL | $ | 26 |
| $ | 18 |
|
MoneyGuard® |
| 22 |
|
| 16 |
|
VUL |
| 34 |
|
| 22 |
|
Term |
| 43 |
|
| 30 |
|
Executive Benefits |
| 30 |
|
| 28 |
|
Total sales | $ | 155 |
| $ | 114 |
|
|
|
|
|
|
|
|
Net Flows |
|
|
|
|
|
|
Deposits | $ | 1,334 |
| $ | 1,219 |
|
Withdrawals and deaths |
| (451 | ) |
| (426 | ) |
Net flows | $ | 883 |
| $ | 793 |
|
|
|
|
|
|
|
|
Contract Holder Assessments | $ | 1,349 |
| $ | 1,270 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Account Values |
|
|
|
|
|
|
General account (1) | $ | 32,377 |
| $ | 37,417 |
|
Separate account (1) |
| 18,249 |
|
| 20,993 |
|
Total account values (1) | $ | 50,626 |
| $ | 58,410 |
|
|
|
|
|
|
|
|
In-Force Face Amount |
|
|
|
|
|
|
UL and other | $ | 361,490 |
| $ | 358,044 |
|
Term insurance |
| 635,123 |
|
| 549,960 |
|
Total in-force face amount | $ | 996,613 |
| $ | 908,004 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Average General Account Values (1) | $ | 32,864 |
| $ | 37,844 |
|
|
|
|
|
|
|
|
(1)Net of reinsurance ceded.
Fee income relates only to interest-sensitive products and includes cost of insurance assessments, expense assessments and surrender charges. Both cost of insurance and expense assessments can have deferrals and amortization related to DFEL. Cost of insurance and expense assessments are deducted from our contract holders’ account values. These amounts are a function of the rates priced into the product and premiums received, face amount in force and account values.
Sales are not recorded as a component of revenues (other than for traditional products) and do not have a significant effect on current quarter income from operations but are indicators of future profitability. Generally, we have higher sales during the second half of the year with the fourth quarter being our strongest. For more information on sales, see “Additional Information” above.
Sales in the table above and as discussed above were reported as follows:
UL, IUL and VUL – first-year commissionable premiums plus 5% of excess premiums received;
MoneyGuard® linked-benefit products – MoneyGuard (UL), 15% of total expected premium deposits, and MoneyGuard Market AdvantageSM (VUL), 150% of commissionable premiums;
Executive Benefits – insurance and corporate-owned UL and VUL, first-year commissionable premiums plus 5% of excess premium received, and single premium bank-owned UL and VUL, 15% of single premium deposits; and
Term – 100% of annualized first-year premiums.
We monitor the business environment, including but not limited to the regulatory and interest rate environments, and make changes to our product offerings and in-force products as needed, and as permitted under the terms of the policies, to sustain the future profitability of our segment.
Net Investment Income and Interest Credited
Details underlying net investment income and interest credited (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Net Investment Income |
|
|
|
|
|
|
Fixed maturity AFS securities, |
|
|
|
|
|
|
mortgage loans on real estate and |
|
|
|
|
|
|
other, net of investment expenses | $ | 587 |
| $ | 644 |
|
Commercial mortgage loan prepayment |
|
|
|
|
|
|
and bond make-whole premiums (1) |
| 13 |
|
| 6 |
|
Alternative investments (2) |
| 54 |
|
| 127 |
|
Surplus investments (3) |
| 34 |
|
| 32 |
|
Total net investment income | $ | 688 |
| $ | 809 |
|
|
|
|
|
|
|
|
Interest Credited | $ | 325 |
| $ | 370 |
|
(1)See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2)See “Consolidated Investments – Alternative Investments” below for additional information.
(3)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities.
A portion of the investment income earned for this segment is credited to contract holder accounts. Statutory reserves will typically grow at a faster rate than account values because of reserve requirements. Investments allocated to this segment are based upon the statutory reserve liabilities and are affected by various reserve adjustments, including financing transactions providing relief from reserve requirements. These financing transactions lead to a transfer of investments from this segment to Other Operations. We expect to earn a spread between what we earn on the underlying general account investments and what we credit to our contract holders’ accounts. We use our investment income to offset the earnings effect of the associated growth of our policy reserves for traditional products. Commercial mortgage loan prepayments and bond make-whole premiums and investment income on alternative investments can vary significantly from period to period due to a number of factors, and, therefore, may contribute to investment income results that are not indicative of the underlying trends.
Benefits
Details underlying benefits (dollars in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Benefits |
|
|
|
|
|
|
Death claims direct and assumed | $ | 1,542 |
| $ | 1,608 |
|
Death claims ceded |
| (619 | ) |
| (608 | ) |
Reserves released on death |
| (164 | ) |
| (204 | ) |
Net death benefits |
| 759 |
|
| 796 |
|
Change in secondary guarantee life |
|
|
|
|
|
|
insurance product reserves |
| 135 |
|
| 171 |
|
Change in MoneyGuard® reserves |
| 142 |
|
| 132 |
|
Other benefits (1) |
| 90 |
|
| 74 |
|
Total benefits | $ | 1,126 |
| $ | 1,173 |
|
|
|
|
|
|
|
|
Death claims per $1,000 of in-force |
| 3.08 |
|
| 3.53 |
|
(1)Includes primarily changes in reserves and dividends on traditional and other products.
Benefits for this segment include claims incurred during the period in excess of the associated reserves for its interest-sensitive and traditional products. In addition, benefits include the change in secondary guarantee and linked-benefit life insurance product reserves. These reserves are affected by changes in expected future trends of assessments and benefits causing unlocking adjustments to these liabilities similar to DAC, VOBA and DFEL. Generally, we have higher mortality in the first quarter of the year due to the seasonality of claims.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Commissions and Other Expenses |
|
|
|
|
|
|
Commissions | $ | 156 |
| $ | 120 |
|
General and administrative expenses |
| 134 |
|
| 133 |
|
Expenses associated with reserve financing |
| 25 |
|
| 25 |
|
Taxes, licenses and fees |
| 43 |
|
| 36 |
|
Total expenses incurred |
| 358 |
|
| 314 |
|
DAC and VOBA deferrals |
| (182 | ) |
| (138 | ) |
Total expenses recognized before |
|
|
|
|
|
|
amortization |
| 176 |
|
| 176 |
|
DAC and VOBA amortization, |
|
|
|
|
|
|
net of interest |
| 132 |
|
| 89 |
|
Other intangible amortization |
| 1 |
|
| 1 |
|
Total commissions and |
|
|
|
|
|
|
other expenses | $ | 309 |
| $ | 266 |
|
|
|
|
|
|
|
|
DAC and VOBA Deferrals |
|
|
|
|
|
|
As a percentage of sales |
| 117.4% |
|
| 121.1% |
|
Commissions and costs that result directly from and are essential to successful acquisition of new or renewal business are deferred to the extent recoverable and for our interest-sensitive products are generally amortized over the life of the contracts in relation to EGPs. For our traditional products, DAC and VOBA are amortized on either a straight-line basis or as a level percent of premium of the related contracts, depending on the block of business. When comparing DAC and VOBA deferrals as a percentage of sales for the three months ended March 31, 2022, to the corresponding period in 2021, the decrease was primarily a result of changes in sales mix to products with lower commission rates. For more information, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates – DAC, VOBA, DSI and DFEL” in our 2021 Form 10-K.
RESULTS OF GROUP PROTECTION
Income (Loss) from Operations
Details underlying the results for Group Protection (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Operating Revenues |
|
|
|
|
|
|
|
Insurance premiums | $ | 1,169 |
| $ | 1,119 |
|
|
Net investment income |
| 85 |
|
| 91 |
|
|
Other revenues (1) |
| 49 |
|
| 44 |
|
|
Total operating revenues |
| 1,303 |
|
| 1,254 |
|
|
Operating Expenses |
|
|
|
|
|
|
|
Interest credited |
| 1 |
|
| 1 |
|
|
Benefits |
| 1,027 |
|
| 970 |
|
|
Commissions and other expenses |
| 327 |
|
| 316 |
|
|
Total operating expenses |
| 1,355 |
|
| 1,287 |
|
|
Income (loss) from operations before taxes |
| (52 | ) |
| (33 | ) |
|
Federal income tax expense (benefit) |
| (11 | ) |
| (7 | ) |
|
Income (loss) from operations | $ | (41 | ) | $ | (26 | ) |
|
(1)Consists of revenue from third parties for administrative services performed, which has a corresponding partial offset in commissions and other expenses.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Income (Loss) from Operations by |
|
|
|
|
|
|
Product Line |
|
|
|
|
|
|
Life | $ | (39 | ) | $ | (71 | ) |
Disability |
| (2 | ) |
| 48 |
|
Dental |
| - |
|
| (3 | ) |
Income (loss) from operations | $ | (41 | ) | $ | (26 | ) |
Comparison of the Three Months Ended March 31, 2022 to 2021
Loss from operations for this segment increased due primarily to the following:
Higher benefits driven by unfavorable experience in our disability business, partially offset by favorable experience in our life business. See “Additional Information” below for further discussion on the impacts to benefits.
Higher commissions and other expenses driven by investments in claims management to address higher claims volume and to improve ongoing operations.
Lower net investment income, net of interest credited, driven by lower investment income on alternative investments within our surplus portfolio.
The increase in loss from operations was partially offset by higher insurance premiums due to growth in the business and favorable persistency.
Additional Information
The total loss ratio for the three months ended March 31, 2022, increased as compared to the three months ended March 31, 2021, due primarily to unfavorable claims severity and higher incidence in our disability business, partially offset by improvement in mortality in our life business driven by fewer pandemic-related deaths and favorable life waiver experience. While case counts and hospitalizations have declined and U.S. pandemic deaths have improved, we continue to expect morbidity headwinds in our disability business and elevated mortality in our life business in the second quarter of 2022. For a discussion of the COVID-19 pandemic, see “Introduction – Executive Summary” above.
For information about the effect of the loss ratio sensitivity on our income (loss) from operations, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Results of Group Protection – Additional Information” in our 2021 Form 10-K.
For information on the effects of current interest rates on our long-term disability claim reserves, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk – Interest Rate Risk – Effect of Interest Rate Sensitivity” in our 2021 Form 10-K.
Details underlying insurance premiums (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Insurance Premiums by Product Line |
|
|
|
|
|
|
Life | $ | 443 |
| $ | 410 |
|
Disability |
| 676 |
|
| 650 |
|
Dental |
| 50 |
|
| 59 |
|
Total insurance premiums | $ | 1,169 |
| $ | 1,119 |
|
|
|
|
|
|
|
|
Sales by Product Line |
|
|
|
|
|
|
Life | $ | 53 |
| $ | 41 |
|
Disability |
| 47 |
|
| 28 |
|
Dental |
| 5 |
|
| 5 |
|
Total sales | $ | 105 |
| $ | 74 |
|
Our cost of insurance and policy administration charges are embedded in the premiums charged to our customers. The premiums are a function of the rates priced into the product and our business in force. Business in force, in turn, is driven by sales and persistency experience.
Sales relate to new contract holders and new programs sold to existing contract holders. We believe that the trend in sales is an important indicator of development of business in force over time. Sales in the table above are the combined annualized premiums for our products.
Net Investment Income
We use our investment income to offset the earnings effect of the associated build of our reserves, which are a function of our insurance premiums and the yields on our investments. Details underlying net investment income (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Net Investment Income |
|
|
|
|
|
|
Fixed maturity AFS securities, |
|
|
|
|
|
|
mortgage loans on real estate and |
|
|
|
|
|
|
other, net of investment expenses | $ | 60 |
| $ | 60 |
|
Commercial mortgage loan prepayment and |
|
|
|
|
|
|
bond make-whole premiums (1) |
| 2 |
|
| 2 |
|
Surplus investments (2) |
| 23 |
|
| 29 |
|
Total net investment income | $ | 85 |
| $ | 91 |
|
(1)See “Consolidated Investments – Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2)Represents net investment income on the required statutory surplus for this segment and includes the effect of investment income on alternative investments for such assets that are held in the portfolios supporting statutory surplus versus the portfolios supporting product liabilities. See “Consolidated Investments – Alternative Investments” below for more information on alternative investments.
Benefits and Interest Credited
Details underlying benefits and interest credited (in millions) and loss ratios by product line were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Benefits and Interest Credited by |
|
|
|
|
|
|
Product Line |
|
|
|
|
|
|
Life | $ | 404 |
| $ | 414 |
|
Disability |
| 589 |
|
| 512 |
|
Dental |
| 35 |
|
| 45 |
|
Total benefits and interest credited | $ | 1,028 |
| $ | 971 |
|
|
|
|
|
|
|
|
Loss Ratios by Product Line |
|
|
|
|
|
|
Life |
| 91.0% |
|
| 101.0% |
|
Disability |
| 87.2% |
|
| 78.8% |
|
Dental |
| 71.1% |
|
| 76.8% |
|
Total |
| 88.0% |
|
| 86.8% |
|
Generally, we experience higher mortality in the first quarter of the year and higher disability claims in the fourth quarter of the year due to the seasonality of claims. For additional information on our loss ratios, see “Additional Information” above.
Commissions and Other Expenses
Details underlying commissions and other expenses (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
Commissions and Other Expenses |
|
|
|
|
|
|
Commissions | $ | 94 |
| $ | 91 |
|
General and administrative expenses |
| 184 |
|
| 175 |
|
Taxes, licenses and fees |
| 33 |
|
| 33 |
|
Total expenses incurred |
| 311 |
|
| 299 |
|
DAC deferrals |
| (21 | ) |
| (21 | ) |
Total expenses recognized before |
|
|
|
|
|
|
amortization |
| 290 |
|
| 278 |
|
DAC and VOBA amortization, net of |
|
|
|
|
|
|
interest |
| 29 |
|
| 30 |
|
Other intangible amortization |
| 8 |
|
| 8 |
|
Total commissions and |
|
|
|
|
|
|
other expenses | $ | 327 |
| $ | 316 |
|
|
|
|
|
|
|
|
DAC Deferrals |
|
|
|
|
|
|
As a percentage of insurance premiums |
| 1.8% |
|
| 1.9% |
|
Commissions and other costs that result directly from and are essential to the successful acquisition of new or renewal business are deferred to the extent recoverable and are amortized as a level percent of insurance premiums of the related contracts, depending on the block of business. Certain broker commissions that vary with and are related to paid premiums are expensed as incurred rather than deferred and amortized. For more information, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Critical Accounting Policies and Estimates – DAC, VOBA, DSI and DFEL” in our 2021 Form 10-K
RESULTS OF OTHER OPERATIONS
Income (Loss) from Operations
Details underlying the results for Other Operations (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Operating Revenues |
|
|
|
|
|
|
|
Insurance premiums (1) | $ | 1 |
| $ | 2 |
|
|
Net investment income |
| 41 |
|
| 34 |
|
|
Other revenues |
| (2 | ) |
| 2 |
|
|
Total operating revenues |
| 40 |
|
| 38 |
|
|
Operating Expenses |
|
|
|
|
|
|
|
Interest credited |
| 12 |
|
| 12 |
|
|
Benefits |
| 14 |
|
| 15 |
|
|
Other expenses |
| 12 |
|
| 29 |
|
|
Interest and debt expense |
| 66 |
|
| 65 |
|
|
Spark program expense |
| 31 |
|
| 13 |
|
|
Total operating expenses |
| 135 |
|
| 134 |
|
|
Income (loss) from operations before taxes |
| (95 | ) |
| (96 | ) |
|
Federal income tax expense (benefit) |
| (15 | ) |
| (18 | ) |
|
Income (loss) from operations | $ | (80 | ) | $ | (78 | ) |
|
|
|
|
|
|
|
|
|
(1)Includes our disability income business, which has a corresponding offset in benefits for changes in reserves.
Comparison of the Three Months Ended March 31, 2022 to 2021
Loss from operations for Other Operations increased due primarily to the following:
Higher Spark program expense as part of our Spark Initiative.
Lower other revenues due to the effect of market fluctuations on assets held as part of certain compensation plans, which decreased during the first quarter of 2022, compared to an increase during the first quarter of 2021.
Less favorable income tax benefit driven by unfavorable market impacts on tax preferred investment income.
The increase in loss from operations was partially offset by the following:
Lower other expenses due to the effect of changes in our stock price on our deferred compensation plans, as our stock price decreased during the first quarter of 2022, compared to an increase during the first quarter of 2021.
Higher net investment income, net of interest credited, related to higher allocated investments driven by an increase in excess capital retained by Other Operations.
Additional Information
We expect to continue making investments as part of our Spark Initiative. For more information, see “Introduction – Executive Summary – Spark Initiative” above and “Introduction – Executive Summary – Significant Operational Matters – Spark and Strategic Digitization Initiatives” in our 2021 Form 10-K.
Net Investment Income and Interest Credited
We utilize an internal formula to determine the amount of capital that is allocated to our business segments. Investment income on capital in excess of the calculated amounts is reported in Other Operations. If our business segments require increases in statutory reserves, surplus or investments, the amount of excess capital that is retained by Other Operations would decrease and net investment income would be negatively affected.
Write-downs for impairments decrease the recorded value of investments owned by the business segments. These write-downs are not included in the income from operations of our business segments. When impairment occurs, assets are transferred to the business segments’ portfolios and will reduce the future net investment income for Other Operations. Statutory reserve adjustments for our business segments can also cause allocations of investments between the business segments and Other Operations.
The majority of our interest credited relates to our reinsurance operations sold to Swiss Re Life & Health America, Inc. (“Swiss Re”) in 2001. A substantial amount of the business was sold through indemnity reinsurance transactions, which is still recorded in our consolidated financial statements. The interest credited corresponds to investment income earnings on the assets we continue to hold for this business. There is no effect to income or loss in Other Operations or on a consolidated basis for these amounts because interest earned on the blocks that continue to be reinsured is passed through to Swiss Re in the form of interest credited.
Benefits
Benefits are recognized when incurred for institutional pension products and disability income business.
Other Expenses
Details underlying other expenses (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||||
| Months Ended |
| ||||
| March 31, |
| ||||
| 2022 |
| 2021 |
| ||
General and administrative expenses: |
|
|
|
|
|
|
Branding | $ | 6 |
| $ | 8 |
|
Other (1) |
| 9 |
|
| 24 |
|
Total general and administrative expenses |
| 15 |
|
| 32 |
|
Taxes, licenses and fees (2) |
| (2 | ) |
| (2 | ) |
Other (3) |
| (1 | ) |
| (1 | ) |
Total other expenses | $ | 12 |
| $ | 29 |
|
(1)Includes expenses that are corporate in nature including charitable contributions, the portion of our deferred compensation plan expense attributable to participants’ selection of LNC stock as the measure for their investment return and other expenses not allocated to our business segments.
(2)Includes state guaranty funds assessments to cover losses to contract holders of insolvent or rehabilitated insurance companies. Mandatory assessments may be partially recovered through a reduction in future premium taxes in some states.
(3)Consists primarily of reimbursements to Other Operations from the Life Insurance segment for the use of proceeds from certain issuances of senior notes that were used as long-term structured solutions, net of expenses incurred by Other Operations for its access to a financing facility and issuance of LOCs.
Interest and Debt Expense
Our current level of interest expense may not be indicative of the future due to, among other things, the timing of the use of cash, the availability of funds from our inter-company cash management program and the future cost of capital. For additional information on our financing activities, see “Liquidity and Capital Resources – Holding Company Sources and Uses of Liquidity and Capital – Debt” below.
REALIZED GAIN (LOSS)
Details underlying realized gain (loss), after-DAC (1) (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Components of Realized Gain (Loss), Pre-Tax |
|
|
|
|
|
|
|
Total operating realized gain (loss) | $ | 55 |
| $ | 48 |
|
|
Total excluded realized gain (loss) |
| (26 | ) |
| (229 | ) |
|
Total realized gain (loss), pre-tax | $ | 29 |
| $ | (181 | ) |
|
|
|
|
|
|
|
|
|
Components of Excluded Realized Gain (Loss), |
|
|
|
|
|
|
|
After-Tax |
|
|
|
|
|
|
|
Realized gain (loss) related to certain financial assets | $ | 5 |
| $ | 25 |
|
|
Realized gain (loss) on the mark-to-market on |
|
|
|
|
|
|
|
certain instruments (2) |
| (9 | ) |
| 19 |
|
|
Variable annuity net derivative results: |
|
|
|
|
|
|
|
Hedge program performance, including unlocking |
|
|
|
|
|
|
|
for GLB reserves hedged and benefit ratio unlocking |
| (247 | ) |
| (42 | ) |
|
GLB NPR component |
| 18 |
|
| (144 | ) |
|
Total variable annuity net derivative results |
| (229 | ) |
| (186 | ) |
|
Indexed annuity forward-starting option |
| 43 |
|
| 17 |
|
|
Excluded realized gain (loss) including benefit |
|
|
|
|
|
|
|
ratio unlocking, after-tax |
| (190 | ) |
| (125 | ) |
|
Less: benefit ratio unlocking, after tax |
| (170 | ) |
| 55 |
|
|
Total excluded realized gain (loss), after-tax | $ | (20 | ) | $ | (180 | ) |
|
(1)DAC refers to the associated amortization of DAC, VOBA, DSI and DFEL and changes in other contract holder funds and funds withheld reinsurance assets and liabilities.
(2)The modified coinsurance investment portfolio includes fixed maturity securities classified as available-for-sale (“AFS”) with changes in fair value recorded in other comprehensive income (loss) (“OCI”). Since the corresponding and offsetting changes in fair value of the embedded derivatives related to the modified coinsurance investment portfolio are recorded in realized gain (loss), volatility can occur within net income (loss). See Note 7 in our 2021 Form 10-K for more information regarding modified coinsurance.
Comparison of the Three Months Ended March 31, 2022 to 2021
We had higher realized losses due primarily to the following:
Unfavorable variable annuity net derivatives results driven by unfavorable hedge program performance due to more volatile markets, partially offset by a favorable GLB NPR component due to credit spreads widening and our associated reserves increasing in 2022 versus decreasing in 2021.
Losses on the mark-to-market on certain instruments due to unfavorable changes in the fair value of embedded derivatives related to certain modified coinsurance arrangements.
The higher realized losses were partially offset by higher gains related to the indexed annuity forward-starting option driven by an increase in discount rates and a decrease in projected index interest credited as a result of market performance.
The above components of excluded realized gain (loss) are described including benefit ratio unlocking, after-tax.
Operating Realized Gain (Loss)
See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Realized Gain (Loss) – Operating Realized Gain (Loss)” in our 2021 Form 10-K for a discussion of our operating realized gain (loss).
Realized Gain (Loss) Related to Certain Financial Assets
For information on realized gain (loss) related to certain financial assets, see Note 12.
Realized Gain (Loss) on the Mark-to-Market on Certain Instruments
See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Realized Gain (Loss) – Realized Gain (Loss) on the Mark-to-Market on Certain Instruments” in our 2021 Form 10-K for a discussion of the mark-to-market on certain instruments. We also recognize the mark-to-market on certain mortgage loans on real estate for which we have elected the fair value option. See Note 13 for additional information.
Variable Annuity Net Derivative Results
See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Realized Gain (Loss) – Variable Annuity Net Derivative Results” in our 2021 Form 10-K for a discussion of our variable annuity net derivative results and how our NPR adjustment is determined.
Details underlying our variable annuity hedging program (dollars in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of |
|
| As of |
|
| As of |
|
| As of |
|
| As of |
| |||||
| March 31, | December 31, | September 30, | June 30, | March 31, | |||||||||||||||
|
| 2022 |
|
| 2021 |
|
| 2021 |
|
| 2021 |
|
| 2021 |
| |||||
Variable annuity hedge program assets (liabilities) |
| $ | 625 |
|
| $ | 721 |
|
| $ | 1,090 |
|
| $ | 881 |
|
| $ | 640 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Variable annuity reserves – asset (liability): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Embedded derivative reserves, pre-NPR (1) |
| $ | 1,699 |
|
| $ | 1,818 |
|
| $ | 1,511 |
|
| $ | 1,569 |
|
| $ | 1,619 |
|
NPR |
|
| 46 |
|
|
| 17 |
|
|
| 94 |
|
|
| 98 |
|
|
| 101 |
|
Embedded derivative reserves |
|
| 1,745 |
|
|
| 1,835 |
|
|
| 1,605 |
|
|
| 1,667 |
|
|
| 1,719 |
|
Insurance benefit reserves |
|
| (1,547 | ) |
|
| (1,231 | ) |
|
| (1,254 | ) |
|
| (1,135 | ) |
|
| (1,164 | ) |
Total variable annuity reserves – asset (liability) |
| $ | 198 |
|
| $ | 604 |
|
| $ | 351 |
|
| $ | 532 |
|
| $ | 555 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10-year CDS spread |
|
| 1.44% |
|
|
| 1.15% |
|
|
| 1.18% |
|
|
| 1.15% |
|
|
| 1.28% |
|
NPR factor related to 10-year CDS spread |
|
| 0.99% |
|
|
| 0.70% |
|
|
| 0.74% |
|
|
| 0.70% |
|
|
| 0.78% |
|
(1)Embedded derivative reserves in an asset (liability) position indicate we estimate the present value of future benefits to be less (greater) than the present value of future net valuation premiums.
For information about the effect of changes in the NPR factor on our net income (loss), see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Realized Gain (Loss) – Variable Annuity Net Derivative Results” in our 2021 Form 10-K.
For additional information about our guaranteed benefits, see “Critical Accounting Policies and Estimates – Future Contract Benefits – Guaranteed Living Benefits” above.
Indexed Annuity Forward-Starting Option
See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Realized Gain (Loss) – Indexed Annuity Forward-Starting Option” in our 2021 Form 10-K for a discussion of our indexed annuity forward-starting option.
CONSOLIDATED INVESTMENTS
Details underlying our consolidated investment balances (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Percentage of |
|
| |||
|
|
|
|
|
|
|
|
| Total Investments |
|
| ||||
|
| As of |
|
| As of |
| As of |
| As of |
|
| ||||
| March 31, | December 31, | March 31, | December 31, |
| ||||||||||
|
| 2022 |
|
| 2021 |
|
| 2022 |
|
| 2021 |
|
| ||
Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fixed maturity AFS securities |
| $ | 110,695 |
|
| $ | 118,746 |
|
| 76.6% |
|
| 77.3% |
|
|
Trading securities |
|
| 4,385 |
|
|
| 4,482 |
|
| 3.0% |
|
| 2.9% |
|
|
Equity securities |
|
| 346 |
|
|
| 318 |
|
| 0.2% |
|
| 0.2% |
|
|
Mortgage loans on real estate |
|
| 17,892 |
|
|
| 17,991 |
|
| 12.4% |
|
| 11.7% |
|
|
Policy loans |
|
| 2,339 |
|
|
| 2,364 |
|
| 1.6% |
|
| 1.5% |
|
|
Derivative investments |
|
| 4,840 |
|
|
| 5,437 |
|
| 3.4% |
|
| 3.6% |
|
|
Alternative investments |
|
| 2,805 |
|
|
| 2,666 |
|
| 1.9% |
|
| 1.7% |
|
|
Other investments |
|
| 1,322 |
|
|
| 1,626 |
|
| 0.9% |
|
| 1.1% |
|
|
Total investments |
| $ | 144,624 |
|
| $ | 153,630 |
|
| 100.0% |
|
| 100.0% |
|
|
Investment Objective
Investments are an integral part of our operations. We follow a balanced approach to investing for both current income and prudent risk management, with an emphasis on generating sufficient current income, net of income tax, to meet our obligations to customers, as well as other general liabilities. This balanced approach requires the evaluation of expected return and risk of each asset class utilized, while still meeting our income objectives. This approach is important to our asset-liability management because decisions can be made based upon both the economic and current investment income considerations affecting assets and liabilities. For a discussion of our risk management process, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2021 Form 10-K.
Investment Portfolio Composition and Diversification
Fundamental to our investment policy is diversification across asset classes. Our investment portfolio, excluding cash and invested cash, is composed of fixed maturity securities, mortgage loans on real estate, real estate (either wholly-owned or in joint ventures) and other long-term investments. We purchase investments for our segmented portfolios that have yield, duration and other characteristics that take into account the liabilities of the products being supported.
We have the ability to maintain our investment holdings throughout credit cycles because of our capital position, the long-term nature of our liabilities and the matching of our portfolios of investment assets with the liabilities of our various products.
Fixed Maturity and Equity Securities Portfolios
Fixed maturity securities consist of portfolios classified as AFS and trading. Details underlying our fixed maturity AFS securities by industry classification (in millions) are presented in the tables below. These tables agree in total with the presentation of fixed maturity AFS securities in Note 4; however, the categories below represent a more detailed breakout of the fixed maturity AFS portfolio. Therefore, the investment classifications listed below do not agree to the investment categories provided in Note 4.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| ||||||||||||
| Net |
|
|
|
|
|
|
|
|
|
| % |
| |
| Amortized |
| Gross Unrealized |
| Fair |
| Fair |
| ||||||
| Cost (1) |
| Gains |
| Losses |
| Value |
| Value |
| ||||
Fixed Maturity AFS Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry corporate bonds: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial services | $ | 16,969 |
| $ | 774 |
| $ | 521 |
| $ | 17,222 |
| 15.6% |
|
Basic industry |
| 4,532 |
|
| 324 |
|
| 88 |
|
| 4,768 |
| 4.3% |
|
Capital goods |
| 7,400 |
|
| 424 |
|
| 210 |
|
| 7,614 |
| 6.9% |
|
Communications |
| 4,234 |
|
| 342 |
|
| 109 |
|
| 4,467 |
| 4.0% |
|
Consumer cyclical |
| 6,070 |
|
| 214 |
|
| 194 |
|
| 6,090 |
| 5.5% |
|
Consumer non-cyclical |
| 17,082 |
|
| 1,057 |
|
| 608 |
|
| 17,531 |
| 15.8% |
|
Energy |
| 4,871 |
|
| 328 |
|
| 81 |
|
| 5,118 |
| 4.6% |
|
Technology |
| 5,242 |
|
| 219 |
|
| 194 |
|
| 5,267 |
| 4.7% |
|
Transportation |
| 3,536 |
|
| 163 |
|
| 64 |
|
| 3,635 |
| 3.3% |
|
Industrial other |
| 2,283 |
|
| 40 |
|
| 101 |
|
| 2,222 |
| 2.0% |
|
Utilities |
| 14,036 |
|
| 928 |
|
| 283 |
|
| 14,681 |
| 13.3% |
|
Government-related entities |
| 1,820 |
|
| 170 |
|
| 44 |
|
| 1,946 |
| 1.8% |
|
Collateralized mortgage and other obligations ("CMOs"): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
| 1,509 |
|
| 40 |
|
| 25 |
|
| 1,524 |
| 1.4% |
|
Non-agency backed |
| 367 |
|
| 43 |
|
| 3 |
|
| 407 |
| 0.4% |
|
Mortgage pass through securities ("MPTS"): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
| 412 |
|
| 9 |
|
| 14 |
|
| 407 |
| 0.4% |
|
Commercial mortgage-backed securities ("CMBS"): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
| 17 |
|
| - |
|
| - |
|
| 17 |
| 0.0% |
|
Non-agency backed |
| 1,639 |
|
| 8 |
|
| 72 |
|
| 1,575 |
| 1.4% |
|
Asset-backed securities ("ABS"): |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized loan obligations ("CLOs") |
| 6,646 |
|
| 3 |
|
| 131 |
|
| 6,518 |
| 5.9% |
|
Credit card |
| 82 |
|
| 17 |
|
| 1 |
|
| 98 |
| 0.1% |
|
Home equity |
| 224 |
|
| 43 |
|
| 2 |
|
| 265 |
| 0.2% |
|
Other |
| 2,093 |
|
| 10 |
|
| 55 |
|
| 2,048 |
| 1.8% |
|
Municipals: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taxable |
| 5,308 |
|
| 768 |
|
| 153 |
|
| 5,923 |
| 5.4% |
|
Tax-exempt |
| 72 |
|
| 7 |
|
| 1 |
|
| 78 |
| 0.1% |
|
Government: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
| 392 |
|
| 31 |
|
| 5 |
|
| 418 |
| 0.4% |
|
Foreign |
| 358 |
|
| 43 |
|
| 18 |
|
| 383 |
| 0.3% |
|
Hybrid and redeemable preferred securities |
| 408 |
|
| 86 |
|
| 21 |
|
| 473 |
| 0.4% |
|
Total fixed maturity AFS securities |
| 107,602 |
|
| 6,091 |
|
| 2,998 |
|
| 110,695 |
| 100.0% |
|
Trading Securities (2) |
| 4,348 |
|
| 168 |
|
| 131 |
|
| 4,385 |
|
|
|
Equity Securities |
| 307 |
|
| 67 |
|
| 28 |
|
| 346 |
|
|
|
Total fixed maturity AFS, trading and equity securities | $ | 112,257 |
| $ | 6,326 |
| $ | 3,157 |
| $ | 115,426 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2021 |
| ||||||||||||
| Net |
|
|
|
|
|
| % |
| |||||
| Amortized |
| Gross Unrealized |
| Fair |
| Fair |
| ||||||
| Cost (1) |
| Gains |
| Losses |
| Value |
| Value |
| ||||
Fixed Maturity AFS Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Industry corporate bonds: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Financial services | $ | 16,438 |
| $ | 1,981 |
| $ | 81 |
| $ | 18,338 |
| 15.4% |
|
Basic industry |
| 4,436 |
|
| 741 |
|
| 11 |
|
| 5,166 |
| 4.4% |
|
Capital goods |
| 7,316 |
|
| 1,040 |
|
| 31 |
|
| 8,325 |
| 7.0% |
|
Communications |
| 4,124 |
|
| 734 |
|
| 7 |
|
| 4,851 |
| 4.1% |
|
Consumer cyclical |
| 5,811 |
|
| 616 |
|
| 22 |
|
| 6,405 |
| 5.4% |
|
Consumer non-cyclical |
| 16,905 |
|
| 2,565 |
|
| 83 |
|
| 19,387 |
| 16.3% |
|
Energy |
| 4,932 |
|
| 728 |
|
| 13 |
|
| 5,647 |
| 4.8% |
|
Technology |
| 5,173 |
|
| 546 |
|
| 34 |
|
| 5,685 |
| 4.8% |
|
Transportation |
| 3,414 |
|
| 423 |
|
| 11 |
|
| 3,826 |
| 3.2% |
|
Industrial other |
| 2,159 |
|
| 174 |
|
| 11 |
|
| 2,322 |
| 2.0% |
|
Utilities |
| 13,785 |
|
| 2,250 |
|
| 38 |
|
| 15,997 |
| 13.5% |
|
Government-related entities |
| 1,863 |
|
| 315 |
|
| 7 |
|
| 2,171 |
| 1.8% |
|
CMOs: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
| 1,544 |
|
| 123 |
|
| 1 |
|
| 1,666 |
| 1.4% |
|
Non-agency backed |
| 360 |
|
| 52 |
|
| 1 |
|
| 411 |
| 0.3% |
|
MPTS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
| 429 |
|
| 21 |
|
| 2 |
|
| 448 |
| 0.4% |
|
CMBS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Agency backed |
| 20 |
|
| - |
|
| - |
|
| 20 |
| 0.0% |
|
Non-agency backed |
| 1,532 |
|
| 61 |
|
| 14 |
|
| 1,579 |
| 1.3% |
|
ABS: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CLOs |
| 6,356 |
|
| 11 |
|
| 49 |
|
| 6,318 |
| 5.3% |
|
Credit card |
| 82 |
|
| 24 |
|
| 1 |
|
| 105 |
| 0.1% |
|
Home equity |
| 236 |
|
| 54 |
|
| - |
|
| 290 |
| 0.2% |
|
Other |
| 1,765 |
|
| 38 |
|
| 4 |
|
| 1,799 |
| 1.5% |
|
Municipals: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Taxable |
| 5,250 |
|
| 1,290 |
|
| 12 |
|
| 6,528 |
| 5.5% |
|
Tax-exempt |
| 72 |
|
| 21 |
|
| - |
|
| 93 |
| 0.1% |
|
Government: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States |
| 375 |
|
| 60 |
|
| 2 |
|
| 433 |
| 0.4% |
|
Foreign |
| 373 |
|
| 64 |
|
| 5 |
|
| 432 |
| 0.4% |
|
Hybrid and redeemable preferred securities |
| 408 |
|
| 107 |
|
| 11 |
|
| 504 |
| 0.4% |
|
Total fixed maturity AFS securities |
| 105,158 |
|
| 14,039 |
|
| 451 |
|
| 118,746 |
| 100.0% |
|
Trading Securities (2) |
| 4,170 |
|
| 343 |
|
| 31 |
|
| 4,482 |
|
|
|
Equity Securities |
| 285 |
|
| 55 |
|
| 22 |
|
| 318 |
|
|
|
Total fixed maturity AFS, trading and equity securities | $ | 109,613 |
| $ | 14,437 |
| $ | 504 |
| $ | 123,546 |
|
|
|
(1)Represents amortized cost, net of the allowance for credit losses.
(2)Certain of our trading securities support our reinsurance funds withheld and modified coinsurance agreements and the investment results are passed directly to the reinsurers. See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Investments – Fixed Maturity and Equity Securities Portfolios – Trading Securities” in our 2021 Form 10-K for further details.
Fixed Maturity AFS Securities
In accordance with the fixed maturity AFS accounting guidance, we reflect stockholders’ equity as if unrealized gains and losses were actually recognized and consider all related accounting adjustments that would occur upon such a hypothetical recognition of unrealized gains and losses. Such related balance sheet effects include adjustments to the balances of DAC, VOBA, DFEL, future contract benefits, other contract holder funds and deferred income taxes. Adjustments to each of these balances are charged or credited to accumulated other comprehensive income (loss) (“AOCI”). For instance, DAC is adjusted upon the recognition of unrealized gains or losses because the amortization of DAC is based upon an assumed emergence of gross profits on certain insurance business. Deferred income tax balances are also adjusted because unrealized gains or losses do not affect actual taxes currently paid.
The quality of our fixed maturity AFS securities portfolio, as measured at estimated fair value and by the percentage of fixed maturity AFS securities invested in various ratings categories, relative to the entire fixed maturity AFS security portfolio (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| As of December 31, 2021 |
| ||||||||||||
|
| Rating Agency |
| Net |
|
|
|
|
|
| Net |
|
|
|
|
|
| ||
NAIC |
| Equivalent |
| Amortized |
| Fair |
| % of |
| Amortized |
| Fair |
| % of |
| ||||
Designation (1) |
| Designation (1) |
| Cost |
| Value |
| Total |
| Cost |
| Value |
| Total |
| ||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
1 |
| AAA / AA / A |
| $ | 59,694 |
| $ | 61,767 |
| 55.8% |
| $ | 58,542 |
| $ | 66,571 |
| 56.1% |
|
2 |
| BBB |
|
| 44,120 |
|
| 45,117 |
| 40.8% |
|
| 42,797 |
|
| 48,130 |
| 40.5% |
|
Total investment grade securities |
|
| 103,814 |
|
| 106,884 |
| 96.6% |
|
| 101,339 |
|
| 114,701 |
| 96.6% |
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Below Investment Grade Securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
3 |
| BB |
|
| 2,148 |
|
| 2,159 |
| 1.9% |
|
| 2,278 |
|
| 2,492 |
| 2.1% |
|
4 |
| B |
|
| 1,479 |
|
| 1,498 |
| 1.3% |
|
| 1,424 |
|
| 1,441 |
| 1.2% |
|
5 |
| CCC and lower |
|
| 95 |
|
| 93 |
| 0.1% |
|
| 51 |
|
| 53 |
| 0.0% |
|
6 |
| In or near default |
|
| 66 |
|
| 61 |
| 0.1% |
|
| 66 |
|
| 59 |
| 0.1% |
|
Total below investment grade securities |
|
| 3,788 |
|
| 3,811 |
| 3.4% |
|
| 3,819 |
|
| 4,045 |
| 3.4% |
| ||
Total fixed maturity AFS securities |
| $ | 107,602 |
| $ | 110,695 |
| 100.0% |
| $ | 105,158 |
| $ | 118,746 |
| 100.0% |
| ||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total securities below investment |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
grade as a percentage of total |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||
fixed maturity AFS securities |
|
| 3.5% |
|
| 3.4% |
|
|
|
| 3.6% |
|
| 3.4% |
|
|
|
(1)Based upon the rating designations determined and provided by the National Association of Insurance Commissioners (“NAIC”) or the major credit rating agencies (Fitch Ratings (“Fitch”), Moody’s Investors Service (“Moody’s”) and S&P Global Ratings (“S&P”)). For securities where the ratings assigned by the major credit rating agencies are not equivalent, the second lowest rating assigned is used. For those securities where ratings by the major credit rating agencies are not available, which does not represent a significant amount of our total fixed maturity AFS securities, we base the ratings disclosed upon internal ratings. The average credit quality was A- as of March 31, 2022.
Comparisons between the NAIC designations and rating agency designations are published by the NAIC. The NAIC assigns securities quality designations and uniform valuations, which are used by insurers when preparing their annual statements. The NAIC designations are similar to the rating agency designations of the Nationally Recognized Statistical Rating Organizations for marketable bonds. NAIC designations 1 and 2 include bonds generally considered investment grade (rated Baa3 or higher by Moody’s, or rated BBB- or higher by S&P and Fitch) by such ratings organizations. However, securities designated NAIC 1 and 2 could be deemed below investment grade by the rating agencies as a result of the current RBC rules for residential mortgage-backed securities (“RMBS”) and CMBS for statutory reporting. NAIC designations 3 through 6 include bonds generally considered below investment grade (rated Ba1 or lower by Moody’s, or rated BB+ or lower by S&P and Fitch).
As of March 31, 2022, and December 31, 2021, 96% and 94%, respectively, of the total fixed maturity AFS securities in an unrealized loss position were investment grade. Our gross unrealized losses recognized in OCI on fixed maturity AFS securities as of March 31, 2022, increased by $2.5 billion since December 31, 2021. For further information on our unrealized losses on fixed maturity AFS securities, see “Composition by Industry Categories of our Unrealized Losses on Fixed Maturity AFS Securities” below.
We regularly review our fixed maturity AFS securities for declines in fair value that we determine to be impairment-related, including those attributable to credit risk factors that may require a credit allowance. We believe the unrealized loss position as of March 31, 2022, did not require an impairment recognized in earnings as (i) we did not intend to sell these fixed maturity AFS securities; (ii) it is not more likely than not that we will be required to sell the fixed maturity AFS securities before recovery of their amortized cost basis; and (iii) the difference in the fair value compared to the amortized cost was due to factors other than credit loss. This conclusion is consistent with our asset-liability management process. Management considered the following as part of the evaluation:
The current economic environment and market conditions;
Our business strategy and current business plans;
The nature and type of security, including expected maturities and exposure to general credit, liquidity, market and interest rate risk;
Our analysis of data from financial models and other internal and industry sources to evaluate the current effectiveness of our hedging and overall risk management strategies;
The current and expected timing of contractual maturities of our assets and liabilities, expectations of prepayments on investments and expectations for surrenders and withdrawals of life insurance policies and annuity contracts;
The capital risk limits approved by management; and
Our current financial condition and liquidity demands.
We recognized $(1) million of credit loss benefit (expense) on our fixed maturity AFS securities for the three months ended March 31, 2022. In order to determine the amount of credit loss, we calculated the recovery value by performing a discounted cash flow analysis based on the current cash flows and future cash flows we expect to recover. To determine the recoverability, we considered the facts and circumstances surrounding the underlying issuer including, but not limited to, the following:
Historical and implied volatility of the security;
The extent to which the fair value has been less than amortized cost;
Adverse conditions specifically related to the security or to specific conditions in an industry or geographic area;
Failure, if any, of the issuer of the security to make scheduled payments; and
Recoveries or additional declines in fair value subsequent to the balance sheet date.
For information on credit loss impairment on fixed maturity AFS securities, see Notes 4 and 12 herein and Note 1 to the consolidated financial statements in our 2021 Form 10-K.
As reported on our Consolidated Balance Sheets, we had $146.6 billion of investments and cash and invested cash, which exceeded the liabilities for our future obligations under insurance policies and contracts, net of amounts recoverable from reinsurers, which totaled $132.6 billion as of March 31, 2022. If it were necessary to liquidate fixed maturity AFS securities prior to maturity or call to meet cash flow needs, we would first look to those fixed maturity AFS securities that are in an unrealized gain position, which had a fair value of $65.4 billion as of March 31, 2022, rather than selling fixed maturity AFS securities in an unrealized loss position. The amount of cash that we have on hand at any point in time takes into account our liquidity needs in the future, other sources of cash, such as the maturities of investments, interest and dividends we earn on our investments and the ongoing cash flows from new and existing business.
As of March 31, 2022, and December 31, 2021, the estimated fair value for all private placement securities was $20.1 billion and $20.7 billion, respectively, representing 14% and 13% of total investments, respectively.
Mortgage-Backed Securities (Included in Fixed Maturity AFS and Trading Securities)
See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Consolidated Investments – Mortgage-Backed Securities” in our 2021 Form 10-K for a discussion of our mortgage-backed securities.
The market value of fixed maturity AFS and trading securities backed by subprime loans was $234 million and represented less than 1% of our total investment portfolio as of March 31, 2022. Fixed maturity AFS securities represented $223 million, or 96%, and trading securities represented $11 million, or 4%, of the subprime exposure as of March 31, 2022. The table below summarizes our investments in fixed maturity AFS securities backed by pools of residential mortgages (in millions) as of March 31, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Subprime/ |
|
|
|
|
|
|
| ||||
| Agency |
| Prime |
| Alt-A |
| Option ARM (1) |
| Total |
| ||||||||||||||||||||
| Net |
|
|
|
| Net |
|
|
|
| Net |
|
|
|
| Net |
|
|
|
| Net |
|
|
|
| |||||
| Amortized | Fair | Amortized | Fair | Amortized | Fair | Amortized | Fair | Amortized | Fair | ||||||||||||||||||||
| Cost |
| Value |
| Cost |
| Value |
| Cost |
| Value |
| Cost |
| Value |
| Cost |
| Value |
| ||||||||||
Type |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
RMBS | $ | 1,920 |
| $ | 1,931 |
| $ | 160 |
| $ | 168 |
| $ | 77 |
| $ | 89 |
| $ | 131 |
| $ | 150 |
| $ | 2,288 |
| $ | 2,338 |
|
ABS home equity |
| 1 |
|
| 1 |
|
| 21 |
|
| 22 |
|
| 22 |
|
| 34 |
|
| 180 |
|
| 208 |
|
| 224 |
|
| 265 |
|
Total by type (2)(3) | $ | 1,921 |
| $ | 1,932 |
| $ | 181 |
| $ | 190 |
| $ | 99 |
| $ | 123 |
| $ | 311 |
| $ | 358 |
| $ | 2,512 |
| $ | 2,603 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rating |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AAA | $ | 1,555 |
| $ | 1,566 |
| $ | 62 |
| $ | 62 |
| $ | - |
| $ | - |
| $ | - |
| $ | - |
| $ | 1,617 |
| $ | 1,628 |
|
AA |
| 360 |
|
| 359 |
|
| 9 |
|
| 9 |
|
| 5 |
|
| 5 |
|
| 10 |
|
| 11 |
|
| 384 |
|
| 384 |
|
A |
| 6 |
|
| 7 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 2 |
|
| 12 |
|
| 12 |
|
| 22 |
|
| 23 |
|
BBB |
| - |
|
| - |
|
| 24 |
|
| 23 |
|
| 7 |
|
| 7 |
|
| 10 |
|
| 10 |
|
| 41 |
|
| 40 |
|
BB and below |
| - |
|
| - |
|
| 84 |
|
| 94 |
|
| 85 |
|
| 109 |
|
| 279 |
|
| 325 |
|
| 448 |
|
| 528 |
|
Total by rating (2)(3)(4) | $ | 1,921 |
| $ | 1,932 |
| $ | 181 |
| $ | 190 |
| $ | 99 |
| $ | 123 |
| $ | 311 |
| $ | 358 |
| $ | 2,512 |
| $ | 2,603 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012 and prior | $ | 398 |
| $ | 422 |
| $ | 99 |
| $ | 110 |
| $ | 99 |
| $ | 123 |
| $ | 311 |
| $ | 358 |
| $ | 907 |
| $ | 1,013 |
|
2013 |
| 115 |
|
| 117 |
|
| - |
|
| - |
|
| - |
|
| - |
|
| - |
|
| - |
|
| 115 |
|
| 117 |
|
2014 |
| 48 |
|
| 50 |
|
| 1 |
|
| 1 |
|
| - |
|
| - |
|
| - |
|
| - |
|
| 49 |
|
| 51 |
|
2015 |
| 145 |
|
| 145 |
|
| 15 |
|
| 15 |
|
| - |
|
| - |
|
| - |
|
| - |
|
| 160 |
|
| 160 |
|
2016 |
| 466 |
|
| 452 |
|
| - |
|
| - |
|
| - |
|
| - |
|
| - |
|
| - |
|
| 466 |
|
| 452 |
|
2017 |
| 230 |
|
| 233 |
|
| - |
|
| - |
|
| - |
|
| - |
|
| - |
|
| - |
|
| 230 |
|
| 233 |
|
2018 |
| 190 |
|
| 199 |
|
| - |
|
| - |
|
| - |
|
| - |
|
| - |
|
| - |
|
| 190 |
|
| 199 |
|
2019 |
| 159 |
|
| 157 |
|
| - |
|
| - |
|
| - |
|
| - |
|
| - |
|
| - |
|
| 159 |
|
| 157 |
|
2020 |
| 70 |
|
| 65 |
|
| 1 |
|
| 1 |
|
| - |
|
| - |
|
| - |
|
| - |
|
| 71 |
|
| 66 |
|
2021 |
| 95 |
|
| 87 |
|
| 34 |
|
| 32 |
|
| - |
|
| - |
|
| - |
|
| - |
|
| 129 |
|
| 119 |
|
2022 |
| 5 |
|
| 5 |
|
| 31 |
|
| 31 |
|
| - |
|
| - |
|
| - |
|
| - |
|
| 36 |
|
| 36 |
|
Total by origination |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
year (2)(3) | $ | 1,921 |
| $ | 1,932 |
| $ | 181 |
| $ | 190 |
| $ | 99 |
| $ | 123 |
| $ | 311 |
| $ | 358 |
| $ | 2,512 |
| $ | 2,603 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity AFS securities backed by pools of |
|
|
|
|
|
|
| |||||||||||||||||||||||
residential mortgages as a percentage of total fixed maturity AFS securities |
|
| 2.3% |
|
| 2.4% |
| |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total prime, Alt-A and subprime/option ARM as a percentage of total fixed maturity AFS securities |
|
| 0.5% |
|
| 0.6% |
|
(1)Includes the net amortized cost and fair value of option adjustable rate mortgages (“ARM”) within RMBS, totaling $117 million and $135 million, respectively.
(2)Does not include the amortized cost of trading securities totaling $131 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $131 million in trading securities consisted of $119 million prime, $1 million Alt-A and $11 million subprime.
(3)Does not include the fair value of trading securities totaling $126 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $126 million in trading securities consisted of $114 million prime, $1 million Alt-A and $11 million subprime.
(4)Based upon the rating designations determined and provided by the major credit rating agencies (Fitch, Moody’s and S&P). For securities where the ratings assigned by the major credit rating agencies are not equivalent, the second lowest rating assigned is used. For those securities where ratings by the major credit rating agencies are not available, which does not represent a significant amount of our total fixed maturity AFS securities, we base the ratings disclosed upon internal ratings.
None of these investments included any direct investments in subprime lenders or mortgages. We are not aware of material exposure to subprime loans in our alternative investment portfolio.
The following summarizes our investments in fixed maturity AFS securities backed by pools of commercial mortgages (in millions) as of March 31, 2022:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Multiple Property |
| Single Property |
| Total |
| ||||||||||||
| Net |
|
|
|
| Net |
|
|
|
| Net |
|
|
|
| |||
| Amortized |
| Fair |
| Amortized |
| Fair |
| Amortized |
| Fair |
| ||||||
| Cost |
| Value |
| Cost |
| Value |
| Cost |
| Value |
| ||||||
Type |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
CMBS (1)(2) | $ | 1,584 |
| $ | 1,523 |
| $ | 72 |
| $ | 69 |
| $ | 1,656 |
| $ | 1,592 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rating |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
AAA | $ | 1,254 |
| $ | 1,217 |
| $ | 11 |
| $ | 10 |
| $ | 1,265 |
| $ | 1,227 |
|
AA |
| 330 |
|
| 306 |
|
| 57 |
|
| 54 |
|
| 387 |
|
| 360 |
|
A |
| - |
|
| - |
|
| 4 |
|
| 5 |
|
| 4 |
|
| 5 |
|
Total by rating (1)(2)(3) | $ | 1,584 |
| $ | 1,523 |
| $ | 72 |
| $ | 69 |
| $ | 1,656 |
| $ | 1,592 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Origination Year |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2012 and prior | $ | 20 |
| $ | 21 |
| $ | 11 |
| $ | 13 |
| $ | 31 |
| $ | 34 |
|
2013 |
| 94 |
|
| 94 |
|
| - |
|
| - |
|
| 94 |
|
| 94 |
|
2014 |
| 15 |
|
| 15 |
|
| - |
|
| - |
|
| 15 |
|
| 15 |
|
2015 |
| 24 |
|
| 24 |
|
| - |
|
| - |
|
| 24 |
|
| 24 |
|
2016 |
| 112 |
|
| 108 |
|
| 4 |
|
| 4 |
|
| 116 |
|
| 112 |
|
2017 |
| 322 |
|
| 319 |
|
| - |
|
| - |
|
| 322 |
|
| 319 |
|
2018 |
| 174 |
|
| 177 |
|
| - |
|
| - |
|
| 174 |
|
| 177 |
|
2019 |
| 301 |
|
| 290 |
|
| - |
|
| - |
|
| 301 |
|
| 290 |
|
2020 |
| 236 |
|
| 210 |
|
| 5 |
|
| 5 |
|
| 241 |
|
| 215 |
|
2021 |
| 220 |
|
| 200 |
|
| 43 |
|
| 39 |
|
| 263 |
|
| 239 |
|
2022 |
| 66 |
|
| 65 |
|
| 9 |
|
| 8 |
|
| 75 |
|
| 73 |
|
Total by origination year (1)(2) | $ | 1,584 |
| $ | 1,523 |
| $ | 72 |
| $ | 69 |
| $ | 1,656 |
| $ | 1,592 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total fixed maturity AFS securities backed by pools of |
|
|
|
|
|
| ||||||||||||
commercial mortgages as a percentage of total fixed maturity AFS securities |
| 1.5% |
|
| 1.4% |
|
(1)Does not include the amortized cost of trading securities totaling $213 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $213 million in trading securities consisted of $132 million of multiple property CMBS and $81 million of single property CMBS.
(2)Does not include the fair value of trading securities totaling $204 million that primarily support our reinsurance funds withheld and modified coinsurance agreements because investment results for these agreements are passed directly to the reinsurers. The $204 million in trading securities consisted of $126 million of multiple property CMBS and $78 million of single property CMBS.
(3)Based upon the rating designations determined and provided by the major credit rating agencies (Fitch, Moody’s and S&P). For securities where the ratings assigned by the major credit rating agencies are not equivalent, the second lowest rating assigned is used. For those securities where ratings by the major credit rating agencies are not available, which does not represent a significant amount of our total fixed maturity AFS securities, we base the ratings disclosed upon internal ratings.
As of March 31, 2022, the net amortized cost and fair value of our fixed maturity AFS exposure to monoline insurers was $324 million and $360 million, respectively.
Composition by Industry Categories of our Unrealized Losses on Fixed Maturity AFS Securities
When considering unrealized gain and loss information, it is important to recognize that the information relates to the position of securities at a particular point in time and may not be indicative of the position of our investment portfolios subsequent to the balance sheet date. Further, because the timing of the recognition of realized investment gains and losses through the selection of which securities are sold is largely at management’s discretion, it is important to consider the information provided below within the context of the overall unrealized gain or loss position of our investment portfolios. These are important considerations that should be included in any evaluation of the potential effect of securities in an unrealized loss position on our future earnings.
The composition by industry categories of all fixed maturity AFS securities in an unrealized loss position (in millions) as of March 31, 2022, was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| % |
|
|
| % |
|
|
|
|
| |||
| Net |
| Net |
| Gross |
| Gross |
|
|
| % |
| |||
| Amortized |
| Amortized |
| Unrealized |
| Unrealized |
| Fair |
| Fair |
| |||
| Cost |
| Cost |
| Losses |
| Losses |
| Value |
| Value |
| |||
Healthcare | $ | 3,568 |
| 7.4% |
| $ | 369 |
| 12.3% |
| $ | 3,199 |
| 7.1% |
|
Banking |
| 3,323 |
| 6.9% |
|
| 217 |
| 7.2% |
|
| 3,106 |
| 6.9% |
|
Technology |
| 2,459 |
| 5.1% |
|
| 194 |
| 6.5% |
|
| 2,265 |
| 5.0% |
|
ABS |
| 7,361 |
| 15.3% |
|
| 183 |
| 6.1% |
|
| 7,178 |
| 15.9% |
|
Electric |
| 2,897 |
| 6.0% |
|
| 180 |
| 6.0% |
|
| 2,717 |
| 6.0% |
|
Local authorities |
| 1,539 |
| 3.2% |
|
| 155 |
| 5.2% |
|
| 1,384 |
| 3.1% |
|
Food and beverage |
| 1,976 |
| 4.1% |
|
| 137 |
| 4.6% |
|
| 1,839 |
| 4.1% |
|
Industrial – other |
| 1,480 |
| 3.1% |
|
| 104 |
| 3.5% |
|
| 1,376 |
| 3.0% |
|
Brokerage asset management |
| 1,068 |
| 2.2% |
|
| 102 |
| 3.4% |
|
| 966 |
| 2.1% |
|
Diversified manufacturing |
| 1,398 |
| 2.9% |
|
| 85 |
| 2.8% |
|
| 1,313 |
| 2.9% |
|
Non-agency CMBS |
| 1,293 |
| 2.7% |
|
| 73 |
| 2.4% |
|
| 1,220 |
| 2.7% |
|
Life |
| 709 |
| 1.5% |
|
| 65 |
| 2.2% |
|
| 644 |
| 1.4% |
|
Pharmaceuticals |
| 935 |
| 1.9% |
|
| 59 |
| 2.0% |
|
| 876 |
| 1.9% |
|
Automotive |
| 949 |
| 2.0% |
|
| 59 |
| 2.0% |
|
| 890 |
| 2.0% |
|
Retail |
| 828 |
| 1.7% |
|
| 57 |
| 1.9% |
|
| 771 |
| 1.7% |
|
Aerospace and defense |
| 707 |
| 1.5% |
|
| 57 |
| 1.9% |
|
| 650 |
| 1.4% |
|
Property and casualty |
| 649 |
| 1.3% |
|
| 51 |
| 1.7% |
|
| 598 |
| 1.3% |
|
Natural gas |
| 638 |
| 1.3% |
|
| 48 |
| 1.6% |
|
| 590 |
| 1.3% |
|
Transportation services |
| 1,102 |
| 2.3% |
|
| 48 |
| 1.6% |
|
| 1,054 |
| 2.3% |
|
Chemicals |
| 853 |
| 1.8% |
|
| 42 |
| 1.4% |
|
| 811 |
| 1.8% |
|
Wireless |
| 434 |
| 0.9% |
|
| 39 |
| 1.3% |
|
| 395 |
| 0.9% |
|
Leisure |
| 567 |
| 1.2% |
|
| 35 |
| 1.2% |
|
| 532 |
| 1.2% |
|
Utility – other |
| 458 |
| 0.9% |
|
| 34 |
| 1.1% |
|
| 424 |
| 0.9% |
|
Midstream |
| 809 |
| 1.7% |
|
| 34 |
| 1.1% |
|
| 775 |
| 1.7% |
|
Metals and mining |
| 393 |
| 0.8% |
|
| 34 |
| 1.1% |
|
| 359 |
| 0.8% |
|
Integrated |
| 390 |
| 0.8% |
|
| 32 |
| 1.1% |
|
| 358 |
| 0.8% |
|
Industries with unrealized losses |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
less than $30 million |
| 9,474 |
| 19.5% |
|
| 505 |
| 16.8% |
|
| 8,969 |
| 19.8% |
|
Total by industry | $ | 48,257 |
| 100.0% |
| $ | 2,998 |
| 100.0% |
| $ | 45,259 |
| 100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total by industry as a percentage of |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
total fixed maturity AFS securities |
| 44.8% |
|
|
|
| 100.0% |
|
|
|
| 40.9% |
|
|
|
As of March 31, 2022, the net amortized cost and fair value of securities subject to enhanced analysis and monitoring for potential changes in unrealized loss position was $126 million and $118 million, respectively.
Mortgage Loans on Real Estate
The following tables summarize key information on mortgage loans on real estate (in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| |||||||||
| Commercial |
| Residential |
| Total |
| % |
| |||
Credit Quality Indicator |
|
|
|
|
|
|
|
|
|
|
|
Current | $ | 16,848 |
| $ | 1,079 |
| $ | 17,927 |
| 99.8% |
|
Delinquent (1) |
| 16 |
|
| 9 |
|
| 25 |
| 0.1% |
|
Foreclosure (2) |
| - |
|
| 17 |
|
| 17 |
| 0.1% |
|
Total mortgage loans on real estate before allowance |
| 16,864 |
|
| 1,105 |
|
| 17,969 |
| 100.0% |
|
Allowance for credit losses |
| (59 | ) |
| (18 | ) |
| (77 | ) |
|
|
Total mortgage loans on real estate | $ | 16,805 |
| $ | 1,087 |
| $ | 17,892 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of December 31, 2021 |
| |||||||||
| Commercial |
| Residential |
| Total |
| % |
| |||
Credit Quality Indicator |
|
|
|
|
|
|
|
|
|
|
|
Current | $ | 17,168 |
| $ | 889 |
| $ | 18,057 |
| 99.8% |
|
Delinquent (1) |
| - |
|
| 14 |
|
| 14 |
| 0.1% |
|
Foreclosure (2) |
| - |
|
| 16 |
|
| 16 |
| 0.1% |
|
Total mortgage loans on real estate before allowance |
| 17,168 |
|
| 919 |
|
| 18,087 |
| 100.0% |
|
Allowance for credit losses |
| (79 | ) |
| (17 | ) |
| (96 | ) |
|
|
Total mortgage loans on real estate | $ | 17,089 |
| $ | 902 |
| $ | 17,991 |
|
|
|
(1)As of March 31, 2022, 3 commercial mortgage loans and 25 residential mortgage loans were delinquent. As of December 31, 2021, 2 commercial mortgage loans and 31 residential mortgage loans were delinquent.
(2)As of March 31, 2022, no commercial mortgage loans and 38 residential loans were in foreclosure. As of December 31, 2021, no commercial mortgage loans and 34 residential mortgage loans were in foreclosure.
As of March 31, 2022, there were 4 specifically identified impaired commercial mortgage loans on real estate with an aggregate carrying value of $1 million and 46 specifically identified impaired residential mortgage loans on real estate with an aggregate carrying value of $18 million. As of December 31, 2021, there were 4 specifically identified impaired commercial mortgage loans on real estate with an aggregate carrying value of $1 million and 50 specifically identified impaired residential mortgage loans on real estate with an aggregate carrying value of $22 million.
The total outstanding principal and interest on commercial mortgage loans on real estate that were two or more payments delinquent as of March 31, 2022, and December 31, 2021, was $16 million and less than $1 million, respectively. The total outstanding principal and interest on the residential mortgage loans on real estate that were three or more payments delinquent as of March 31, 2022, and December 31, 2021, was $9 million and $14 million, respectively.
The carrying value of mortgage loans on real estate by business segment (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of |
|
| As of |
|
| ||
| March 31, | December 31, |
| ||||||
|
| 2022 |
|
| 2021 |
|
| ||
Segment |
|
|
|
|
|
|
|
|
|
Annuities |
| $ | 6,542 |
|
| $ | 6,732 |
|
|
Retirement Plan Services |
|
| 4,284 |
|
|
| 4,326 |
|
|
Life Insurance |
|
| 3,835 |
|
|
| 3,890 |
|
|
Group Protection |
|
| 1,422 |
|
|
| 1,435 |
|
|
Other Operations |
|
| 1,809 |
|
|
| 1,608 |
|
|
Total mortgage loans on real estate |
| $ | 17,892 |
|
| $ | 17,991 |
|
|
The composition of commercial mortgage loans (in millions) by property type, geographic region and state is shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
|
| As of March 31, 2022 |
| ||||||
| Carrying |
|
|
|
| Carrying |
|
|
| ||
| Value |
| % |
|
| Value |
| % |
| ||
Property Type |
|
|
|
|
| State |
|
|
|
|
|
Apartment | $ | 5,604 |
| 33.3% |
| CA | $ | 4,385 |
| 26.1% |
|
Industrial |
| 3,807 |
| 22.7% |
| TX |
| 1,539 |
| 9.2% |
|
Office building |
| 3,726 |
| 22.2% |
| NY |
| 1,074 |
| 6.4% |
|
Retail |
| 2,529 |
| 15.0% |
| FL |
| 811 |
| 4.8% |
|
Other commercial |
| 709 |
| 4.2% |
| MD |
| 710 |
| 4.2% |
|
Hotel/motel |
| 245 |
| 1.5% |
| PA |
| 695 |
| 4.1% |
|
Mixed use |
| 185 |
| 1.1% |
| GA |
| 673 |
| 4.0% |
|
Total | $ | 16,805 |
| 100.0% |
| WA |
| 656 |
| 3.9% |
|
Geographic Region |
|
|
|
|
| TN |
| 572 |
| 3.4% |
|
Pacific |
| 5,368 |
| 31.9% |
| AZ |
| 535 |
| 3.2% |
|
South Atlantic |
| 3,591 |
| 21.4% |
| OH |
| 467 |
| 2.8% |
|
Middle Atlantic |
| 2,073 |
| 12.3% |
| VA |
| 449 |
| 2.7% |
|
West South Central |
| 1,679 |
| 10.0% |
| NC |
| 440 |
| 2.6% |
|
East North Central |
| 1,208 |
| 7.2% |
| WI |
| 338 |
| 2.1% |
|
Mountain |
| 1,203 |
| 7.2% |
| UT |
| 327 |
| 1.9% |
|
East South Central |
| 695 |
| 4.1% |
| OR |
| 326 |
| 2.0% |
|
West North Central |
| 480 |
| 2.9% |
| SC |
| 309 |
| 1.8% |
|
New England |
| 466 |
| 2.8% |
| Non U.S. |
| 42 |
| 0.2% |
|
Non U.S. |
| 42 |
| 0.2% |
| All other states |
| 2,457 |
| 14.6% |
|
Total | $ | 16,805 |
| 100.0% |
| Total | $ | 16,805 |
| 100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
The following table shows the principal amount (in millions) of our commercial and residential mortgage loans by year in which the principal is contractually obligated to be repaid:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| As of March 31, 2022 |
| |||||||||
| Commercial |
| Residential |
| Total |
| % |
| |||
Principal Repayment Year |
|
|
|
|
|
|
|
|
|
|
|
2022 | $ | 698 |
| $ | 11 |
| $ | 709 |
| 3.9% |
|
2023 |
| 785 |
|
| 14 |
|
| 799 |
| 4.5% |
|
2024 |
| 1,122 |
|
| 15 |
|
| 1,137 |
| 6.3% |
|
2025 |
| 1,132 |
|
| 16 |
|
| 1,148 |
| 6.4% |
|
2026 |
| 1,433 |
|
| 17 |
|
| 1,450 |
| 8.1% |
|
2027 and thereafter |
| 11,710 |
|
| 1,000 |
|
| 12,710 |
| 70.8% |
|
Total | $ | 16,880 |
| $ | 1,073 |
| $ | 17,953 |
| 100.0% |
|
|
|
|
|
|
|
|
|
|
|
|
|
See Note 4 for information regarding our loan-to-value and debt-service coverage ratios and our allowance for credit losses.
Alternative Investments
Investment income (loss) on alternative investments by business segment (in millions) was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Annuities | $ | 7 |
| $ | 17 |
|
|
Retirement Plan Services |
| 4 |
|
| 12 |
|
|
Life Insurance |
| 54 |
|
| 126 |
|
|
Group Protection |
| 4 |
|
| 11 |
|
|
Other Operations |
| 1 |
|
| 4 |
|
|
Total (1) | $ | 70 |
| $ | 170 |
|
|
(1)Includes net investment income on the alternative investments supporting the required statutory surplus of our insurance businesses.
As of March 31, 2022, and December 31, 2021, alternative investments included investments in 318 and 311 different partnerships, respectively, and the portfolio represented approximately 2% of total investments. The partnerships do not represent off-balance sheet financing and generally involve several third-party partners. Some of our partnerships contain capital calls, which require us to contribute capital upon notification by the general partner. These capital calls are contemplated during the initial investment decision and are planned for well in advance of the call date. The capital calls are not material in size and are not material to our liquidity. Alternative investments are accounted for using the equity method of accounting and are included in other investments on our Consolidated Balance Sheets.
Non-Income Producing Investments
As of March 31, 2022, and December 31, 2021, the carrying amount of fixed maturity securities, mortgage loans on real estate and real estate that were non-income producing was $12 million and $14 million, respectively.
Net Investment Income
Details underlying net investment income (in millions) and our investment yield were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Net Investment Income |
|
|
|
|
|
|
|
Fixed maturity AFS securities | $ | 1,057 |
| $ | 1,101 |
|
|
Trading securities |
| 42 |
|
| 42 |
|
|
Equity securities |
| 3 |
|
| - |
|
|
Mortgage loans on real estate |
| 169 |
|
| 169 |
|
|
Policy loans |
| 25 |
|
| 30 |
|
|
Commercial mortgage loan prepayment |
|
|
|
|
|
|
|
and bond make-whole premiums (1) |
| 52 |
|
| 27 |
|
|
Alternative investments (2) |
| 70 |
|
| 170 |
|
|
Consent fees |
| 1 |
|
| 2 |
|
|
Other investments |
| 29 |
|
| 5 |
|
|
Investment income |
| 1,448 |
|
| 1,546 |
|
|
Investment expense |
| (36 | ) |
| (36 | ) |
|
Net investment income | $ | 1,412 |
| $ | 1,510 |
|
|
(1)See “Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums” below for additional information.
(2)See “Alternative Investments” above for additional information.
|
|
|
|
|
|
|
|
|
|
| For the Three |
| ||
| Months Ended |
| ||
| March 31, |
| ||
| 2022 |
| 2021 |
|
Interest Rate Yield |
|
|
|
|
Fixed maturity AFS securities, mortgage loans on |
|
|
|
|
real estate and other, net of investment expenses | 3.80% |
| 3.96% |
|
Commercial mortgage loan prepayment and |
|
|
|
|
bond make-whole premiums | 0.15% |
| 0.08% |
|
Alternative investments | 0.21% |
| 0.51% |
|
Net investment income yield on invested assets | 4.16% |
| 4.55% |
|
|
|
|
|
|
We earn investment income on our general account assets supporting fixed annuity, term life, whole life, UL, interest-sensitive whole life and the fixed portion of retirement plan and VUL products. The profitability of our fixed annuity and life insurance products is affected by our ability to achieve target spreads, or margins, between the interest income earned on the general account assets and the interest credited to the contract holder on our average fixed account values, including the fixed portion of variable. Net investment income and the interest rate yield table each include commercial mortgage loan prepayments and bond make-whole premiums, alternative investments and contingent interest and standby real estate equity commitments. These items can vary significantly from period to period due to a number of factors and, therefore, can provide results that are not indicative of the underlying trends.
Commercial Mortgage Loan Prepayment and Bond Make-Whole Premiums
Prepayment and make-whole premiums are collected when borrowers elect to call or prepay their debt prior to the stated maturity. A prepayment or make-whole premium allows investors to attain the same yield as if the borrower made all scheduled interest payments until maturity. These premiums are designed to make investors indifferent to prepayment.
LIQUIDITY AND CAPITAL RESOURCES
Overview
Liquidity refers to our ability to generate adequate amounts of cash from our normal operations to meet cash requirements with a prudent margin of safety. Capital refers to our long-term financial resources to support the operations of our businesses, to fund long-term growth strategies and to support our operations during adverse conditions. Our ability to generate and maintain sufficient liquidity and capital depends on the profitability of our businesses, general economic conditions and access to the capital markets and other sources of liquidity and capital as described below.
When considering our liquidity, it is important to distinguish between the needs of our insurance subsidiaries and the needs of the holding company, LNC. As a holding company with no operations of its own, LNC is largely dependent upon the dividend capacity of its insurance subsidiaries as well as their ability to advance or repay funds to it through inter-company borrowing arrangements, which may be affected by factors influencing the insurance subsidiaries’ RBC and statutory earnings performance. Disruptions, uncertainty or volatility in the capital and credit markets, including any current or future impacts related to the COVID-19 pandemic, may materially affect our business operations and results of operations. These poor market conditions may reduce our insurance subsidiaries’ statutory surplus and RBC requiring them to retain more capital and may pressure their ability to pay dividends to LNC, which may lead us to take steps to preserve or raise additional capital. We monitor and adjust our liquidity and capital plans in light of market conditions, as well as changing needs and opportunities. Based on the sources of liquidity available to us as discussed below, we currently expect to be able to meet the holding company’s ongoing cash needs and to have sufficient capital to offer downside protection. For factors that could cause actual results to differ materially from those set forth in this section and that could affect our expectations for liquidity and capital, see “Part I – Item 1A. Risk Factors” in our 2021 Form 10-K and “Forward-Looking Statements – Cautionary Language” above. For a discussion of the COVID-19 pandemic, see “Introduction – Executive Summary” above.
Consolidated Sources and Uses of Liquidity and Capital
Our primary sources of liquidity and capital are insurance premiums and fees, investment income, maturities and sales of investments, issuance of debt and contract holder deposits. We also have access to alternative sources of liquidity as discussed below. Our primary uses are to pay policy claims and benefits, to fund commissions and other general operating expenses, to purchase investments, to fund policy surrenders and withdrawals, to pay dividends to our stockholders, to repurchase our stock and to repay debt. Our operating activities provided (used) cash of $753 million and $(642) million for the three months ended March 31, 2022 and 2021, respectively.
Holding Company Sources and Uses of Liquidity and Capital
The primary sources of liquidity and capital at the holding company level are dividends and interest payments from subsidiaries, augmented by holding company short-term investments, bank lines of credit and the ongoing availability of long-term public financing under an effective shelf registration statement, which allows us to issue, in unlimited amounts, securities, including debt securities, preferred stock, common stock, warrants, stock purchase contracts, stock purchase units and depository shares. These sources support the general corporate needs of the holding company, including its common stock dividends, common stock repurchases, interest and debt service, funding of callable securities, acquisitions and investment in core businesses.
Details underlying the primary sources of the holding company’s liquidity (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Dividends from Subsidiaries |
|
|
|
|
|
|
|
LNL | $ | 25 |
| $ | 180 |
|
|
Lincoln Investment Management Company |
| 16 |
|
| - |
|
|
Lincoln National Reinsurance Company (Barbados) Limited |
| 85 |
|
| 75 |
|
|
Total dividends from subsidiaries | $ | 126 |
| $ | 255 |
|
|
|
|
|
|
|
|
|
|
Interest from Subsidiaries |
|
|
|
|
|
|
|
Interest on inter-company notes | $ | 29 |
| $ | 29 |
|
|
The table above focuses on significant and recurring cash flow items and excludes the effects of certain financing activities, including the periodic issuance and retirement of debt, cash flows related to our inter-company cash management program and certain investing activities, including capital contributions to subsidiaries. These activities are discussed below. Taxes have been eliminated from the analysis due to a tax sharing agreement among our primary subsidiaries resulting in a modest effect on net cash flows at the holding company. Also excluded from this analysis is the modest amount of investment income on short-term investments of the holding company and employee stock exercise activity related to our stock-based incentive compensation plans. See “Part IV – Item 15(a)(2)
Financial Statement Schedules – Schedule II – Condensed Financial Information of Registrant” in our 2021 Form 10-K for the holding company cash flow statement. For information regarding limits on the dividends that our insurance subsidiaries may pay without prior approval, see “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Holding Company Sources and Uses of Liquidity and Capital – Restrictions on Subsidiaries’ Dividends” in our 2021 Form 10-K.
Insurance Subsidiaries’ Statutory Capital and Surplus
Our regulatory capital levels are also affected by statutory accounting rules, which are subject to change by each applicable insurance regulator. Our term products and UL products containing secondary guarantees require reserves calculated pursuant to XXX and AG38, respectively. Our insurance subsidiaries employ strategies to reduce the strain caused by XXX and AG38 by reinsuring the business to reinsurance captives. Our captive reinsurance and reinsurance subsidiaries provide a mechanism for financing a portion of the excess reserve amounts in a more efficient manner and free up capital the insurance subsidiaries can use for any number of purposes, including paying dividends to the holding company. We use long-dated LOCs and debt financing as well as other financing strategies to finance those reserves. Included in the LOCs issued as of March 31, 2022, was approximately $1.9 billion of long-dated LOCs issued to support inter-company reinsurance arrangements for UL products containing secondary guarantees. For information on the LOCs, see the credit facilities table in Note 12 in our 2021 Form 10-K. Our captive reinsurance and reinsurance subsidiaries have also issued long-term notes of $3.9 billion to finance a portion of the excess reserves as of March 31, 2022; of this amount, $3.1 billion involve exposure to variable interest entities. For information on these long-term notes issued by our captive reinsurance and reinsurance subsidiaries, see Note 3 in our 2021 Form 10-K. We have also used the proceeds from senior note issuances of $875 million to execute long-term structured solutions primarily supporting reinsurance of UL products containing secondary guarantees. LOCs and related capital market solutions lower the capital effect of term products and UL products containing secondary guarantees.
We continue to analyze the use of our existing captive reinsurance structures, as well as additional third-party reinsurance arrangements, and our current hedging strategies relative to managing the effects of equity markets and interest rates on the statutory reserves, statutory capital and the dividend capacity of our life insurance subsidiaries.
Debt
Although our subsidiaries currently generate adequate cash flow to meet the needs of our normal operations, periodically LNC may issue debt to maintain ratings and increase liquidity, as well as to fund internal growth, acquisitions and the retirement of its debt.
Details underlying our debt activities (in millions) for the three months ended March 31, 2022, were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Maturities, |
| Change |
|
|
|
|
|
|
|
| ||||
|
|
|
|
|
|
| Repayments |
| in Fair |
|
|
|
|
|
|
|
| ||||
| Beginning |
|
|
|
| and |
| Value |
|
| Other |
|
| Ending | |||||||
| Balance |
| Issuance |
| Refinancing |
| Hedges |
| Changes (1) |
| Balance | ||||||||||
Short-Term Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Current maturities of long-term debt | $ | 300 |
| $ | - |
|
| $ | (300 | ) |
| $ | - |
|
| $ | - |
|
| $ | - |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-Term Debt |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Senior notes | $ | 4,867 |
| $ | 300 |
|
| $ | - |
|
| $ | (58 | ) |
| $ | (6 | ) |
| $ | 5,103 |
Term loans |
| 250 |
|
| - |
|
|
| - |
|
|
| - |
|
|
| - |
|
|
| 250 |
Subordinated notes (2) |
| 995 |
|
| - |
|
|
| - |
|
|
| - |
|
|
| - |
|
|
| 995 |
Capital securities (2) |
| 213 |
|
| - |
|
|
| - |
|
|
| - |
|
|
| - |
|
|
| 213 |
Total long-term debt | $ | 6,325 |
| $ | 300 |
|
| $ | - |
|
| $ | (58 | ) |
| $ | (6 | ) |
| $ | 6,561 |
(1)Includes the non-cash reclassification of long-term debt to current maturities of long-term debt, accretion (amortization) of discounts and premiums, amortization of debt issuance costs and amortization of adjustments from discontinued hedges, as applicable.
(2)To hedge the variability in rates, we purchased interest rate swaps to lock in a fixed rate of approximately 5% over the remaining terms of the subordinated notes and capital securities.
On March 1, 2022, we completed the issuance and sale of $300 million aggregate principal amount of our 3.40% senior notes due 2032. We intend to use the net proceeds from the offering for general corporate purposes, which may include the repayment of debt on or prior to its maturity.
LNC made interest payments to service debt of $70 million and $69 million for the three months ended March 31, 2022 and 2021, respectively.
For additional information about our short-term and long-term debt, see Note 12 in our 2021 Form 10-K and Note 9 herein.
Capital Contributions to Subsidiaries
LNC made capital contributions to subsidiaries of zero and $65 million for the three months ended March 31, 2022 and 2021, respectively.
Return of Capital to Common Stockholders
One of our primary goals is to provide a return to our common stockholders through share price accretion, dividends and stock repurchases. In determining dividends, the Board of Directors takes into consideration items such as current and expected earnings, capital needs, rating agency considerations and requirements for financial flexibility. The amount and timing of share repurchases depends on key capital ratios, rating agency expectations, the generation of free cash flow and an evaluation of the costs and benefits associated with alternative uses of capital. Free cash flow for the holding company generally represents the amount of dividends and interest received from subsidiaries less interest paid on debt. For additional information regarding share repurchases, see “Part II – Item 2(c)” below.
Details underlying return of capital to common stockholders (in millions) were as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| For the Three |
|
| ||||
| Months Ended |
|
| ||||
| March 31, |
|
| ||||
| 2022 |
| 2021 |
|
| ||
Dividends to common stockholders | $ | 80 |
| $ | 81 |
|
|
Repurchase of common stock |
| 400 |
|
| 105 |
|
|
Total cash returned to common stockholders | $ | 480 |
| $ | 186 |
|
|
|
|
|
|
|
|
|
|
Number of shares repurchased |
| 5.8 |
|
| 1.9 |
|
|
Alternative Sources of Liquidity
Inter-Company Cash Management Program
In order to manage our capital more efficiently, we have an inter-company cash management program where certain subsidiaries can lend to or borrow from the holding company to meet short-term borrowing needs. The cash management program is essentially a series of demand loans between LNC and participating subsidiaries that reduces overall borrowing costs by allowing LNC and its subsidiaries to access internal resources instead of incurring third-party transaction costs. As of March 31, 2022, the holding company had a net outstanding receivable (payable) of $109 million from (to) certain subsidiaries resulting from loans made by subsidiaries in excess of amounts placed (borrowed) by the holding company and subsidiaries in the inter-company cash management account. Any change in holding company cash management program balances is offset by the immediate and equal change in holding company cash and invested cash. Loans under the cash management program are permitted under applicable insurance laws subject to certain restrictions. For our Indiana-domiciled insurance subsidiary, the borrowing and lending limit is currently 3% of the insurance company’s admitted assets as of its most recent year end. For our New York-domiciled insurance subsidiary, it may borrow from LNC less than 2% of its admitted assets as of its most recent year end but may not lend any amounts to LNC.
Facility Agreement for Senior Notes Issuance
LNC entered into a facility agreement in 2020 with a Delaware trust that gives LNC the right over a 10-year period to issue, from time to time, up to $500 million of 2.330% senior notes to the trust in exchange for a corresponding amount of U.S. Treasury securities held by the trust. By agreeing to purchase the 2.330% senior notes in exchange for U.S. Treasury securities upon exercise of the issuance right, the trust will provide a source of liquid assets for the Company. The issuance right will be exercised automatically in full upon our failure to make certain payments to the trust, if the failure to pay is not cured within 30 days, or upon certain bankruptcy events involving LNC. We are also required to exercise the issuance right in full if our consolidated stockholders’ equity (excluding AOCI) falls below $2.75 billion, subject to adjustment from time to time in certain cases, and upon certain other events described in the facility agreement. For additional information, see Note 12 in our 2021 Form 10-K.
Federal Home Loan Bank
Our primary insurance subsidiary, LNL, is a member of the Federal Home Loan Bank (“FHLB”) of Indianapolis (“FHLBI”). Membership allows LNL access to the FHLBI’s financial services, including the ability to obtain loans and to issue funding agreements as an alternative source of liquidity that are collateralized by qualifying mortgage-related assets, agency securities or U.S. Treasury securities. Borrowings under this facility are subject to the FHLBI’s discretion and require the availability of qualifying assets at LNL. As of March 31, 2022, LNL had an estimated maximum borrowing capacity of $7.0 billion under the FHLBI facility and maximum available borrowing based on qualifying assets of $3.9 billion. As of March 31, 2022, LNL had outstanding borrowings of $3.9 billion under this facility reported within payables for collateral on investments on the Consolidated Balance Sheets. Lincoln Life & Annuity Company of New York (“LLANY”) is a member of the Federal Home Loan Bank of New York (“FHLBNY”) with an estimated maximum borrowing capacity of $750 million. Borrowings under this facility are subject to the FHLBNY’s discretion and require the availability of qualifying assets at LLANY. As of March 31, 2022, LLANY had no outstanding borrowings under this facility. For additional information, see “Payables for Collateral on Investments” in Note 4.
Securities Lending Programs and Repurchase Agreements
Our insurance subsidiaries, by virtue of their general account fixed-income investment holdings, can access liquidity through securities lending programs and repurchase agreements. As of March 31, 2022, our insurance subsidiaries had securities pledged under securities lending agreements with a carrying value of $258 million. In addition, our insurance and reinsurance subsidiaries had access to $1.75 billion through committed repurchase agreements, of which $25 million was utilized as of March 31, 2022. The cash received in our securities lending programs and repurchase agreements is typically invested in cash and invested cash or fixed maturity AFS securities. For additional information, see “Payables for Collateral on Investments” in Note 4.
Collateral on Derivative Contracts
Our cash flows associated with collateral received from counterparties (when we are in a net collateral payable position) and posted with counterparties (when we are in a net collateral receivable position) change as the market value of the underlying derivative contract changes. The net collateral position depends on changes in interest rates and equity markets related to the amount of the exposures hedged. As of March 31, 2022, we were in a net collateral payable position of $4.3 billion compared to $4.9 billion as of December 31, 2021. In the event of adverse changes in fair value of our derivative instruments, we may need to post collateral with a counterparty. If we do not have sufficient high quality securities or cash and invested cash to provide as collateral, we have committed liquidity sources through facilities that can provide up to $1.25 billion of additional liquidity to help meet collateral needs. Access to such facilities is contingent upon interest rates having achieved certain threshold levels. In addition to these facilities, we have the facility agreement for senior notes issuance, the FHLB facilities and the repurchase agreements discussed above as well as the five-year revolving credit facility discussed in Note 12 in our 2021 Form 10-K to leverage that would be eligible for collateral posting. For additional information, see “Credit Risk” in Note 5.
Ratings
Financial Strength Ratings
See “Part I – Item 1. Business – Financial Strength Ratings” in our 2021 Form 10-K for information on our financial strength ratings.
Credit Ratings
See “Part II – Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Liquidity and Capital Resources – Ratings” in our 2021 Form 10-K for information on our credit ratings.
If our current financial strength ratings or credit ratings were downgraded in the future, terms in our derivative agreements may be triggered, which could negatively affect overall liquidity. For the majority of our derivative counterparties, there is a termination event with respect to LNC if its long-term senior debt ratings drop below BBB-/Baa3 (S&P/Moody’s); or with respect to LNL if its financial strength ratings drop below BBB-/Baa3 (S&P/Moody’s). Our long-term senior debt held a rating of A-/Baa1 (S&P/Moody’s) as of March 31, 2022. In addition, contractual selling agreements with intermediaries could be negatively affected, which could have an adverse effect on overall sales of annuities, life insurance and investment products. See “Part I – Item 1A. Risk Factors – Covenants and Ratings – A downgrade in our financial strength or credit ratings could limit our ability to market products, increase the number or value of policies being surrendered and/or hurt our relationships with creditors” in our 2021 Form 10-K for more information.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
We analyze and manage the risks arising from market exposures of financial instruments, as well as other risks, in an integrated asset-liability management process that considers diversification. We have exposures to several market risks including interest rate risk, equity market risk, credit risk and, to a lesser extent, foreign currency exchange risk. For information on these market risks, see “Part II – Item 7A. Quantitative and Qualitative Disclosures About Market Risk” in our 2021 Form 10-K. See also “Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Introduction – Executive Summary” above.
Item 4. Controls and Procedures
Conclusions Regarding Disclosure Controls and Procedures
We maintain disclosure controls and procedures, which are designed to ensure that information required to be disclosed in the reports we file or submit under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to the Company’s management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. As of the end of the period required by this report, we, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Exchange Act). Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in timely alerting them to material information relating to us and our consolidated subsidiaries required to be disclosed in our periodic reports under the Exchange Act.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the quarter ended March 31, 2022, that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.
A control system, no matter how well designed and operated, can provide only reasonable assurance that the control system’s objectives will be met. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
PART II – OTHER INFORMATION
Item 1. Legal Proceedings
Reference is made to Vida Longevity Fund, LP v. Lincoln Life & Annuity Company of New York, previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2021. On March 31, 2022, the court issued an order granting plaintiff’s motion for class certification and certified a class of all current or former owners of six universal life insurance products issued by LLANY that were assessed a cost of insurance charge any time on or after June 27, 2013.
See Note 10 in “Part I – Item 1. Financial Statements” for further discussion regarding this matter and other contingencies.
Item 1A. Risk Factors
In addition to the factors set forth in “Part I – Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations – Forward-Looking Statements – Cautionary Language,” you should carefully consider the risks described under “Part I – Item 1A. Risk Factors” in our Form 10-K for the year ended December 31, 2021. Such risks and uncertainties are not the only ones facing our Company. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also impair our business operations. If any of these risks actually occur, our business, financial condition and results of operations could be materially affected. In that case, the value of our securities could decline substantially.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(c) The following summarizes purchases of equity securities by the Company during the quarter ended March 31, 2022 (dollars in millions, except per share data):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (c) Total Number |
| (d) Approximate Dollar |
| |||
|
| (a) Total |
|
|
| of Shares |
| Value of Shares |
| ||||
|
| Number |
| (b) Average |
| Purchased as Part of |
| that May Yet Be |
| ||||
|
| of Shares |
| Price Paid |
| Publicly Announced |
| Purchased Under the |
| ||||
Period |
| Purchased (1) |
| per Share |
| Plans or Programs (2) |
| Plans or Programs (2) |
| ||||
1/1/22 – 1/31/22 |
|
| - |
| $ | - |
|
| - |
| $ | 1,264 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2/1/22 – 2/28/22 |
|
| 4,757,657 |
|
| 67.26 |
|
| 4,757,657 |
|
| 944 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
3/1/22 – 3/31/22 |
|
| 1,059,739 |
|
| 75.49 |
|
| 1,059,739 |
|
| 864 |
|
(1)Of the total number of shares purchased, no shares were received in connection with the exercise of stock options and related taxes. For the quarter ended March 31, 2022, there were 5,817,396 shares purchased as part of publicly announced plans or programs.
(2)On November 10, 2021, our Board of Directors authorized an increase in our securities repurchase authorization, bringing the total aggregate repurchase authorization to $1.5 billion. As of March 31, 2022, our remaining security repurchase authorization was $864 million. The security repurchase authorization does not have an expiration date. The amount and timing of share repurchases depends on key capital ratios, rating agency expectations, the generation of free cash flow and an evaluation of the costs and benefits associated with alternative uses of capital. Our stock repurchases may be effected from time to time through open market purchases or in privately negotiated transactions and may be made pursuant to an accelerated share repurchase agreement or Rule 10b5-1 plan.
Item 6. Exhibits
The Exhibits included in this report are listed in the Exhibit Index beginning on page 93, which is incorporated herein by reference.
LINCOLN NATIONAL CORPORATION
Exhibit Index for the Report on Form 10-Q
For the Quarter Ended March 31, 2022
|
|
|
|
Form of Nonqualified Stock Option Agreement for Successor CEO and CFO (effective February 2022).* | |
Form of Restricted Stock Unit Award Agreement for Successor CEO and CFO (effective February 2022).* | |
Form of Nonqualified Stock Option Agreement for CEO (effective February 2022).* | |
Form of Restricted Stock Unit Award Agreement for Section 16 Officers (effective February 2022).* | |
101.INS | XBRL Instance Document – the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. |
101.SCH | XBRL Taxonomy Extension Schema Document. |
101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document. |
101.LAB | XBRL Taxonomy Extension Label Linkbase Document. |
101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document. |
101.DEF | XBRL Taxonomy Extension Definition Linkbase Document. |
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
*This exhibit is a management contract or compensatory plan or arrangement.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
|
|
|
|
|
| LINCOLN NATIONAL CORPORATION |
|
|
|
| By: | /s/ Randal J. Freitag |
|
| Randal J. Freitag Executive Vice President and Chief Financial Officer |
|
|
|
| By: | /s/ Adam Cohen |
|
| Adam Cohen Senior Vice President and Chief Accounting Officer |
Dated: May 5, 2022 |
|
|